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“If a man will begin with certainties, he shall end in doubts; but if he 
will be content to begin with doubts he shall end in certainties.” 
 
Francis Bacon 
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Abstract 
 
The present work focused on the role of the cannabinoid receptor type 1 (CB1) in 
synaptic plasticity, memory and emotionality in mice. CB1 is abundantly expressed in 
the central nervous system and is mainly (if not exclusively) located on GABAergic 
and glutamatergic nerve cells. CB1 is a G-protein coupled receptor which is 
essentially inhibiting transmitter release from presynaptic GABAergic or glutamatergic 
nerve terminals.  
To differentiate between the physiological significance of CB1 expressed on 
glutamatergic and GABAergic nerve terminals, the studies included work with three 
different CB1-deficient mouse lines: A conventional knock-out mouse line (total-CB1-
ko mice) with a deficiency of CB1 in the entire brain and two conditional knock-out 
mouse lines using the Cre/lox P recombination system, and leading to cell type 
specific deficiency of CB1 on GABAergic neurons (GABA-CB1-ko mice) or 
glutamatergic neurons (Glu-CB1-ko mice).  
As a common model for alterations in synaptic plasticity and hippocampus-dependent 
memory, we studied long-term potentiation in the hippocampus at first. The 
hippocampus is an essential brain structure being involved in spatial and episodic-
like memory. We showed that there is an increase of hippocampal LTP in vivo at the 
perforant path-dentate gyrus granule cell synapse in total-CB1-ko mice, but failed to 
detect any difference in LTP levels for GABA-CB1-ko and Glu-CB1-ko mice. Also, 
short-term plasticity using a paired-pulse stimulation protocol is unchanged in the 
three mouse lines. Eventually, augmented theta rhythm that is believed to underlie 
enhanced cognitive abilities could not be found in total-CB1-ko mice. 
Our hypothesis of memory improvement in CB1-deficient mouse lines could not be 
verified in three tests for memory that are based on a spontaneous preference for 
novelty: The social recognition test, the object recognition test and the open field 
habituation test. We consequently tested the mice in two memory tasks that rely on 
an aversive test situation. In the water maze spatial discrimination task, again no 
differences could be assessed for acquisition of the task in total-CB1-ko and Glu-
CB1-ko mice. Curiously, Glu-CB1-ko mice demonstrate more flexible behaviour in 
reversal learning indicating that CB1 on glutamatergic neurons may lead to 
perseverant and persistent behaviour. Eventually, we could show for the first time 
that there is a differential contribution of CB1 on either GABAergic neurons or 
glutamatergic neurons in the background contextual fear conditioning task. Here, 
mice were tested in the shock context and in a different context containing the grid 
floor as a similar aspect to the shock context, called grid context. GABA-CB1-ko mice 
reveal increased fearful behaviour specifically in the grid context. This might indicate 
an increased context generalisation and/or a feature learning strategy in GABA-CB1-
ko mice. In contrast, Glu-CB1-ko mice display increased fearful behaviour specifically 
for the shock context, indicating a conjunctive learning strategy. Total-CB1-ko mice 
showed an increased fear response in both contexts, representing a mixed 
phenotype of Glu-CB1-ko and GABA-CB1-ko mice. Another novel finding confirming 
a large body of evidence is the fact that total-CB1-ko and Glu-CB1-ko mice manifest 
a deficit of extinction for the conditioned tone, providing first evidence that CB1 on 
glutamatergic neurons is essential for short-term extinction of auditory-cued fear 
memory.  
Any changes in memory performance might be obscured by altered emotionality in 
the knockout mouse lines. In classical tests for anxiety such as the elevated plus-
maze and the light/dark box, we found a tendency of increased anxiety in total-CB1-
ko and Glu-CB1-ko mice and a tendency of a decrease of anxiety in GABA-CB1-ko 
Abstract 
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mice at most. Strikingly, we were able to show that CB1-ko and Glu-CB1-ko mice, in 
contrast to GABA-CB1-ko, avoid the open arms of the elevated plus-maze more than 
wildtype mice on a second exposure to the maze indicating an increased one-trial 
sensitisation. Furthermore remarkably, CB1-ko and Glu-CB1-ko mice showed 
increased anxiety-related behaviour whereas GABA-CB1-ko mice revealed an 
unchanged or anxiolytic phenotype in three different tests of emotionality: The open 
field test, the novel object exploration test and the novel juvenile exploration test. 
These tests were carried out under low and high light conditions. Here, as opposed to 
the elevated plus-maze and the light/dark box, the animals cannot retract from an 
aversive situation that is bright light in the testing environment which may cause 
sufficient activation of the endocannabinoid system thus leading to a detectable and 
profound phenotype in the animals. Interestingly, altered emotionality seems to 
depend on the averseness of the test situation, as CB1-ko and Glu-CB1-ko animals 
do not or only mildly differ from their wildtype littermates under lowly aversive 
conditions but show increased anxiety under highly aversive conditions in the 
aforementioned tests. This strongly suggests that the endocannabinoid system might 
dampen states of anxiety in highly aversive and stressful environments. More 
precisely, CB1 on GABAergic neurons rather leads to an anxiogenic effect, whereas 
CB1 on glutamatergic neurons prominently leads to an anxiolytic phenotype which 
we refer to as “the Yin and the Yang effect” of CB1 in emotionality. 
Altogether, our study illustrates the value of conditional mouse mutants for which cell-
type specific ablation of a gene of interest exist in order to understand the role of CB1 
in synaptic plasticity, memory and emotionality. Our findings add another level of 
complexity to the picture of endocannabinoid action in fear and anxiety, which has to 
be considered if the endocannabinoid system is going to be exploited as a 
therapeutic target for the treatment of anxiety disorders.  
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1. Introduction 
 
1.1 May CB1 be with you! 
 
“Cytokine network, epilepsy, long-term potentiation, tolerance to morphine, metabolic 
syndrome, ischemia, neurogenesis, body weight, human breast cancer, seizures, 
fear extinction, neural cell development, plasticity in the CNS, emotional learning, 
neuropathic pain, obesity, contextual learning and memory, schizophrenia, addiction, 
excitotoxic damage, pain suppression, control of motor function, Parkinson's 
disease.”  
Typing in the term “CB1” into the literature search engine PubMed leads to a sheer 
endless list of keywords the cannabinoid receptor type 1 (CB1) is associated with. 
Especially, CB1 and its ligands, the cannabinoids, have been shown to have a 
plethora of effects on nerve cells, brain circuits and behaviour and the literature is still 
expanding.  
At least since the psychedelic 1960ies and the hippie era, cannabis products, i.e. 
leaves and blossoms of the cannabis plant (Cannabis sativa), are known for their 
powerful mind-altering effects. The physiological and psychoactive effects of 
cannabis intoxication are vast and cannabis products can be used for medical 
treatment as: Analgesic, anaesthetic, anticonvulsant, tranquilizing, anti-inflammatory, 
antispasmodic, antiemetic or appetite stimulating agents (Ameri, 1999). The cannabis 
plant comprises approximately 60 cannabinoid compounds with the primary 
psychoactive constituent being isolated in the 1960ies as ∆9-tetrahydrocannabinol 
(∆9-THC) (Mechoulam and Gaoni, 1965), and today we know a large number of 
naturally occurring or synthetic cannabinoid compounds (Pertwee, 1999). 
The effects of cannabinoids could be better understood when, in 1990, the 
cannabinoid receptor type 1 (CB1) was molecularly cloned from rat brain (Matsuda et 
al., 1990). This initiated the hunt for an endogenous ligand, that was firstly 
discovered in 1992 as n-arachidonoylethanolamine, also called anandamide (from 
the Sanskrit word ananda, meaning “bearer of internal bliss and tranquillity”) (Devane 
et al., 1992;Zuardi, 2006). CB1, its endogenous ligands and its synthesising and 
degrading enzymes constitute what is now referred to as the endocannabinoid 
system. The function of the endocannabinoid system may be very different from the 
intoxicate effects of exogenously administered cannabinoids, and several functional 
roles have already been implicated, including the modulation of pain (Calignano et 
al., 1998), feeding (Di Marzo et al., 2001), drug dependence (Ledent et al., 1999), 
neuroexcitotoxicity (Monory et al., 2006), depression (Gobbi et al., 2005) and 
cognition (Terranova et al., 1996).  
 
1.2 Overview of the endocannabinoid system: Neuroanatomy of CB1 
 
To date, two cannabinoid receptors have been cloned that is CB1 and the 
cannabinoid receptor type 2 (CB2). Whereas CB2 is primarily localised on immune 
system cells and tissues (Munro et al., 1993), CB1 is exclusively expressed in the 
central nervous system (Herkenham et al., 1990) and is the subject for investigation 
of the present study. A simplified illustration of the endocannabinoid system is given 
in Figure 1. The anatomical localisation of CB1 in the brain has been visualised using 
in situ hybridisation to detect mRNA levels, and autoradiography and 
immunohistochemistry of the receptor itself. CB1 is virtually omnipresent in the brain 
and can be found in several regions including neocortex, hippocampus, nucleus 
accumbens, basal ganglia, hypothalamus, amygdala, and cerebellum (Herkenham et 
Introduction 
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al., 1990). Within the hippocampus, CB1 is very densely expressed in the molecular 
layer of the dentate gyrus, and also in the stratum pyramidale and stratum lacunosum 
moleculare of ammons horn (CA3 and CA1 region) as well as the subiculum 
(Herkenham et al., 1990).  
On a cellular level, CB1 is undetectable on somatic cell membranes and dendrites, 
but is highly expressed on axons and axon terminals, i.e. the presynaptic 
compartment, as could be shown by electron microscopical studies (Katona et al., 
1999;Katona et al., 2001). Importantly, CB1 can be found on gamma-aminobutyric 
acid-ergic (GABAergic) neurons, that are mainly interneurons, and glutamatergic 
neurons (pyramidal cells, granule cells, and mossy cells in the hippocampus and 
principal neurons elsewhere), which was clearly revealed only very recently 
(Domenici et al., 2006;Katona et al., 2006;Kawamura et al., 2006;Marsicano et al., 
2003;Monory et al., 2006). Remarkably, on excitatory terminals, the level of CB1 is 
about 10-20 times lower than on inhibitory terminals (Kawamura et al., 2006). 
Focusing more precisely on the hippocampus, CB1 is expressed at high levels on 
inhibitory terminals of cholecystokinin(CCK)-positive basket cells (85% of these CB1-
positive interneurons contain CCK) (Hajos et al., 2000;Katona et al., 1999;Tsou et al., 
1999). CCK-positive GABAergic neurons clasp about 40% of all GABAergic cells in 
the hippocampus (Marsicano and Lutz, 1999).  
CB1 distribution in the amygdala is markedly heterogeneous (Katona et al., 
2001;McDonald and Mascagni, 2001). High levels are found in the basolateral 
complex, nucleus of the lateral olfactory tract, the periamygdaloid cortex, and the 
amygdalohippocampal areas. In contrast, CB1 is sparsely expressed in the medial, 
central, and intercalated nuclei. CB1 is primarily expressed on GABAergic CCK-
containing axon terminals, but it is likely that glutamatergic neurons carry CB1, too 
(Domenici et al., 2006), similarly as it is clearly shown for the hippocampus and 
cerebellum (Kawamura et al., 2006). 
It seems to turn out that beside of GABAergic and glutamatergic cells, cholinergic 
and dopminergic nerve terminals in the hippocampus express CB1 as well to a 
relatively high percentage (Degroot et al., 2006). 
 
1.3 CB1 and its signal transduction pathways 
 
As member of the G protein-coupled receptor family (GPCR), CB1 is a G-protein 
coupled receptor of the Gi/0 type, with a typical seven-transmembrane-spanning 
structure. It is expressed on the cell surface with its binding domain exposed to the 
extracellular space. CB1 is much more densely expressed in the brain than any other 
G-protein-coupled receptor. In several brain regions CB1 is present in densities that 
are comparable to those of GABA or glutamate receptor channels. Binding of a 
ligand causes a dissociation of α and βγ G- protein subunits from CB1. Release of 
the α subunit leads to inhibition of adenylyl cyclase, thereby reducing cAMP levels in 
the cell and altering the activity of cAMP-dependent protein kinases. The βγ subunit 
may directly inhibit different ion channels (Freund et al., 2003;Howlett, 2002). CB1 
has been reported to modulate the activity of N- and P/Q-type voltage-dependent 
calcium channels and to enhance the activation of the voltage-dependent A-type 
potassium channel and the inwardly rectifying potassium channel (Deadwyler et al., 
1995;MacKie et al., 1995). A third well characterised messenger system of CB1 is the 
stimulation of mitogen-activated protein kinase (MAPK) (Bouaboula et al., 1995). 
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1.4 Endocannabinoids 
 
Beside of the afore mentioned anandamide, a variety of endocannabinoids were 
identified to date. Endocannabinoids comprise a family of eicosanoid and related 
unsaturated fatty acid derivatives that can stimulate CB1. Altogether five 
endocannabinoids have been discovered so far, with anandamide and 2-
arachidonylglycerol (2-AG) being the most dominant and best investigated ones 
(Howlett, 2002). The regional distribution of anandamide and 2-AG correspond quite 
closely with each other, with the highest concentrations found in the striatum, 
brainstem, hippocampus, cerebellum and neocortex (Fride, 2005). Noteworthy, 
anandamide and 2-AG did not match so well with CB1 distribution (Bisogno et al., 
1999). One could assume that endocannabinoids may activate additional receptors 
(as will be discussed in more detail below), but it could also be explained by cellularly 
inhomogeneous receptor densities on highly specific populations of neurons.  
Endocannabinoids are synthesised and released on demand from the soma and 
dendrites in a non-vesicular manner, and act on cells located near their site of 
synthesis in a paracrine fashion (Lutz, 2004). Some evidence suggests that 
endocannabinoids are synthesised constitutively resulting in a constant activation of 
CB1 (Losonczy et al., 2004). The synthesis and release of endocannabinoids 
requires two steps: (1) Neuronal depolarisation and activation of voltage-gated Ca2+ 
channels (VGCCs) that elevate intracellular calcium concentration to a micromolar 
range, and/or (2) activation of the Gq-protein-coupled metabotropic glutamate 
receptor 1 or 5 (mGluR1 and mGluR5) (Maejima et al., 2001;Ohno-Shosaku et al., 
2002a) and/or (3) activation of muscarinic acetylcholine receptors 1 or 3 (mAChR1 
and mAChR3) (Kim et al., 2002;Ohno-Shosaku et al., 2003) and the resulting 
activation of phospholipase Cβ (PLCβ) (Hashimotodani et al., 2005) and (4) there is 
some evidence that activation of dopamine D1 receptors can decrease levels of 
anandamide and 2-AG in the limbic forebrain, and activation of dopamine D2 
receptors can stimulate anandamide efflux in the dorsal striatum (Giuffrida et al., 
1999;Patel et al., 2003). Eventually, (5) glucocorticoids can feed back onto 
hypothalamic neurons via endocannabinoids and thereby block the release of 
neuropeptides (Di et al., 2003).  
The biosynthesis and metabolic pathways of the endocannabinoids, anandamide and 
2-AG, have several features in common. For synthesis of anandamide, n-
arachidonoyl-phosphatidylethanolamine is cleaved by phospholipase D. In the case 
of 2-AG, phosphatidylinositol is cleaved to yield 1,2-diacylglycerol, catalysed by 
phospholipase C. Diacylglycerol in turn is converted into 2-AG, catalysed by 
diacylglycerol lipase (DAGL). Both steps additively lead to the synthesis of 2-AG 
(Piomelli, 2003). Anandamide and 2-AG then travel backwards across the synaptic 
cleft, acting as retrograde messengers at CB1, present on the presynaptic axon 
terminal (Alger, 2002;Kreitzer and Regehr, 2002). Endocannabinoids are rapidly 
removed from the extracellular space. Both release and removal seem to be 
facilitated by a membrane transport process (called anandamide membrane 
transporter, AMT) that is not molecularly characterised yet. In the presynapse and 
postsynapse, endocannabinoids are degraded via intracellular enzymatic hydrolysis, 
being accomplished by fatty acid amide hydrolase (FAAH) for anandamide, and 
monoglyceride lipase (MGL) and probably cyclooxygenase-2 (COX-2) for 2-AG 
(Gulyas et al., 2004;Hashimotodani et al., 2007;McKinney and Cravatt, 2005;Slanina 
and Schweitzer, 2005). A simplified overview of the endocannabinoid system is 
depicted in Figure 1. 
Introduction 
 16
The affinity and activity of endocannabinoids at CB1 can be very different. 
Anandamide rather behaves like a partial agonist of CB1 in most assays of functional 
activity, whilst 2-AG appears to be a full agonist, although its affinity to CB1 is lower 
than that of anandamide (Pertwee, 2005b). Also, anandamide is degraded in the 
brain primarily at a postsynaptic site but not in presynaptic terminals whereas 2-AG 
degradation occurs pre- and postsynaptically. Consequently, effects of anandamide 
on neurons are longer lasting than those of 2-AG, which acts only transiently 
(Hashimotodani et al., 2007). Therefore, 2-AG and anandamide might function as 
short-lived and long-lived retrograde messengers in the brain, respectively.  
 
Figure 1: Schematic and simplified overview of the encocannabinoid system. After 
depolarisation of the postsynaptic membrane and influx of calcium ions (1) or activation of mGluRs (2), 
endocannabinoids are synthesised from membrane lipids and released from the postsynpase (3). 
They then travel backwards through the synaptic cleft and bind to CB1 expressed by glutamatergic 
and GABAergic neurons (4). Activation of CB1 which is a Gi/o coupled receptor leads to a block of Ca2+ 
channels amongst other processes (5). Eventually, transmitter release is decreased (6). 
Endocannabinoids are degraded in the pre- and postsynaptic compartment (not shown).  
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1.5 Effects of CB1 activation on transmitter release 
 
Activation of CB1 has several effects, with most of them potentially and ultimately 
resulting in hyperpolarisation of the cell and reduction of release of the transmitters 
GABA and glutamate at the presynapse:  
1) CB1 activation can lead to downregulation of voltage-dependent N-type and 
P/Q-type calcium channel (VGCC) activity (Mackie et al., 1995), that are 
known to be required for release of transmitter from hippocampal synapses 
(Shen and Thayer, 1998),  
2) CB1 activation can cause upregulation of activity of A-type and inwardly 
rectifying potassium channels (Deadwyler et al., 1995;MacKie et al., 
1993;Schweitzer, 2000), an effect that is mediated by inhibition of adenylyl 
cyclase and decreases PKA-dependent phosphorylation of the channel (Mu et 
al., 2000),  
3) CB1 activation inhibits the production of cyclic adenosinmonophosphate 
(cAMP) by negatively regulating adenylyl cyclase. Thereby, cAMP-dependent 
protein kinase A (PKA) signalling is downregulated with consequences on 
possibly reduced LTP and less depolarisation (Childers and Deadwyler, 
1996;Hoffman and Lupica, 2000;Twitchell et al., 1997;van Beugen et al., 
2006).  
4) CB1 activation leads to phosphorylation and thereby activation of p42/p44 
mitogen-activated protein kinase (MAPK, also known as extracellular signal-
regulated kinase 1 and 2, ERK1 and ERK2), leading to the expression of 
immediate early gene zif268 and c-fos (Derkinderen et al., 2003). ERK is 
involved in synaptic plasticity and appears to be important during the early 
phase of LTP (Adams and Sweatt, 2002;Winder et al., 1999). Zif268 is a 
transcription factor that is essential for the transition from short- to long-term 
synaptic plasticity and for the expression of long-term memory (Jones et al., 
2001a). The localised increase in endocannabinoid production could facilitate 
local synaptic efficiency by activating signalling pathways important for a long-
term modification. 
A direct evidence for the regulation of transmitter release of GABA and glutamate is 
the decrease of the frequency of evoked quantal synaptic events after application of 
CB1 agonists, measured electrophysiologically (Auclair et al., 2000;Shen et al., 
1996). A decrease of radiolabelled neurotransmitter GABA and glutamate can also 
be measured chemically in hippocampal slices that were previously incubated with 
tritium-labelled GABA or glutamate (Katona et al., 1999;Kofalvi et al., 2003). The CB1 
agonist WIN55,212-2 inhibited evoked GABAA receptor mediated inhibitory 
postsynaptic currents (IPSCs) recorded from CA1 pyramidal cells in the slice 
preparation (Hajos et al., 2000;Hoffman and Lupica, 2000), an effect that is absent in 
CB1-knockout (CB1-ko) mice (Hajos et al., 2001). In addition, a reduction of field 
excitatory postsynaptic potentials (fEPSPs) or excitatory postsynaptic currents 
(EPSCs) could be shown for different agonists thus suppressing glutamatergic 
transmission (Ameri et al., 1999;Ameri and Simmet, 2000;Misner and Sullivan, 
1999;Shen et al., 1996;Sullivan, 1999) whereas application of the antagonist 
SR141716 slightly facilitates neuronal excitation (Ameri et al., 1999). Eventually, in 
vivo microdialysis could directly reveal a decrease of glutamate and GABA after 
application of WIN55,212-2 (Ferraro et al., 2001;Fujiwara and Egashira, 2004). 
WIN55,212-2 blocks IPSCs with an EC50 value 10 times smaller than the one 
necessary to suppress EPSCs in hippocampal slices (Hajos and Freund, 2002). 
Thus, axon terminals releasing GABA are much more sensitive to 
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(endo)cannabinoids than terminals that release glutamate. One could speculate that 
moderate neuronal activity may preferentially reduce inhibitory input, while stronger 
activity could suppress both excitatory and inhibitory inputs. This also suggests that 
two endocannabinoid signalling pathways exist in parallel in the brain with possibly 
different stages of recruitment. Nevertheless, endocannabinoid-mediated modulation 
is dependent on postsynaptic activity (Wilson and Nicoll, 2002), although it is 
suggested that GABAergic transmission in the hippocampus is tonically inhibited by 
endocannabinoids (Hentges et al., 2005;Neu et al., 2007). 
Beside of the main inhibitory and excitatory transmitter, GABA and glutamate, an 
inhibitory effect of CB1 activation can be also observed for the monoamines 
noradrenalin, dopamine, and serotonin and for acetylcholine. The exact mechanism 
for this regulation is unclear and may be secondary to excitation or inhibition of the 
respective monoaminergic and cholinergic cells. Noradrenalin release can be 
inhibited in the hippocampus of guinea-pig and human, but not of mouse and rat 
(Schlicker et al., 1997). Dopamine release can be inhibited in rat caudate-putamen 
(Cadogan et al., 1997). Serotonin release can be blocked in mouse neocortex 
(Nakazi et al., 2000). Moreover, cannabinoids inhibit acetylcholine (ACh) release in 
the rat, mouse and human hippocampus and neocortex but not in the striatum 
(Gifford and Ashby, Jr., 1996;Kathmann et al., 2001a;Steffens et al., 2003). However, 
all these data were obtained from in vitro preparations and the situation might be 
different in vivo. CB1 antagonist SR141716 increases noradrenalin release in the 
prefrontal cortex and hypothalamus, dopamine release in the prefrontal cortex and 
serotonin release in the prefrontal cortex and nucleus accumbens in vivo (Tzavara et 
al., 2001;Tzavara et al., 2003a). Low doses of cannabinoids increase, whereas high 
doses decrease the release of ACh in prefrontal cortex and hippocampus in vivo 
(Acquas et al., 2000;Gessa et al., 1998). 
 
1.6 Effects of CB1 activation on synaptic plasticity 
 
Already in the 1980ies, it was shown that ∆9-THC can inhibit high frequency 
stimulation (HFS)-induced long-term potentiation (LTP) in the CA1 region of the 
hippocampus (Nowicky et al., 1987). Later on, anandamide was also proven to have 
a concentration-dependent effect on LTP, although it did not block LTP completely 
(Terranova et al., 1995). Speaking about synaptic plasticity, we have to distinguish 
between short-term synaptic plasticity (in the range of seconds) and long-term 
synaptic plasticity (in the range of hours or days).  
(1) Short-term synaptic plasticity: In the hippocampus and in the cerebellum, it could 
be demonstrated that brief postsynaptic depolarisation of a neuron or a train of 
postsynaptic action potentials can transiently suppress inhibitory GABAergic synaptic 
transmission onto that neuron, a process called depolarisation-induced suppression 
of inhibition (DSI). It could be further on shown that DSI is a retrograde signalling 
process, i.e. it is induced in the postsynaptic cell and expressed as a presynaptic 
reduction in GABA release from interneurons. This presynaptic inhibition is caused by 
postsynaptically released endocannabinoids (Ohno-Shosaku et al., 2001;Wilson and 
Nicoll, 2001). In a similar manner, endocannabinoids affect glutamatergic synapses 
which is called depolarisation-induced suppression of excitation (DSE) (Kreitzer and 
Regehr, 2001;Ohno-Shosaku et al., 2002b). DSE and DSI are responsible for short-
term modifications of synaptic plasticity, and are thought to last between 5 and 60 s 
(Freund et al., 2003). Their resulting inhibition can not account for long-term plasticity 
of synapses, but may be important in facilitating depolarisation, and therefore 
induction of LTP during a high-frequency stimulation (Carlson et al., 2002). Indeed, 
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CB1-dependent long-term DSI potentiation (at least in the range of 15 min) takes 
place in CA1 of the hippocampus after a tetanic stimulation as has been show 
recently. This phenomenon could not be described for DSE (Chen et al., 2007). 
(2) Long-term synaptic plasticity: A very different mechanism for endocannabinoids 
has been suggested recently. A normally subthreshold high frequency stimulation 
could induce LTP if it was delivered during the phase of DSI suggesting that the 
endocannabinoids released following depolarisation of a pyramidal cell may facilitate 
the induction of LTP as it would be predicted if they selectively reduced inhibitory 
GABAergic input (Carlson et al., 2002;Varma et al., 2001). 
Another endocannabinoid-mediated modulation of synaptic plasticity is long-term 
depression (LTD). In the hippocampal CA1 region or in the basolateral amygdala, 
stimulation protocols that cause long-term potentiation at excitatory synapses onto 
pyramidal neurons simultaneously produce long-term depression at adjacent 
inhibitory synapses called long-term depression of inhibition (LTD-I), which is 
mediated by endocannabinoids (Azad et al., 2004;Chevaleyre and Castillo, 
2003;Marsicano et al., 2002). Whereas DSI is triggered by a brief release of 
endocannabinoids, LTD-I is induced after an activation of CB1 for minutes. Together 
with activity-dependent DSI potentiation (Chen et al., 2007), LTD-I is a mechanism of 
localised and persistent reduction of certain GABAergic synapses. Ultimately, by 
disinhibition, LTD-I can enhance excitatory synaptic transmission. CB1 dependent 
long-term depression of excitation (LTD-E) was similarly shown for cortical pyramidal 
neurons projecting onto medium spiny neurons of the striatum (Gerdeman et al., 
2002) and also at cortical pyramidal neurons synapsing onto neurons in the nucleus 
accumbens (Robbe et al., 2002). 
What might be the functional significance of these phenomena? For example, if the 
excitability of the postsynaptic neuron is high, DSI can facilitate LTP of glutamatergic 
inputs (Carlson et al., 2002). On the other hand, in CB1 knock-out mice that lack DSI 
(Wilson et al., 2001), LTP is enhanced (Bohme et al., 2000;Reibaud et al., 1999). The 
behavioural consequence remains unclear as Hampson and colleagues observed 
that only very high frequency firing rates (>30 Hz) produced cannabinoid release and 
lead to DSI, which usually do not occur at a behavioural level of spatial exploration 
but do occur during slow wave sleep and in epilepsy (Hampson et al., 2003). 
 
1.7 Aim of the study 
 
What is the physiological role of CB1, a receptor that is so widely distributed and that 
simultaneously influences antagonistic (i.e. glutamatergic and GABAergic) 
components of the central nervous system? There are several keystone publications 
that lead us to the here presented investigation: 
1) Genetical disruption of CB1 leads to an enhancement of LTP in two brain 
structures among others: The hippocampus and the amygdala (Bohme et al., 
2000;Marsicano et al., 2002). 
2) It was suggested that blocking of CB1, either pharmacologically or genetically, 
can have memory enhancing effects (Bohme et al., 2000;Reibaud et al., 
1999;Terranova et al., 1996). 
3) The release of endocannabinoids and the activation of CB1 modulate fear and 
anxiety (Bortolato et al., 2006;Kathuria et al., 2003;Marsicano et al., 2002). 
As the hippocampus is essential for episodic or spatial memory (Squire, 1992) and 
the amygdala is required for emotional memory (LeDoux, 2000), both of which richly 
express CB1, we were interested in the question of which effect the activation of CB1 
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has on hippocampal synaptic plasticity, hippocampus-dependent learning and 
anxiety-related behaviour. 
There are three ways of tackling the endocannabinoid system and its functions: (1) 
Administration of exogenous cannabinoids, (2) boosting the effect of 
endocannabinoids by blocking their degradation or reuptake, (3) pharmacological or 
genetical disruption of CB1. By the means of the first approach it is questionable if a 
physiological role of CB1 can be depicted when the whole brain is flooded with an 
agonist. Moreover, it is nearly impossible to distinguish between GABAergic and 
glutamatergic effects under in vivo conditions. Admittedly, the second approach is 
promising as it would focus concisely on those synapses that are active during 
certain behaviour. As already described above, CB1 is primarily localised on 
GABAergic and glutamatergic nerve terminals, where its primary effect is to decrease 
transmitter release. As a result of this distribution, CB1 activation might have 
dramatically different physiological and behavioural consequences, depending on the 
balance of its effects on GABAergic and glutamatergic transmission within a neural 
network.  
We were in the ideal situation of having three different mouse lines in order to study 
the endocannabinoid system: (1) A conventional knock-out mouse line (below 
referred to as total-CB1-ko) and two conditional knock-out mouse lines using the 
Cre/loxP system, (2) leading to cell type specific deficiency of CB1 in GABAergic 
neurons (below referred to as GABA-CB1-ko) or (3) in glutamatergic neurons (below 
referred to as Glu-CB1-ko). It was the overall goal to pin down which population of 
cells carrying CB1 is mainly involved in synaptic plasticity, learning and memory, and 
emotionality. We were interested in the differential contribution of CB1 expressed on 
glutamatergic neurons and GABAergic neurons in synaptic plasticity and memory on 
the one hand and anxiety on the other hand, as it is summarised in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Schematic outline of the experimental work: We hypothesised that CB1 expressed on 
glutamatergic or GABAergic neurons may differentially affect memory and synaptic plasticity on the 
one hand and anxiety on the other hand. 
 
We have to consider a couple of difficulties when integrating our data in available 
concepts. Assessing the function of CB1 will depend on many parameters such as 
the genetic background of the animals tested, the experimental conditions used, the 
steady-state level of endocannabinoids and the neurobiological substrate examined. 
For example, most of the studies dealing with CB1 investigate systemic effects of 
agonists and antagonists in artificial systems like cell culture or slice preparations 
which can be very different from the situation in the behaving animal. Knock out 
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animal models miss CB1 during the whole ontogeny of the animal and at any time of 
an experiment. Most of the times, it is not the endogenous ligands (e.g. anandamide 
or 2-AG) used in the studies but newly developed synthetic ligands with different 
binding kinetics and potencies. These investigations are for sure valuable in allowing 
us to discover basic mechanisms of CB1 receptor activation and its physiological and 
behavioural consequences. However, it is likely that the effects of endocannabinoids 
may be different as they cause their effects at activated synapses in a precise 
temporal and spatial manner and the reader should bear in mind that physiological 
mechanisms can be fairly different from experimental models used in the cited and 
also in our studies. Another challenge is the fact that inbred C57Bl/6 and outbred 
Swiss CD1 strains of mice have been utilised as genetic background for the 
generation of CB1-ko mice. These strains of mice have been used to develop four 
independent CB1-ko mouse lines, with Zimmer et al., Robbe et al. and Marsicano et 
al. using the C57Bl/6 strain and Ledent et al. using the CD1 strain (Ledent et al., 
1999;Marsicano et al., 2002;Robbe et al., 2002;Zimmer et al., 1999). Inconsistencies 
in published experiments might depend on the respective knockout mouse line that is 
used in a study (some further information on this issue is given to the reader in 
chapter 4.4.2 Genetic background of CB1-ko mice). Beside of that, many 
pharmacological studies were carried out in rats. Altogether, the use of rats or mice 
as classical animal models is not further indicated in this work.  
The presented thesis falls into three parts that we would like to introduce shortly.  
1.7.1 An electrophysiological model for synaptic plasticity in the hippocampus: 
Is LTP altered in CB1-deficient mice? 
Both, learning and memory and synaptic plasticity are believed to involve changes in 
the connection between neurons. The synaptic plasticity and memory hypothesis 
states that activity-dependent synaptic plasticity is induced at appropriate synapses 
during memory formation and is both necessary and sufficient for the information 
storage underlying memory processes (Martin et al., 2000). The most widely studied 
model for these phenomena is called long-term potentiation (LTP). LTP, firstly 
described in 1973 by Tim Bliss and Terje Lomo (Bliss and Lomo, 1973), is an abrupt 
and sustained increase in synaptic efficacy of a specific brain pathway resulting from 
the application of brief high-frequency electrical bursts. LTP has been shown to occur 
in many different brain regions of the brain, and it is mostly investigated in the 
hippocampus (Bliss and Collingridge, 1993). At the same time, the hippocampus is a 
region of the brain that is necessary for the formation of episodic memories in 
humans and for spatial learning and memory in rodents (Squire, 1992). The literature 
on these issues is vast, and only very recently, direct evidence was presented that 
hippocampus-dependent learning leads to observable LTP at a subset of 
hippocampal synapses, and suppression of LTP after learning a task abolishes the 
very same memory of that task (Pastalkova et al., 2006;Whitlock et al., 2006). 
We were interested if synaptic transmission and especially synaptic plasticity is 
altered in our mutant mice. Bohme et al. measured fEPSPs in the CA1 region of 
hippocampal slice preparations after stimulation of Schaffer collaterals (Bohme et al., 
2000). They could show that mice lacking CB1 had stronger LTP than their wild type 
controls. The mutant mice showed no alterations in the basic excitability after 
stimulation of the Schaffer collaterals. Also, they did not see any difference for short-
term synaptic plasticity like paired-pulse facilitation (which is further described below).  
Anatomically, the hippocampus forms part of the medial temporal lobe (Amaral and 
Witter, 1989). The hippocampal formation, as all other cortical areas, consists of two 
major neuron types: Excitatory principal cells and inhibitory interneurons. The former 
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include hippocampal pyramidal cells and dentate gyrus granule cells accounting for 
about 90% of the entire neuronal population, and the remaining 10% of cells are 
GABAergic interneurons (Freund and Buzsaki, 1996). We focused on the 
hippocampus as it is one of the areas with the highest density of CB1 receptor 
(Herkenham et al., 1991), and relatively large amounts of anandamide have been 
found in the hippocampus of rats and humans (Felder et al., 1996). As DAGL, the 
enzyme mediating the formation of 2-AG, is being found in the dentate gyrus granule 
cells (Katona et al., 2006), CB1 mRNA is expressed in the entorhinal cortex which 
projects to the dentate gyrus molecular layer (Mailleux and Vanderhaeghen, 
1992;Marsicano and Lutz, 1999) and cannabinoid receptor is dense in the molecular 
layer and moderate in the granule cell layer and the hilus of the dentate gyrus 
(Herkenham et al., 1991), these findings suggest that endocannabinoids are released 
in the dentate gyrus and CB1 is located on perforant path axonal terminals. The 
perforant path, coming from the entorhinal cortex, is the major excitatory input 
pathway to the dentate gyrus of the hippocampus. For the electrophysiological 
recordings, we hence focused on the perforant path-dentate gyrus granule cell 
synapse. 
We investigated the phenomenon of LTP in anaesthetised mice in vivo for several 
reasons. Firstly, it resembles physiological processes more closely than experiments 
done in brain slices. The in vivo preparation potentially makes enough substrate 
available for subsequent biochemical analysis after LTP induction. Furthermore, it 
allows the investigation of extrahippocampal influences on LTP that are lost in the 
slice preparation. Previous studies of LTP in genetically modified mice have revealed 
discrepancies between results obtained in vitro or in vivo (Bordi et al., 1997;Errington 
et al., 1997;Nosten-Bertrand et al., 1996) in that enhanced LTP was found in vivo but 
not in vitro. On the other hand, in vitro brain slices show limitations of recording 
duration due to tissue deterioration (Teyler, 1980). The artificiality of the slice 
preparation is further revealed in a recent study: Al Hayani and coworkers could 
show that the CB1 agonist WIN55,212-2 causes a decrease of paired-pulse 
depression of population-spike recorded in hippocampal slices at 28-30°C, whereas it 
causes an increase of paired-pulse depression of pop-spike at 35°C (Al Hayani and 
Davies, 2002) , a quite dramatic difference. 
Six electrophysiological characteristics of the dentate gyrus were compared across 
the knockout mouse lines: (1) The relationship between perforant path stimulation 
and the resulting granule cell field excitatory postsynaptic potential (fEPSP), i.e. the 
number of granule cells synchronously depolarising. (2) The relationship between 
perforant path stimulation and the resulting granule cell population-spike (pop-spike), 
i.e. a number of granule cells synchronously firing an action potential. (3) Presynaptic 
facilitation, measured by a paired-pulse protocol of fEPSP. (4) Polysynaptic feedback 
inhibition of granule cells, measured by a paired-pulse protocol of pop-spike. (5) 
Induction and maintenance of LTP of fEPSP and pop-spike. (6) Lastly, we assessed 
theta oscillations in the dentate gyrus after a sensory stimulation. Theta rhythm is a 
prevalent electroencephalographic (EEG) signal in the hippocampus that oscillates in 
a frequency range of 3 to 12 Hz. It is commonly regarded as a physiological encoding 
frequency in memory formation (Buzsaki, 2002). An increase in theta rhythm might 
be one underlying mechanism for an enhancement in learning and synaptic plasticity 
(Holscher et al., 1997;Wiebe and Staubli, 2001). 
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1.7.2 Behavioural paradigms for the measurement of learning and memory: Are 
cognitive abilities altered in CB1-deficient mice? 
Learning and memory can be defined as an experience-dependent generation of 
enduring internal representations, or lasting modifications in such representations 
(i.e. learning) and the retentions of these representations, or the capacity to 
reactivate these representations (i.e. memory) (Dudai, 1989). Because memories in 
the brain cannot directly be observed, their expression must be inferred from overt 
behavioural expressions in an indirect manner.  
It was shown that local administration of the CB1 agonist CP55940 into the dorsal 
hippocampus impaired the choice accuracy in a radial arm maze task. This effect 
was specific to cognition since other pharmacological effects of the agonist were 
absent, thus highlighting the important role of the hippocampus for cognitive 
alterations due to CB1 activation (Lichtman et al., 1995). When dealing with learning 
and memory tasks, one has to bear in mind that a novel environment or situation that 
is intended to be suitable for gathering information and thus learning, elicits an 
emotional and cognitive response at the same time. Hence, learning and memory 
tasks used here are never purely cognitive tasks. 
To check for hippocampus-dependent memory performance and to have a potential 
correlation to our electrophysiological recordings from the hippocampus, we applied 
several hippocampus–dependent tasks. A set of various memory tasks was chosen 
that rely on different performance requirements as the outcome of individual tests can 
vary dramatically and lead to a wrong result (Gerlai, 2002). We chose tasks that do 
not rely on appetitive motivation as it has been shown that differences in CB1-ko 
mice from the respective wildtype animals can not be expected in those tasks (Holter 
et al., 2005). In addition, the endocannabinoid system seems to be a modulator of 
the brain reward system, as CB1-ko mice have e.g. a reduced sensitivity in the 
rewarding effects of sucrose (Sanchis-Segura et al., 2004), which is an obvious pitfall 
when using appetitively motivated learning tasks with food reward. Briefly, we would 
like to outline our applied tasks. 
Water maze spatial discrimination task: In contrast to the classical Morris water 
maze, two platforms swimming in a pool of water are used in this test that are visible 
to the animal. The mouse escapes from the pool by using distal spatial cues to locate 
the unsinkable platform that provides support whereas the other platform sinks if the 
animal enters it. Whereas the safe platform stays at the same position relative to the 
spatial cues, the sinkable platform changes the position around the water maze rim. 
Mice use an allocentric spatial strategy in this test to locate the safe platform which 
depends on an intact hippocampus. As an exposure to water is aversive to rodents, 
escape from the water is a positive reinforcement in this test (Arns et al., 
1999;Steckler et al., 1999). Compared to the Morris water maze, the water maze 
used in the present study task is less stressful to the animals as it is considerably 
less time the mouse is enforced to swim in order to reach the safe platform. In our 
test, the accuracy, i.e. the choice to swim to the stable or to the floating platform, is 
used as a measurement for learning performance compared to the latency to swim to 
the platform in the Morris maze reported by many authors which might include 
sensory or motor impairments or inappropriate search strategies of the animals. 
 Object recognition task: This task is based on the spontaneous tendency of 
rodents to explore a novel object more than a familiar one. It consists of a first trial 
during which mice are placed in an open field in the presence of an object (such as a 
piece of plastic or a small glass bottle) and a second trial during which mice are 
allowed to explore the open field in the presence of a familiar object, that was 
previously explored, and a novel object. Recognition memory is assessed by 
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comparing the time spent exploring each object during the second trial (Dodart et al., 
1997;Ennaceur and Delacour, 1988). Long-term object recognition memory requires 
the hippocampus in mice for the completion of the task (Hammond et al., 2004). An 
advantage of the object recognition test is that it neither needs positive reinforcement 
(e.g. food reward) nor negative reinforcement (e.g. electric foot shock) nor rule 
learning (e.g. operant conditioning) but rather exploits the animal’s innate preference 
for novelty. 
Social recognition: Similar to the object recognition task, this task takes advantage 
of the innate drive of an animal to investigate nonfamiliar over familiar conspecifis 
and does not need positive or negative reinforcement (e.g. food reward or electric 
foot shock, respectively), too. Social recognition can be studied in rodents by placing 
a juvenile in a cage with an adult. The adult will spontaneously investigate the 
younger animal, and the duration of this investigation reflects the familiarity between 
the two animals. A repeated exposure to the same juvenile and a novel juvenile at 
the same time results in a decrease in investigation time of the familiar juvenile 
compared to the novel one. Hence, the difference in investigation times between the 
first and second exposure can be used as an index of social memory. This effect 
diminishes as the length of interexposure period increases. Social recognition 
memory is dependent on the hippocampus (Engelmann and Landgraf, 1994;Kogan 
et al., 2000;Richter et al., 2005).  
Contextual fear conditioning: In a Pavlovian or classical conditioning procedure, 
the presentation of a neutral stimulus, such as a tone, is paired with an aversive 
stimulus, such as an electric foot shock. By associating it with the shock (i.e. the 
unconditioned stimulus = US), the previously neutral tone (i.e. the conditioned 
stimulus = CS) becomes aversive when subsequently given alone and can be used 
to elicit a number of behaviours associated with fear. The mouse will display a natural 
defensive response termed freezing that is an immobile posture in which the animal 
is highly alert (Blanchard and Blanchard, 1969). Rodents can learn simple 
associations between US and e.g. tone or light as CS (called elemental learning) but 
they can also learn contextual stimuli, i.e. a set stimuli of the shock chamber itself 
(configural learning). We applied the background contextual fear conditioning 
paradigm, in which mice are placed into a distinctive context where they receive an 
aversive footshock. Animals subsequently display conditioned fear-related 
behaviours, i.e. freezing, in the presence of the context alone. Learning of the 
contextual stimuli requires a normally functioning hippocampus and amygdala 
(Gerlai, 1998;LeDoux, 2003;Paylor et al., 1994). Previous studies indicate that the 
hippocampus is differentially involved in contextual fear learning depending on 
whether or not the unconditioned stimulus is signalled by a discrete cue. When the 
footshock immediately follows presentation of an auditory stimulus (which hence is in 
the foreground), conditioning to the context is thought to occur in the “background” 
since the phasic auditory cue is the stimulus that principally becomes associated with 
the footshock. In the absence of a discrete cue, conditioning to the context occurs in 
the “foreground” since contextual cues are the only stimuli available to be associated 
with the footshock. It has been shown that hippocampal lesions specifically disrupt 
background contextual conditioning (Phillips and LeDoux, 1994). 
Open field habituation: Neglecting the component of anxiety and focusing on the 
exploratory activity, the open field task can be defined as a memory task. As an open 
field is a novel environment, the animal acquires information of this current 
environment by means of exploratory activity. Rodents submitted for the first time to 
an open field display higher spatial exploration (i.e. locomotion and rearing) than in 
successive exposures. Thus, the decrement in the response to successive 
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exposures, i.e. a decrease of locomotion, is taken as an index of habituation, a form 
of non-associative memory (Cerbone and Sadile, 1994). Animals with enhanced 
cognitive ability habituate more easily to a novel environment. The hippocampus is 
an essential structure that detects and responds to novel stimuli and is involved in 
open field habituation memory (Degroot et al., 2005;Vianna et al., 2000;Winograd 
and Viola, 2004). 
1.7.3 Behavioural models for the measurement of anxiety and emotionality: Is 
emotionality altered in CB1-deficient mice? 
Anxiety can be viewed as an appropriate, adaptive response to impending danger 
that is integral to an organism’s preparations to either cope with or avoid a potential 
environmental threat (Holmes and Cryan, 2006). Generally, if one speaks of 
emotionality, anxiety or fear, we certainly do not know whether an animal is indeed 
“anxious” or “fearful”. However, by measuring behavioural and physiological 
responses (e.g. changes in heart rate, blood pressure or hormone level), it is possible 
to elicit similar anxiety-associated behavioural and physiological responses as can be 
observed in humans. Ultimately, drugs that are known to reduce anxiety can be 
studied in the respective behavioural test paradigm and should alter the behaviour 
under investigation. 
Rodents show a strong propensity to explore novel objects and environments. 
Exploration is a fundamental component of the behavioural repertoire of a rodent and 
allows the animal to familiarize itself with the surrounding on the search for food, 
social partner or shelter. The exploratory behaviour is inhibited by a wide variety of 
aversive stimuli that are thought to induce anxiety. For example, rodents explore less 
under bright illumination, after receiving an electric shock or in the presence of a 
predator. A very profound behavioural inhibition is freezing, when an animal remains 
immobile in a state of readiness for possible flight. Thus, by measuring the 
exploratory activity, it is possible to quantify an animal’s state of anxiety (Belzung and 
Griebel, 2001). If there is an increase of anxiety-related behaviour, this is called to 
have an anxiogenic effect whereas if there is a decrease of anxiety-related 
behaviour, this is called to have an anxiolytic effect. A number of tests have been 
developed which assess anxiety by measuring changes in exploratory behaviour or 
coping behaviour. Most importantly, all these models are sensitive to anxiolytic drugs 
(such as the “gold standard” benzodiazepine), evidencing their validity. We applied 
three categories of anxiety tests: On the one hand there are tests where the animal 
can choose whether to stay in a safe environment or in a putative risky environment 
(elevated plus maze, light/dark test). On the other hand there are tests where the 
mouse is enforced to remain in an aversive environment without any choice (open 
field, social exploration, and object exploration). Thirdly, we included a test in which 
mice that are more anxious must engage in an active behaviour (defensive marble 
burying) as opposed to passive behaviours utilized to avoid anxiogenic stimuli (plus 
maze, light/dark test). Briefly, we would like to introduce the reader to the applied test 
paradigms. 
Elevated plus-maze: The apparatus comprises a plus-shaped maze with four arms 
radiating out from a central platform. Only two opposing arms are enclosed on three 
sides by walls. The entire maze is raised of the floor. Rodents will show a preference 
for the closed areas with walls because of thigmotaxic behaviour. The avoidance of 
the open arms is assumed to stem from a rodent’s aversion to open, exposed spaces 
without any thigmotaxic cues. The standard measures taken are the number of 
entries made from the central platform into the open and closed arms and the amount 
of time being spent there (Lister, 1987).  
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The elevated plus-maze trial 1/2 protocol allows investigating a memory of the fearful 
experience: Animals are exposed to the elevated plus-maze on two consecutive 
days, and prior test experience produces enduring changes in the behavioural 
response. There is a decrease in exploration of the open arm on day two compared 
to day one, which is called one-trial sensitization. It seems like rodents acquire some 
kind of memory of the potentially dangerous areas (Carobrez and Bertoglio, 2005). 
Light/dark test: The apparatus consists of two compartments, one painted black and 
being dark, and a second that is brightly illuminated. As nocturnal rodents like mice 
and rats find bright light aversive they will avoid the lit compartment. The number of 
transitions, the distance moved and time spent in the lit compartment is a measure of 
anxiety (Bourin and Hascoet, 2003;Costall et al., 1989). 
Defensive marble burying: Rodents spontaneously sue available bedding material 
to bury unpleasant sources of discomfort present in their home environment (Archer 
et al., 1987). Burying behaviour consists in forward-shoving the diggable material 
over the source of aversion using the snout and forepaws in order to avoid and 
protect from the localized threat. Marble burying is described as a defensive 
behaviour reflecting the anxiety state of the animals (Nicolas et al., 2006;Poling et al., 
1981). This test is of special interest to us as it consists of an active coping strategy 
of the animal in contrast to the passive avoidance of aversive surroundings like in the 
plus-maze or light/dark test.  
Social interaction: Social behaviour between animals, such as sniffing, close 
following, grooming, mounting and aggression are inhibited by anxiety and can be 
used to infer changes in anxiety. The amount of social interaction is also dependent 
on aversive stimuli in the environment, such as bright light (de Angelis and File, 
1979;File and Seth, 2003). 
Novel object exploration: A response to a novel object is thought to be a measure 
of a conflict between an exploratory drive and a neophobic avoidance of the 
potentially threatening object. Aversive environmental conditions can enhance the 
anxiogenic response (Belzung and Le Pape, 1994).  
Open field: For this test procedure, the animal is placed in a rectangular arena, and 
the horizontal (i.e. locomotion) and vertical (i.e. rearing) exploratory activity is 
measured. However, rodents tend to explore an open field less under bright 
illumination, providing an aversive stimulus used to elicit anxiety (Hale et al., 2006). 
Another index of anxiety is thigmotaxis that is the tendency of an animal to stay in 
close proximity with perimeters within the environment (e.g. walls), supposably 
because of increasing an animals chance of avoiding detection by potential 
predators. The time spent in contact with the walls as well as the distance walked 
along the walls serves as a measure of thigmotaxis (Archer, 1973). 
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2. Methods 
 
2.1 Animals 
2.1.1 Animal housing 
Male mice, aged between 3–5 months, were maintained in standard conditions with 
food (Altromin Standard-Diät 1310, Altromin GmbH, Germany) and tap water ad 
libitum in Makrolon type II cages with sawdust bedding (Altromin Faser Einstreu, 
Altromin GmbH, Germany), at 22 +/- 2° C room temperature and 55 +/- 5% humidity. 
Mice were kept in a reversed light-dark cycle with lights off at 9 a.m. and lights on at 
9 p.m. if not stated otherwise. Experiments were conducted in the dark phase of the 
day between 9:30 a.m. to 2 p.m. All mutant mice were bred in house. 
C57BL/6NCrlBR mice for social interaction and recognition test were purchased from 
Charles River (Charles River WIGA (Deutschland) GmbH, Sulzfeld, Germany).  
The fact that the animals used in this study were singly housed shall be briefly 
discussed here. Principally, rodents are considered to be social animals, and it is 
recommended to avoid individual housing (Van Loo et al., 2003). Moreover, the 
performance in learning and memory tests decreases in singly housed mice (Voikar 
et al., 2005). On the other hand, mice establish strong dominance hierarchies 
(Poshivalov, 1980) and social status affects anxiety levels in this species (Ferrari et 
al., 1998). Singly housed mice show less behavioural variability, probably due to the 
hierarchical aggressiveness and rivalry found in group housed mice (Voikar et al., 
2005). 
To avoid confounds from social status, subjects were kept individually in cages. The 
only exception were mice used for social interaction test that were group housed as 
this is a requirement for an intact olfactory memory and prevents from the 
development of aggression.  
The Committees on Animal Health and Care of the local government 
(Regierungspräsidium Oberbayern) approved all experimental procedures.  
2.1.2 Generation of CB1 mutant mice 
Gene-targeted mice can be created using the phage P1-derived Cre/LoxP 
recombination system. Marsicano and colleagues generated a line of mice that 
carries a CB1 gene flanked by lox P sites (the CB1 gene is now called “floxed”). The 
Cre enzyme, a DNA recombinase derived from P1 bacteriophages, recognizes these 
lox P sites. When such mice are bred to transgenic strains that express Cre 
recombinase, floxed genes will be deleted in all tissues in which the Cre recombinase 
is active. This strategy is now frequently used for the tissue-specific inactivation of 
genes (Sauer, 1998).  
Briefly, a construct containing the entire open reading frame of CB1 gene flanked by 
two lox P sites was generated and electroporated into mouse embryonic stem cells to 
obtain the floxed allele. Mice bearing the floxed allele were then crossed with 
transgenic mice expressing Cre recombinase ubiquitously. Mice carrying a germ-line 
transmissible deletion of CB1 were backcrossed into C57BL/6N mice (Marsicano et 
al., 2002). These mice are called total-CB1-ko mice in the presented work. 
Using the Cre/Lox P system in which Cre recombinase was under the control of 
regulatory sequences of the Nex gene (only expressed in glutamatergic neurons of 
the forebrain), Marsicano and colleagues created conditional knockout mice in which 
CB1 was deleted in all principal glutamatergic neurons of the forebrain (including the 
neocortex, amygdala and hippocampus), but was spared in GABAergic interneurons 
(and cerebellum), henceforth termed as Glu-CB1-ko mice (Monory et al., 2006). A 
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third line of mice, in which the Cre recombinase was under control of the regulatory 
sequences of the Dlx5/Dlx6 gene lacks CB1 in forebrain GABAergic neurons, 
henceforth called GABA-CB1-ko mice (Monory et al., 2006). A brief description of the 
mouse lines is summarised in Table 1. The anatomical distribution of CB1 mRNA in 
brains of the mouse lines with an in situ hybridisation is depicted in Figure 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Specific deletion of CB1 in different neuronal subpopulations in conditional CB1 
mutant mice as revealed by in situ hybridisation. Micrographs showing CB1 mRNA expression of 
wildtype (A, D, G, J), GABA-CB1-ko (B, E, H, K) and Glu-CB1-ko (C, F, I, L) mice. Sections were 
taken from the level of the caudate putamen (A-C), dorsal hippocampus (D-F) and cerebellum (G-I) 
and detailed enlargements of the hippocampus are given (J-L). In the mutant lines, deletion of CB1 is 
mainly restricted to the forebrain. In GABA-CB1-ko mice (B, E, H, K), CB1 mRNA is absent in all 
GABAergic neurons and is expressed only in non-GABAergic cells (low uniform staining). In Glu-CB1-
ko mice (C, F, I, L), CB1 mRNA is absent in the majority of cortical glutamatergic neurons. The intense 
scattered dots indicate high expression levels of CB1 in GABAergic interneurons. Modified from 
Monory et al., 2006.  
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    Table 1: Overview of the three knockout mouse lines 
Mouse Line Total-CB1-ko GABA-CB1-ko Glu-CB1-ko 
Promotor control Conventional Dlx5/Dlx6 Nex 
Affected cells 
 
 
 
All CB1-bearing 
cells in the brain 
All GABAergic 
neurons in the 
forebrain i.e. 
neocortex, 
hippocampus, 
amygdala, but 
present in other 
brain regions, such 
as midbrain, 
and cerebellum 
Glutamatergic cells 
in the forebrain, i.e. 
neocortex, striatum, 
hippocampus, 
amygdala, but 
present in other 
brain regions, such 
as midbrain 
and cerebellum 
 
 
All lines were in a mixed genetic background, with a predominant C57BL/6NCrlBR 
contribution to which they were backcrossed for at least 3-6 generations. Mice used 
in single experiments were littermates. The breeding pairs for total-CB1-ko and 
wildtype mice were heterozygous animals. For Glu-CB1-ko and GABA-CB1-ko mice 
and the respective littermates, the breeding pairs consisted of a mother negative for 
Cre recombinase (C-) and a father positive for Cre recombinase (C+). The genotype 
was verified using polymerase chain reaction (PCR) according to protocols previously 
established (Marsicano et al., 2002;Monory et al., 2006) The experimenter was 
always blind to the genotype of the mice. We were allowed to use the mutant mouse 
lines in this study with very kind permission from Dr. Giovanni Marsicano (University 
of Bordeaux, France) and Prof. Beat Lutz (University of Mainz, Germany). 
Electrophysiological recordings in an in vivo preparation were carried out with naïve 
animals.  
Behavioural experiments were conducted in four screens with separate cohorts of 
animals for every screen, as it is depicted in Figure 4:  
1. Screen: Separation of animals and individual housing. Object recognition 
test (30lux). Open field test (0 lux). Contextual fear conditioning (0.7 mA). 
2. Screen: Social recognition test (500 lux). Separation of animals and 
individual housing. Open field test (700 lux). 
3. Screen: Social interaction test (0 lux). Separation of animals and individual 
housing. Object exploration test (500 lux). Elevated plus-maze test. 
Contextual fear conditioning (1.5 mA). 
4. Screen: Separation of animals and individual housing. Light/dark box, 
elevated-plus maze, marble burying test. 
Another cohort of animals was employed for the water maze spatial discrimination 
task.  
Animals were transferred from the vivarium to the laboratory always 1-2 days before 
the experiment. The different tests were carried out with 2-3 days apart from each 
other. 
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Figure 4: Schedule of the behavioural testing. Four screens were carried out to analyse memory 
and anxiety in the three mouse lines. Please note that experiments that were more aversive to the 
animals were always done in the end of a series. Experiments of one screen were conducted within 
about three weeks. Black boxes highlight lowly aversive testing conditions whereas white boxes 
highlight highly aversive testing conditions for experiments where we specifically and intentionally 
changed the environmental conditions. Grey boxes indicate experiments under standard laboratory 
conditions. The water maze spatial discrimination task was carried out with a separate cohort of 
animals and is not included in the scheme. 
 
2.2 Electrophysiology 
2.2.1 Surgery and field recordings 
Experiments were carried out in a Faraday cage constructed in house. Mice were 
anaesthetised with 1-1.5% isoflurane (Forene, Abbott, Wiesbaden) under control of a 
vapor (Vapor 19.3, Drägerwerk AG, Lübeck), in 99.9% O2 and placed in a stereotaxic 
frame (TSE Systems, Bad Homburg, Germany). Deep anaesthesia was indicated by 
lack of a pedal reflex and by regular breathing. Temperature was maintained at 
37.5°C with a heating blanket and constantly monitored via a rectal probe and a 
homoeothermic blanket control unit (Harvard Apparatus, Edenbridge, UK). The open 
eyes of the animals were protected from desiccation with eye ointment (Bepanthen, 
Roche Basel, Switzerland). Surgical procedure was done under control of a binocular 
(OPMI pico, Zeiss, Jena). The skin was cut and the bone surface treated with 3% 
H2O2 to make the suturae of the skull better visible. Skull surface was exposed and 
holes in the skull were drilled with a dental turbine (KaVo EWL Typ 4912, 
Biberach/Riss, Germany, speed: 30000 rpm). A reference silver wire electrode was 
positioned on the frontal cortical surface. A borosilicate-glass recording micropipette 
(GC120T-10, Harvard Apparatus, Edenbridge, UK) was manufactured with an 
electrode puller (Zeitz-Instrumente, DMZ-Universal Puller, München, Germany) and 
back-filled with 0.9% NaCl (with an in vitro impedance of 0.5-2 MΏ). The pipette was 
lowered into the cell body layer of the dentate granule cells (stereotactic co-ordinates: 
1.8 mm posterior to bregma, 1.6 mm lateral to the midline, 1.4 mm below the cortical 
surface, according to the mouse brain atlas (Paxinos and Franklin, 2001). The 
granule cell layer was located by observing the spontaneous multiunit activity (with 
filter adjustment of 300 Hz – 10 kHz, gain of 100 000) using a differential amplifier (A-
M Systems Model 1700, Carlsborg, USA). Coming from the cortical surface, there are 
Social  
recognition
Open 
field 
Social  
interaction
Object  
exploration
Contextual 
fear  
conditioning
1.5 mA  
Object  
recognition
Open
field 
Contextual 
fear  
conditioning
0.7 mA  
Marble  
burying 
Elevated
plus 
maze
Light/dark 
box 
Screen 1 
Screen 2 
Screen 3 
Screen 4 
 
Methods 
 31
two prominent cell layers that is the pyramidal cell layer of the cornu ammonis CA1 
and eventually the granule cell layer of the dentate gyrus. Multiunit activity was 
monitored with an oscilloscope (Grundig Electronic, MO 53, Nürnberg, Germany) and 
a loud speaker (RIM Electronics RSV 70 B, Loomis, USA), respectively. When 
approaching the pyramidal or granule cell layer, this can be seen or heard as an 
intense spontaneous firing of cells. As soon as the granule cell layer was reached, 
the recording electrode was left in position and the stimulating electrode was 
inserted. Now, evoked field excitatory postsynaptic potentials (fEPSP) were amplified 
through the differential amplifier (at a gain of 100, 0.1-3 kHz bandpass filtered, and 
digitised at 10 kHz using an analogue-digital converter (Pico Technology, St. Neots, 
UK). A bipolar stimulating electrode was used that consisted of a two-pin connector 
(Harwin M22-6140306, Portsmouth, UK) with a 1 cm long stainless steel cannula and 
a Teflon-isolated tungsten wire (WT-3t, Science Products GmbH, Hofheim, wire tip 
diameter: 0.03 mm). The tip of the wire protruded from the cannula with 0.4 mm. It 
was positioned in the angular bundle of the perforant path (stereotactic co-ordinates: 
3.5 mm lateral to lambda, 1.0-1.5 mm below the cortical surface). Electrode depth 
was adjusted in order to maximise the field response to a square wave test 
stimulation (100-900 µA, 50 µs) that was applied with a stimulator (World Precision 
Instruments Stimulus Isolator A265, Sarasota, USA). Initially, coming from the cortical 
surface, the tissue was stimulated maximally with 900 µA. As soon as a fEPSP 
became visible, current was lowered so that eventually a fEPSP could be observed 
with about 100 µA. When the position of the stimulation electrode was optimal the 
recording electrode was slightly shifted ventrally or dorsally to improve the signal. 
After both stimulating and recording electrodes were properly positioned in the 
perforant path and the dentate granule cell layer, respectively, the preparation was 
allowed to stabilise for 30 min prior to baseline recording, with test stimuli injected 
every 30 s. Data acquisition was done with a personal computer using the LTP 
program (LTP Program Version 2.4, Bristol, UK). An example of typical waveforms 
from the dentate gyrus can be seen in Figure 6. 
At the end of the experiment, in a subset of mice, small electrolytic lesions were 
made through the stimulating and recordings electrode with a voltage generator 
manufactured in-house (DC 1.5 mA for 10 s). 10 min after lesioning the brain, the 
mice were given an overdose of isoflurane. The brain was removed, deep-frozen and 
sectioned on a cryostat microtome (Microm Laborgeräte GmbH, HM 500 OM, 
Waldorf, Germany). The position of the electrode tracks in the dentate hilus and 
angular bundle of the perforant path could then be verified using sections stained 
with cresyl violet. An example of correct placement of the electrodes is depicted in 
Figure 5A and B. 
 
 
 
 
 
 
 
 
 
 
 
 
Methods 
 32
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Marking of the stimulating and recording site in the mouse brain. Recording electrode 
in the upper granule cell layer of the dentate gyrus (A) and the stimulating electrode in the perforant 
path (B) of the left hemisphere. Black arrows indicate electrolytic lesions made at the tip of the 
electrodes, as was typical for the electrophysiological experiments. 
2.2.2 Current-response relationships 
The relationship between stimulation current and evoked response (i.e. input/output 
curve, I/O curve) was determined at the beginning of each experiment. Single 
square-wave pulses (50 µs) were delivered at currents of 100-1000 µA in 100 µA 
steps at 0.033 Hz with each test current repeated three times. The fEPSP initial 
slope, measured as the voltage difference between two constant time-points set at 
the onset of fEPSP and between fEPSP and pop-spike onset (20-80%), and the pop-
spike amplitude, measured as the voltage difference between the peak of the initial 
and late positive components and trough of the pop-spike, were measured for each 
response, as it is depicted in Figure 6A-C. 
2.2.3 Paired-pulse protocols 
Pairs of identical stimulation pulses were applied with varying the inter-pulse interval. 
Two protocols were used:  
1. Pre-synaptic stimulation: Stimulation current was set to below the population 
spike threshold for each animal and inter-pulse intervals (IPIs), i.e. the time 
between two pulses, were varied from 10-100 ms in 10 ms steps and from 
500-2000 ms in 500 ms steps. fEPSP peak heights of each of the pair of 
responses were compared, and the second peak height expressed as a ratio 
of the first (Figure 6D). Three determinations were made at each inter-pulse 
interval and a mean value calculated.  
2. Poly-synaptic feedback inhibition: Stimulation currents were set to evoke a 
population spike with 40-60% amplitude of the maximal response and 
interpulse intervals were varied from 10-100 ms in 10 ms steps and from 500-
2000 in 500 ms steps. Pop-spike amplitudes of each of the pair of responses 
were compared, and the second pop-spike amplitude expressed as a ratio of 
the first. Three determinations were made at each inter-pulse interval and a 
mean value calculated. 
The changes are expressed by the paired-pulse ratio (PPR), which is the ratio of the 
amplitude of the second response divided by that of the first. A ratio bigger than one 
is called paired-pulse facilitation (PPF) whereas a ratio smaller than one is called 
paired-pulse depression (PPD). 
A  B
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Figure 6: Local field potential traces recorded from the dentate gyrus. Local field potential traces 
recorded from the molecular layer of the dentate gyrus (A) and from the granule cells layer of the 
dentate gyrus (B) evoked by stimulating the perforant path. A negative going fEPSP is overlaid by a 
positive going pop-spike in the molecular layer in (A), whereas a positive going fEPSP is overlaid by a 
negative going pop-spike in the granule cell layer in (B). (C) Parameters measured of an evoked 
potential recorded in the granule cell layer: fEPSP slope (difference in point a and b divided by their 
difference in time) and pop-spike amplitude (difference in amplitude between points c and d). (D) 
Paired-pulse stimulation for fEPSP with an interpulse interval of 20 ms. The peak height of the two 
fEPSPs was measured for analyses. Calibration is indicated with a horizontal and vertical bar, 
respectively. 
2.2.4 Induction of long-term potentiation (LTP) 
Induction and maintenance of LTP was examined following high-frequency 
stimulation (HFS) of the perforant path. Test stimuli (50 µs), using a current sufficient 
to produce a population spike of 1-3 mV , were given at 30 s intervals for 30 min in 
order to establish a steady baseline response. HFS (six trains of six biphasic pulses 
of 50 µs length at 400 Hz, 200 ms intertrain interval, at a selected current that was at 
the lowest asymptotic level that evoked maximum pop-spike amplitude as derived 
from the I/O curve) was then applied to induce LTP. Recording of test responses was 
then continued, with the same current as before, for a 1 h period post-HFS. The 
fEPSP slope and the population-spike amplitude were measured for each test 
response. The baseline fEPSP slope and population-spike amplitude were calculated 
from the average of responses over a 10 min period prior to the HFS. All fEPSP 
slope and population-spike amplitude values were then expressed as a percentage 
of the baseline value and 10 consecutive responses were averaged.  
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2.2.5 Hippocampal electroencephalography (EEG) 
Hippocampal electroencephalographic activity was recorded in the dentate gyrus 
granule cell layer. Surgery and positioning of the recording electrode was 
accomplished as described above. For EEG experiments, mice were anaesthetised 
with urethane (ethyl carbamate) (Sigma-Aldrich Chemie GmbH, München, Germany) 
with a dose of 1.5 mg/kg intraperitoneally. Deep anaesthesia was indicated by lack of 
a pedal reflex and by regular breathing. At this plane of anaesthesia no spontaneous 
theta activity was present in the hippocampal EEG, but could be elicited robustly by 
sensory stimulation. A frequency of 3-6 Hz was analysed as this is the typical rhythm 
under urethane anaesthesia that can be eliminated by metabotropic acetylcholine-
receptor (mACh-R) antagonists (Kramis et al., 1975). A tail pinch with a forceps for 
10 s served as a sensory stimulus. Animals which did not show theta activity in the 
10 s epoch after stimulation were discarded. EEG was recorded continuously and the 
tail pinch was administered for three times with a 10 min interval in each mouse. 
During this interval theta activity came back to baseline level. EEG activity was 
filtered at 0.1-500 Hz and amplified with a gain of 500. EEG trace was recorded with 
a Signal analogue/digital board (Signal micro 1401, Cambridge Electronic Design 
Limited (CED), Cambridge, UK) and Signal software (Signal Version 2.03, Cambridge 
Electronic Design Limited (CED), Cambridge, UK) at a rate of 2000 Hz. Hippocampal 
EEG records were analysed offline with Igor software (Igor Pro, Version 5.0, 
WaveMetrics Inc., Lake Oswego, USA). For further characterisation, a 30 s-activity 
epoch before tail pinch and a 500 s-activity epoch after tail pinch were analysed. 
EEG amplitude and frequency spectra were generated from 10 s activity epochs by 
Fast Fourier Transform (FFT). FFT analysis provided maximal peak power (µV2) and 
was assessed for a 0.1-20 Hz band and subsequently for the theta band (3-6 Hz) 
over time. Theta activity was expressed as a percentage of the 30 s-baseline activity 
measured before the tail pinch. 
 
2.3 Behavioural Testing 
2.3.1 Water maze spatial discrimination task 
A circular swimming pool (80 cm in diameter, 30 cm high, white plastic) was filled to a 
depth of 20 cm with water (21 +/- 1°C, rendered opaque by addition of a non-toxic 
dye). At the outside of the maze, eight start boxes (10 x 10 x 26 cm), also filled with 
water and fitted with sliding doors, were fixed, from which the animal could swim into 
the centre of the maze when the door was raised. Introduction of start boxes allowed 
tracking of the animal as soon as it entered the circular open field of the maze. Two 
identically looking circular platforms with white surface and dark grey rim were used 
(each 10 cm in diameter, protruding approximately 0.5 cm above the water surface). 
One platform was stable and provided support (“correct platform”), the other platform 
was floating and sank when a mouse tried to climb on it (“incorrect platform”). 
Performance was recorded by the experimenter always standing behind the start 
box. Illumination in the testing room was about 50 lux on the water surface. 
Animals were first habituated to the testing by placing them for 1 min on the stable 
platform in the middle of the pool. On the following day, subjects were trained to 
choose between the two platforms over six sessions (acquisition stage, ten trials per 
session, one session in the morning per day). On each trial, the stable platform 
remained in the same position (counterbalanced within groups), while the floating 
platform changed position from trial to trial in a pseudorandom manner (five possible 
positions). It was ensured that the spatial relationship between the platforms did not 
consistently reward turns into one direction and the distance between the start 
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position and each of the two platforms was equal over ten trials. A trial started by 
placing a mouse in one of six possible start boxes in a pseudorandom sequence and 
the door was opened. All positions except the start positions in front of and opposite 
to the correct platform were used. Data recording started when the subject had left 
the start box. A trial terminated when a mouse climbed onto one of the two platforms 
or after 30 s. If the mouse climbed onto the stable platform within 30 s, it was allowed 
to stay there for another 10 s before it was returned to the home cage. If an animal 
made an incorrect choice (climbing on the incorrect platform), or after 30 s had 
lapsed, it was gently placed on the correct platform and allowed to stay there for 10 s 
before it was returned to the home cage. Animals were trained in squads of four. 
Inter-trial-intervals were approximately 2-4 min and each session lasted 
approximately 30 min. 
On day six, the floating platform was moved to the position of the stable platform and 
remained in the same position over the trials whereas the stable platform changed 
the position from trial to trial according to the rules previously applied to the floating 
platform (reversal stage). This was done to ensure that animals had learnt a spatial 
location rather than the ability to discriminate the two platforms by other means. 
Furthermore, hippocampus-dependent reversal learning and memory extinction could 
be assessed. 
The accuracy measure includes percentage of correct choices in the water maze. 
Choice latency was measured during water maze performance with a handheld 
stopwatch. A choice was made if an animal touched one of the platforms with its 
forepaws or its snout.  
2.3.2 Social interaction and olfactory recognition 
Olfactory recognition was tested during the beginning of the light phase (between 
8:00 and 12:00 a.m.). Group-housed experimental subjects were separated by 
transferring them to new Makrolon Type II cage (27 x 16 x 12 cm) with fresh bedding 
material 2 h before starting the session. Light intensity in the testing room on the level 
of the cages was 500 lux.  
A social discrimination session consisted of two 4 min exposures of juveniles of the 
C57BL/6NCrlBR strain (20-30 days old) to the adult mouse in the adult’s cage. 
During the first exposure (sampling trial), a juvenile was exposed to the adult animal, 
and the duration of the active investigatory behaviour (mainly sniffing and licking of 
the anogenital region, mouth, ears, trunk and tail of the juvenile and close following of 
the juvenile) and aggressive behaviour (biting, riding on back) of the adult towards 
the juvenile were recorded manually by a trained observer with a personal computer. 
Exploration time of this first encounter was used for the social interaction test. The 
juvenile was then removed and kept individually in a fresh cage. Short-term and long-
term memory was tested after a retention interval of either 1 h or 24 h. The juvenile 
was re-exposed to the adult (choice trial), but this time with an additional, previously 
not presented juvenile of the same age and strain. The duration of investigatory and 
aggressive behaviour of the adult towards each juvenile was measured 
simultaneously. Significantly longer investigation duration of the new juvenile 
compared to the familiar juvenile was taken as evidence for an intact recognition 
memory. A recognition index was calculated for each animal and was expressed by 
the ratio (Tnew) / (Told + Tnew) with T being the time spent exploring the juveniles. After 
each session, the experimental subjects were transferred back to their cage mates. 
Whereas social recognition was carried out under 500 lux illumination, the social 
interaction was accomplished under 0 lux or 500 lux illumination. 
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2.3.3 Novel object exploration and object recognition 
The object recognition test was performed in the dark phase of the animals’ light/dark 
cycle. Experimental subjects were habituated to the test arena (a Makrolon Type I 
cage, 36 x 22 x 14 cm, with sawdust bedding material and transparent walls) on two 
days for 10 min. Throughout the experiment, no cleaning of the box was allowed in 
order to saturate it with the animal’s own olfactory stimuli. The light intensity for 
testing was 30 lux at the level of test apparatus. On the third day, the mouse was 
transferred into the same test cage and after 10 min two objects were placed in a 
symmetrical position at the short walls of the cage. When placing the objects into the 
cage, the mouse was put in another Makrolon Type II cage for about 10 s and 
eventually put back into the test cage. Two identical objects were presented in the 
first trial (sampling trial). The duration of the sampling session was 10 min. 
Exploration time of this first encounter was used for the novel object exploration test. 
The retention interval was either 3 h or 24 h, for which the mouse was left in the test 
cage (with food and water ad libidum in the latter case) and short-term and long-term 
memory was tested, respectively. During the second encounter, one familiar object 
and one new object were introduced to the animal (test trial). The testing session 
again comprised 10 min. A small CCD camera (Conrad Electronics, München, 
Germany) was mounted above the Makrolon cage to enable behavioural observation 
and leaving the animal undisturbed. The time spent exploring each object during 
sampling and test were recorded manually online with a personal computer and also 
videotaped. Exploration was defined as follows: Directing the nose towards the object 
at a distance of no more than 2 cm and/or touching the object with the nose and 
paws. Sitting on the object was not considered as exploratory behaviour. Between 
sessions, objects were thoroughly cleaned with soap water to eliminate olfactory 
cues. We used four different sets of objects that were: (1) A cone made of aluminium 
(height: 12 cm x diameter: 6 cm), (2) a light bulb on a plastic socket (9 cm x 4 cm), 
(3) a flask made from yellow plastic filled with sand (12 cm x 4 cm), (4) a black bottle 
made of glass filled with water (13 cm x 5 cm). We used objects that were rather big 
(so that the mouse will spend more time exploring the object) and that differed in 
material and texture (so that the mouse could discriminate it more easily) (Abdul 
Ennaceur, personal communication). Objects had to be heavy enough that a mouse 
could not displace them. The order of objects used per subject per session was 
determined randomly, but it was always combined the cone with the light bulb and 
the black bottle with the plastic flask, so that novel and familiar objects were 
counterbalanced. A recognition index was calculated for each animal and was 
expressed by the ratio (Tnew) / (Told + Tnew) with T being the time spent exploring the 
objects. Whereas object recognition was carried out under 30 lux illumination, the 
novel object exploration was accomplished under 30 lux or 500 lux illumination. 
2.3.5 Contextual fear conditioning 
Conditioning chambers (ENV-307A, MED Associates, St. Albans, USA) consisted of 
a house light (0.6 lux, ENV-215M, MED Associates, St. Albans, USA), transparent 
plastic walls and aluminium walls, and mouse-shock floor consisting of grids (grid 
harness package: ENV-407, Shocker/Scrambler: ENV 414, MED Associates, St. 
Albans, USA). The conditioning context, which is further referred to as shock context, 
had a cubic shape. The grid was cleaned with 70% ethanol. The tray underneath the 
cage was filled with sawdust and sprayed with 70% ethanol to provide an olfactory 
cue. For memory testing, two different contexts were used. The first test context, 
further referred as grid context, had a shape of a hexagonal prism, with opaque side 
walls with rough surface. It was illuminated with a stimulus light (12 lux, ENV-221M, 
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MED Associates, St. Albans, USA) and cleaned with water containing isoamylacetate 
(1:2000, banana aroma) as a monomolecular odour. The same grid floor of the 
conditioning context served as a floor, and the tray underneath the cage was filled 
with sand (Quarzsand, Sakret Trockenbaustoffe Europa GmbH & Co. KG, Berlin, 
Germany) and sprayed with isoamylacetate as an olfactory cue. The second test 
context, further referred to as neutral context, consisted of a Plexiglas cylinder. It was 
illuminated with a house light (0.3 lux, ENV215-M, MED Associates, St. Albans, USA) 
and cleaned with 1% acetic acid. The floor was covered with sawdust bedding that 
was sprayed with 1% acetic acid.  
All contexts were located in soundproof isolation cubicles (ENV-018M, MED 
Associates, St. Albans, USA) that were additionally isolated with acoustic foam. 
Tones were generated by audio stimulus generators (ANL-926, MED Associates, St. 
Albans, USA) and applied by speakers (DTW 110 NG, Visaton, Conrad Electronics, 
München, Germany) mounted to the ceiling of the isolation cubicle over the 
respective context chambers. Small CCD cameras (Conrad Electronics, München, 
Germany) were mounted onto the back plane of the isolation cubicles to enable 
behavioural observation and recording on videotape. Experiments were controlled by 
commercial software (MED-PC for Windows v1.17) via interfaces (DIG 715) and the 
respective control panels (SG 215, all MED Associates, St. Albans, USA). For 
background contextual fear conditioning, animals were placed into the conditioning 
chamber. After 3 min, a 20 s tone (9 kHz sine wave, 80 dB) was presented that 
terminated with a 2 s scrambled electric footshock (0.5, 0.7 or 1.5 mA). It is important 
to know here that the tested mouse strains did not differ in pain threshold or auditory 
perception (C.T. Wotjak, personal communication). Animals were returned to their 
home cages 60 s after shock application. To measure the contextual freezing 
response, animals were placed into the grid context for 5 min, 24 h after conditioning 
(day1). Animals were then returned to their home cages. 2 h later, animals were 
placed into the original conditioning chamber, i.e. the shock context, for 5 min. This 
protocol was again carried out on day 2 and day 7. To measure the freezing 
response to the tone without confounding influences of contextual memory, 
conditioned mice were tested in the neutral context. After 3 min, the conditioning tone 
was presented (9 kHz, 80 dB) for 5 min. Mice were returned to their home cages 60 s 
after the end of tone presentation. An overview of the fear conditioning schedule is 
given in Figure 7. 
 
 
 
 
 
 
 
 
Figure 7: Schedule of the background contextual fear conditioning task. Mice were conditioned 
with a single tone shock association (either at 0.7 mA or at 1.5 mA) on day 0. On day 1, 2, and 7 
following the conditioning procedure, animals were firstly exposed to the grid context and 
subsequently to the shock context for 5 min, respectively. On day 8, mice were exposed to a novel 
context where the conditioning tone was presented for 5 min. 
 
 d0 d1 d2
CS+ 
d7 d8 
300s300s    300s 300s    300s 300s    300s
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The animals’ behaviour was videotaped. We focused on freezing as a measure of 
fear. This response is frequently used in studies with aversive classical conditioning. 
It is easy to quantify and not induced in naïve mice by a neutral unconditioned 
stimulus of intermediate intensity. Freezing behaviour is defined as the absence of all 
movements except for respiration and was quantified off-line by a trained observer 
and measured second-by-second.  
 
      Table 2: Overview of the three different contexts used for fear conditioning 
Context Shock context Grid context Neutral context 
Shape Cubicle Hexagonal Prism Cylinder 
Walls two aluminium walls 
and two transparent 
Plexiglas walls 
opaque Plexiglas 
walls with rough 
surface 
Transparent 
Plexiglas walls 
Floor Metal grid floor Metal grid floor sawdust bedding 
Cleaning/odour 70% ethanol Water containing 
isoamylacetate 
(1:2000, banana 
aroma) 
1% acetic acid 
Illumination Lighting of 0.6 lux Lighting of 12 lux Lighting of 0.3 lux 
2.3.6 Elevated plus-maze test 
The elevated plus-maze (EPM) was made of black plastic and consisted of two open 
arms (30 x 5 cm), and two enclosed arms (30 x 5 x 15 cm). A neutral zone of 5 x 5 
cm interconnected all four arms. The open arms had a rim with a height of 0.5 cm. 
The EPM was located 120 cm above the floor. The light intensity was 300 lux at the 
end of the open arms and 70 lux at the starting point of the open arms. In the closed 
arms light intensity was 50 lux and 60 lux on the central platform. A CCD camera 
(Conrad Electronics, München, Germany) was mounted over the plus-maze in order 
to observe the mouse’ behaviour and leave it undisturbed behind a curtain. At the 
beginning of the experiment, each mouse was placed on the central platform facing a 
closed arm. During the 5 min test, the time in percent spent on the open arms (time 
open arm/ (time open arm + time closed arm) x 100), open arm entries in percent 
(entries open arm/ (entries open arm + entries closed arm) x 100) and the number of 
entries into the closed and open arms were scored using the computer software 
program Plus maze (E. Fricke, München, Germany). Mice were considered to have 
entered an open or closed arm when all four paws were on the arm. After each test, 
the plus-maze was cleaned with water containing detergent and dried with tissue.  
2.3.7 Light/dark exploration 
Testing took place in four boxes (Coulbourn Instruments, Allentown, USA). Each box 
was divided into two equally sized compartments (L26 x W13 x H38 cm). One 
compartment was made of clear plastic walls and was illuminated with bright light of 
350 lux, an intensity that seems to be sufficiently aversive to reduce exploration in the 
lit compartment (Costall et al., 1989;Marsch et al., 2007), while the other 
compartment was made of black plastic, not illuminated and covered by a black roof. 
An opening, 7.5 x 7.5 cm wide, connected the two parts of the box. Two infrared 
sensor rings allowed measurement of vertical and horizontal activity, as will be further 
described below for the open field test. 
A session started by placing the animal in the centre of the dark compartment and 
lasted for 15 min. From the raw data, entries made into, relative distance travelled in 
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and relative time spent in the lit compartment over the 15 min period were calculated 
using Tru Scan Software Version 1.1 A (Coulbourn Instruments, Allentown, USA) and 
by means of customised macros implemented into Microsoft Excel (TruScan). 
2.3.8 Defensive marble burying 
One day prior to behavioural testing, mice were housed in a Makrolon type II cage on 
a thick layer (5 cm) of sawdust. On the testing day, 12 glass marbles with a diameter 
of 1 cm (Simba Toys GmbH, Fürth, Germany) were evenly spaced in the home cage 
in the presence of the mouse. Illumination in the cage was 0 lux. After 15 min the 
number of marbles at least two-thirds covered by sawdust was counted. 
2.3.4 Open field test 
Animals were tested in four open field boxes (L26 x W26 x H38 cm high) (Coulbourn 
Instruments, Allentown, USA), made of a white floor and clear plastic walls. The 
arena was subdivided in a centre and margin compartment with the margin clasping 
an area 4.5 cm away from the walls. The apparatus was equipped with infrared 
photocell sensors (sensor spacing 1.52 cm) and allowed measurement of vertical and 
horizontal activity (sampling frequency 4 Hz) and was connected to a personal 
computer equipped with TruScan Software Version 1.1 A. Each box, including its 
sensor rings, was surrounded by an additional box (47 x 47 x 38 cm, white plastic), 
which prevented the animals from seeing each other. 
A session started by placing the animal in the centre of the field. Mice were allowed 
to explore the apparatus for 30 min. The test was carried out at two different light 
conditions: 0 lux or 700 lux. The mice had to complete two runs using identical light 
conditions in the open field with a retention interval of 24 h. The total distance 
travelled, time rested, time spent in the margin, relative distance travelled in the 
margin and vertical activity (rearing) were measured offline in 3 min time-bins using 
the Tru Scan Software Version 1.1 A (Coulbourn Instruments, Allentown, USA) and 
by means of customised macros implemented into Microsoft Excel (TruScan). 
 
2.4 Statistical analysis 
Data were analysed by analyses of variance (ANOVA) for repeated measurements 
and followed by multiple pair-wise comparisons with the Student-Newman-Keul's 
post hoc test separately per line with genotype as an independent and time/day as a 
dependent variable. Data were Greenhouse-Geisser adjusted if they failed to pass 
Mauchley’s test of sphericity indicating that the groups’ variances were significantly 
different. Two-tailed Student’s t-test was used to compare genotypes for data 
containing two groups. For another subset of experiments, one-sample t-test was 
used to check for differences from chance level. 2 x 2 contingency tables and two-
sided Chi-square test were used to analyse responder versus non-responder 
characteristics. Data are presented as means +/- standard errors of the mean 
(S.E.M.). Statistical significance was set at p ≤ 0.05. 
For data illustration, we used GraphPad Prism Version 4.0 software (GraphPad 
Software Inc., San Diego, USA). For statistical analysis, SPSS 12.0 for Windows 
(SPSS Inc., Chicago, USA), GraphPad Prism Version 4.0 and Statistica 5.0 for 
Windows (StatSoft, Tulsa, USA) software were applied. 
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3. Results 
 
For the matter of clarity and brevity, all statistical parameters of a given experiment 
are summarised in Tables 3-37 in the Appendix. In the results sections we report only 
those non-significant and significant differences with the respective level of 
significance that are essential for the experiments under study. For further 
parameters, the degrees of freedom, error values and sample sizes the reader is 
kindly referred to the Tables shown in the Appendix. The respective tables are 
indicated for each experiment. 
 
3.1 Electrophysiology 
3.1.1 Current-response relationships 
As an indicator of basal synaptic transmission and excitability, the fEPSP slope and 
pop-spike amplitude across a range of stimulation currents were compared across 
the knockout mouse lines. Knockout mice and their respective wildtype littermates did 
not have significantly different responses for fEPSP slope for all three mouse lines 
(Figure 8A-C, Table 3). However, for pop-spike amplitude, GABA-CB1-ko mice had 
significantly larger responses than the wildtype mice over the whole range of stimulus 
intensities (p < 0.001) (Figure 8E, Table 3). Glu-CB1-ko had a strong tendency of 
increased pop-spike amplitudes (p = 0.067) as well (Figure 8F, Table 3). No 
differences were found for pop-spike responses for total-CB1-ko mice compared to 
their wildtype littermates (Figure 8D, Table 3).  
3.1.2 Paired-pulse facilitation of fEPSP slope 
Presynaptic short-term synaptic plasticity was investigated using the paired-pulse 
protocol for fEPSP. The paired-pulse facilitation profiles (inter-pulse interval: 10-100 
ms) were similar between ko and wt mice of all three lines (Figure 8G-I, Table 3). In 
each case, maximum facilitation of the second response was obtained with a 10-20 
ms inter-pulse interval. There were no significant differences in the degree of 
facilitation between knockout and wildtype mice of the three lines.  
3.1.3 Paired-pulse inhibition and facilitation of pop-spike 
Inhibitory feedback onto granule cells could be investigated using the paired-pulse 
protocol of pop-spike. Paired-pulse stimulation at intensities above threshold for 
evoking a pop-spike of about 50% of the maximal response was conducted with the 
three knockout lines (Figure 8J-L, Table 3). At shorter inter-pulse intervals (< 40 ms) 
the pop-spike evoked by the second pulse was inhibited relative to the first pulse. At 
the shortest interval, i.e. at 10 ms, complete inhibition of the second spike was 
observed for all three knockout mouse lines. At inter-pulse intervals between 40-100 
ms, the second pulse was facilitated relative to the first pulse. Spike facilitation 
peaked at inter-pulse intervals of 60-80 ms in all mice tested. At inter-pulse intervals 
ranging from 500-2000 ms, paired-pulse ratio declined to 1, indicating decreasing 
facilitatory or inhibitory processes occurring for these intervals. For the three 
intervals, that is 10-30 ms, 40-100 ms and 500-2000 ms, no statistically significant 
differences could be found between knockout mice and the respective wildtype 
littermates of the three mouse lines. Only total-CB1-ko mice were close to 
significance to show less paired-pulse facilitation between 40-100 ms compared to 
wildtype mice (genotype: p = 0.058). 
 
 
Results 
 41
 
 
Figure 8: Current-response relationships and short-term synaptic plasticity. Evoked potentials 
were recorded from the granule cell layer in vivo from anaesthetized mice. (A-F) Current-response 
relationship for total-CB1-ko, GABA-CB1-ko and Glu-CB1-ko mice and the respective wildtype 
littermates. (A-C) Slope of the evoked fEPSP over a range of stimulation currents. (D-F) Pop-spike 
amplitude over a range of stimulation currents. Data are shown as mean +/- S.E.M. ↑↑ p < 0.01 (main 
effect of genotype). Sample sizes are indicated for genotypes.  
(G-I) Paired-pulse facilitation of fEPSP. The relative change of fEPSP peak height from the first to the 
second response of each pair is plotted against the inter-pulse interval. Paired-pulse facilitation was 
observed over an inter-stimulus interval (IPI) range of 10-100 ms. Data are shown as mean +/- S.E.M. 
Sample sizes are indicated for genotypes. Dotted lines indicate equal peak heights of both pulses. 
(J-L) Paired-pulse inhibition and facilitation of pop-spike. The relative change in pop-spike amplitude 
from the first to the second response of each pair is plotted against the inter-pulse interval. Paired-
pulse depression was seen over an inter-stimulus interval range of 10-30 ms and paired-pulse 
facilitation was observed over an inter-stimulus interval (IPI) range of 40-100 ms. Facilitation 
recovered to a level of 1 as the IPI increased. Data are shown as the mean +/- S.E.M. Sample sizes 
are indicated for genotypes. Dotted lines indicate equal pop-spike amplitudes of both pulses.  
Please see Table 3 for statistical details. 
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3.1.4 Long-term potentiation (LTP) 
We next investigated long-term synaptic plasticity using the model of LTP. The 
baseline pop-spike amplitude for each mouse was set in the range of 1-3 mV pop-
spike amplitude. We measured baseline responses of fEPSP and pop-spike with a 
frequency of 0.03 Hz for 30 min. Then, high-frequency stimulation was administered 
into the perforant path and responses were again measured with the same current 
used for baseline stimulation. We found no genotype differences for LTP of fEPSP 
over the period of 1 h after tetanus injection for all three mouse lines when comparing 
knockout mice with the respective wildtype littermates (Figure 10A-C, Table 3).  
 
 
 
 
 
 
 
 
 
Figure 9: Evoked potential traces of a representative total-CB1-wt mouse. (A) Evoked potential 
during baseline stimulation. (B) Evoked potential 30 min after HFS. Enlargement of the pop-spike can 
be seen after LTP induction. Calibration is indicated with a horizontal and vertical bar, respectively. 
 
 
Figure 10: Long-term potentiation (LTP). (A-F) LTP of fEPSP slope and pop-spike amplitude in the 
granule cell layer of the dentate gyrus following high-frequency stimulation. (A-C) Time course of the 
slope of fEPSP responses evoked by a test pulse, expressed as a percentage of the baseline 
response (10 min before HFS) that is set to 100% (dotted line). One data-point is the average of ten 
responses. Data are the mean +/- S.E.M. (D-F) Time course of the amplitude of the pop-spike 
responses evoked by a test pulse, expressed as a percentage of the baseline (10 min before HFS) 
response that is set to 100% (dotted line). One data-point is the average of ten responses. Data are 
the mean +/- S.E.M. Sample sizes are indicated for genotypes. Arrows indicate the point of application 
of HFS. ↑ p < 0.05 (main effect of genotype). Please see Table 3 for statistical details. 
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A robust enhancement of pop-spike amplitudes persisted for at least 60 min in all 
genotypes of the three mouse lines (Figure 9 and Figure 10 D-F, Table 3). However, 
we could observe no difference for pop-spike amplitudes for the GABA-CB1-ko and 
the Glu-CB1-ko mice compared to the wildtype control mice (Figure 10E+F, Table 3). 
In contrast, total-CB1-ko mice showed significantly enhanced LTP compared to their 
wildtype littermates over the time course of 1 h after tetanus application (p < 0.05) 
(Figure 10D, Table 3). When comparing the individual levels of LTP of pop-spike in 
the total-CB1-ko mice, obviously only a subset of mice is responsible for the 
genotype difference in LTP (Figure 11). 
 
 
 
 
 
 
 
 
 
Figure 11: Pop-spike amplitude after LTP induction. Pop-spike amplitude in percent from baseline 
for the indicated mouse line and genotype for the one point in time 60 min after HFS. Each point 
represents one animal. Bars indicate the mean. 
3.1.5 Hippocampal electroencephalography (EEG) after tail pinch 
EEG activity was recorded from the granule cell layer of the dentate gyrus in 
urethane-anaesthetised total-CB1-ko mice and the respective wildtype controls. EEG 
activity in the theta range may be an indicator for enhanced cognitive abilities and 
possibly altered emotionality in animals. Pinching the mouse’s tail for 10 s elicited 
robust theta rhythm that occurred within 1-5 s and lasted over the analysed time-
frame of 6 min. Figure 12 shows representative 10 s traces of raw EEG activity 
before and after tail-pinch in total-CB1-ko mice. Spectral analysis of EEG revealed a 
prominent theta band that was evident 10 s following tail-pinch (Figure 13A). In order 
to study the sequence of theta oscillation over time, a baseline was measured for 30 
s. Then, a tail pinch of 10 s was administered and EEG was again measured for 360 
s. Theta activity was raised to about 115% of baseline level which was significantly 
different from baseline (interval: p < 0.001) (Figure 13B, Table 4). There were no 
significant differences for the total-CB1-ko mice from the respective wildtype 
littermates. 
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Figure 12: Representative local field potential EEG recordings in the dentate gyrus of a total-
CB1-wt mouse. Two 10 s epochs are shown, either 10 s before (baseline) (A) or 10 s after tail pinch 
(B). Calibration is indicated with a horizontal and vertical bar, respectively. 
 
Figure 13: Theta oscillations in the dentate gyrus of anaesthetised mice. (A) Fast Fourier 
Transform (FFT) analysis of total-CB1-ko animals and the respective wildtype controls. Each FFT 
analysis is the average of 10 s, recorded 10 s after the tail pinch. Dotted lines indicate the 3-6 Hz 
range that was defined as theta frequency. Data are the mean +/- S.E.M. Sample sizes are indicated 
for genotypes. (B) Averaged power spectra from all total-CB1-ko mice and the wildtype littermates for 
a sequence 30 s before and 500 s after the tail-pinch. EEG activity appeared within 10 s following 
initiation of the tail-pinch and lasted the whole 500 s epoch. When compared with wildtype mice, the 
averaged 3-6 Hz EEG spectral power band of total-CB1-ko mice was unaltered. Dotted lines indicate 
the range of the 10 s-tail pinch. Sample sizes are indicated for genotypes. Data are the mean +/- 
S.E.M. Please see Table 4 for statistical details. 
 
3.2 Learning and Memory 
3.2.1 Water maze spatial discrimination task 
Allocentric spatial discrimination learning was tested with a two-choice water maze 
task. Total-CB1-ko and Glu-CB1-ko mice and their respective wildtype littermates 
were trained to choose between two platforms with one platform being stable and 
providing support (correct platform) and the other platform floating and sinking when 
a mouse tried to climb on it (incorrect platform). For total-CB1-ko and Glu-CB1-ko 
mice and the respective wildtype mice, we found a significant increase in accuracy 
over days (day: p < 0.01 each), and a significant decrease in latency over days (day: 
p < 0.001 each), thus the animals successfully learned the task (Figure 14, Table 5). 
There was no overall effect between genotypes for the latency to swim to a platform 
over the days. Furthermore, no genotype difference could be seen in accuracy for the 
two mouse lines for the acquisition of the task. On day 6, the former stable platform 
became the sinkable platform and vice versa. For accuracy, reversal training 
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revealed that Glu-CB1-ko mice showed significantly less tendency to swim to the old 
location of the correct platform on day 6 and day 7 (genotype: p < 0.01) compared to 
the wildtype mice (Figure 14D, Table 5). No such differences could be found for total-
CB1-ko mice and the wildtype controls for reversal training (Figure 14C, Table 5). 
Figure 14: Water maze spatial discrimination task. (A-B) Choice latency to reach one of the 
platforms in total-CB1-ko mice (A) and Glu-CB1-ko mice (B) and the respective wildtype mice during 
the water maze spatial discrimination task. Day 1-5 displays acquisition training which is followed by 
reversal training on day 6-9 (separated by a vertical dotted line). (C-D) Accuracy (percentage correct 
choices) during water maze spatial discrimination task in total-CB1-ko mice (C) and Glu-CB1-ko (D) 
mice and the respective wildtype littermates. Day 1-5 displays acquisition training which is followed by 
reversal training on day 6-9 (separated by a vertical dotted line). The horizontal dotted lines represent 
chance performance (50 %). Data are expressed as mean values with error bars denoting S.E.M. ** p 
< 0.01. Sample sizes are indicated for genotypes. Please see Table 5 for statistical details. 
3.2.2 Social recognition 
We conducted a social recognition task after a short interval (1 h) or a long interval 
(24 h) to test short-term and long-term memory of mice for a familiar conspecific. As 
assessed by a one-sample t-test with a column mean different from 0.5 (i.e. chance 
level), total-CB1-ko (p < 0.01), total-CB1-wt (p < 0.001), GABA-CB1-ko (p < 0.05) 
and Glu-CB1-wt (p < 0.001) mice were able to discriminate between an already 
encountered familiar conspecific and a new juvenile mouse 1h after the first exposure 
whereas GABA-CB1-wt and Glu-CB1-ko mice failed to do so (Figure 15A, Table 6). 
After 24 h, only total-CB1-wt (p < 0.01), GABA-CB1-ko (p < 0.01) and GABA-CB1-wt 
(p < 0.05) mice were able to discriminate familiar from new juveniles (Figure 15B, 
Table 6).  
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Genotype differences were analysed with a two-tailed t-test. For recognition memory 
after 1 h or 24 h, there were no significant genotype differences except for Glu-CB1-
ko mice that showed a decrease in memory performance compared to their wildtype 
littermates (p < 0.05) after an 1 h interval (Figure 15A, Table 7). 
 
Figure 15: Social recognition memory. Short-term (1h) and long-term (24h) social recognition 
memory in total-CB1-ko mice, GABA-CB1-ko mice and Glu-CB1-ko mice and the respective wildtype 
mice. After a 4 min-sampling trial, social recognition was tested in a 4 min-choice trial 1h or 24h 
thereafter. A recognition index RI (Tnew) / (Told + Tnew) with T being the respective exploration time) was 
calculated. (A) Recognition index after 1 h. (B) Recognition index after 24 h. The dotted lines indicate 
chance level (0.5). Values are means +/- S.E.M. Sample sizes are given in Table 7 (Appendix). + p < 
0.05, ++ p < 0.01, +++ p < 0.001, one-sample t-test against chance level. # p < 0.05, two-tailed t-test. 
Please see Table 6+7 for statistical details. 
3.2.3 Object recognition 
An object recognition task was accomplished to test mice for short-term and long-
term memory performance. After having become acquainted with an object, mice 
were exposed to a novel object and a familiar one 3 h or 24 h thereafter. We applied 
a one-sample t-test with column mean different from 0.5 (i.e. chance level). After a 3 
h intertrial interval, mice of all three lines were able to discriminate the new object 
except for total-CB1-wt mice which showed a strong tendency to discriminate 
between the familiar and the new object (p = 0.08) (Figure 16A, Table 6). After a 24 
h-intertrial interval, in contrast, no genotype of the three lines could discriminate the 
new object from the old one except for total-CB1-wt mice that showed a strong 
tendency to discriminate between the familiar and the new object (p = 0.06) (Figure 
16B, Table 6). Two-tailed t-tests performed separately for the mouse lines failed to 
reveal significant genotype differences for the three mouse lines neither at the 3 h 
nor at the 24 h interval (Figure 16, Table 7).  
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Figure 16: Object recognition memory. Short-term (3h) and long-term (24h) object recognition 
memory in total-CB1-ko mice, GABA-CB1-ko mice and Glu-CB1-ko mice and the respective wildtype 
littermates. After a 10 min-sampling trial, object recognition was tested in a 10 min-choice trial 3h or 
24h later. A recognition index RI (Tnew) / (Told + Tnew) with T being the respective exploration time) was 
calculated. (A) Recognition index after 3 h. (B) Recognition index after 24 h. The dotted lines indicate 
chance level (0.5). Values are means +/- S.E.M. Sample sizes are given in Table 7 (Appendix). + p < 
0.05, +++ p < 0.001, one-sample t-test against chance level. P-value is indicated if it is close to 
significance. Please see Table 6+7 for statistical details. 
3.2.4 Contextual fear conditioning 
In order to understand the ability of mice of the three lines to discriminate between a 
shock context where the animals experienced an electric footshock and a grid 
context where they received no shock, we assessed fear conditioning to a context 
and to a tone in a background contextual fear conditioning task. Mice were exposed 
to the grid context and to the shock context on days 1, 2 and 7 after conditioning. On 
day 8, mice were exposed to another neutral context where the tone of the 
conditioning procedure was presented to the mice. Furthermore, mice were 
conditioned either with 0.7 mA or with 1.5 mA footshock intensity. 
On day 1 after conditioning with 0.7 mA, GABA-CB1-ko mice showed increased 
levels of freezing in the grid context (genotype: p < 0.05) whereas no significant 
differences could be found for total-CB1-ko and Glu-CB1-ko mice, compared to the 
respective wildtype controls (Figure 17A, C, E, Table 8). Glu-CB1-ko mice revealed 
higher levels of freezing in the shock context (genotype: p < 0.05) but total-CB1-ko 
and GABA-CB1-ko mice showed no significant differences here, compared with the 
wildtype controls, respectively (Figure 17A, C, E, Table 8). On day 2, total-CB1-ko 
and GABA-CB1-ko mice had increased levels of freezing in the grid context 
(genotype: p < 0.05 and p < 0.01, respectively) whereas Glu-CB1-ko mice showed no 
significant difference, compared to the respective wildtype littermates (Figure 17A, C, 
E, Table 8). However, Glu-CB1-ko mice showed augmented freezing-levels in the 
shock context (genotype: p < 0.05) and total-CB1-ko mice had a strong tendency to 
freeze more in the shock context (genotype: p < 0.07), but GABA-CB1-ko mice did 
not show any significant differences, compared to the wildtype littermates (Figure 
17A, C, E, Table 8). On day 7, freezing of GABA-CB1-ko mice was elevated in the 
grid context (genotype: p < 0.01) but no significant elevation could be seen in total-
CB1-ko and Glu-CB1-ko mice, compared to the wildtype controls, respectively 
(Figure 17A, C, E, Table 8). Total-CB1-ko mice had increased freezing levels in the 
shock context (interval x genotype: p < 0.01) and Glu-CB1-ko mice had a strong 
tendency to show increased freezing in the shock context (genotype: p < 0.06), but 
 
Results 
 48
GABA-CB1-ko mice revealed no significant differences, always compared with the 
respective wildtype control animals (Figure 17A, C, E, Table 8).  
On day 1 after conditioning with 1.5 mA, total-CB1-ko mice, GABA-CB1-ko mice and 
Glu-CB1-ko mice displayed increased levels of freezing in the grid context (genotype: 
p < 0.001, p < 0.005 and p < 0.05, respectively), always compared with the 
respective wildtype animals (Figure 17B, D, F, Table 9). Total-CB1-ko mice revealed 
higher levels of freezing in the shock context (genotype x interval: p < 0.05), whereas 
no significant differences were found for GABA-CB1-ko mice and Glu-CB1-ko mice, 
compared with the wildtype littermates (Figure 17B, D, F, Table 9). On day 2, total-
CB1-ko mice had increased levels of freezing in the grid context (genotype: p < 
0.001), whereas GABA-CB1-ko and Glu-CB1-ko mice showed no significant 
differences, compared with the respective wildtype controls (Figure 17B, D, F, Table 
9). GABA-CB1-ko mice had a strong tendency to freeze more in the shock context 
(genotype: p < 0.08), but total-CB1-ko mice and Glu-CB1-ko mice did not display any 
significant differences, compared to the wildtype control mice (Figure 17B, D, F, 
Table 9). On day 7, freezing of total-CB1-ko mice was elevated in the grid context 
(genotype: p < 0.001), but no significant difference was found for GABA-CB1-ko and 
Glu-CB1-ko mice, compared with the wildtype controls, respectively (Figure 17B, D, 
F, Table 9). Glu-CB1-ko mice had increased freezing in the shock context (genotype: 
p < 0.01), but no significant differences were seen in total-CB1-ko and GABA-CB1-ko 
mice, compared to the wildtype controls (Figure 17B, D, F, Table 9).  
We next tested whether mice of the three lines were able to discriminate between the 
two contexts. When being conditioned with 0.7 mA, on day 1, total-CB1-ko mice 
(genotype x context: p < 0.01), total-CB1-wt mice (genotype x context: p < 0.05), 
GABA-CB1-ko mice (genotype x context: p < 0.005) and GABA-CB1-wt mice 
(genotype x context: p < 0.001) had higher freezing levels in the shock context 
compared to the grid context, but Glu-CB1-ko and Glu-CB1-wt mice failed to do so 
(Table 12). On day 2, GABA-CB1-wt mice (genotype x context: p < 0.005) and Glu-
CB1-ko mice (genotype x context: p < 0.05) displayed higher freezing levels in the 
shock context, but total-CB1-ko, total-CB1-wt, GABA-CB1-ko and Glu-CB1-wt mice 
failed to do so (Table 12). On day 7, GABA-CB1-wt mice were close to significance to 
reveal higher levels of freezing (genotype x context: p < 0.059) and Glu-CB1-ko mice 
(genotype x context: p < 0.01) indeed revealed higher levels of freezing in the shock 
context compared to the grid context, whereas total-CB1-ko, total-CB1-wt, GABA-
CB1-ko and Glu-CB1-wt mice showed similar levels of freezing in both contexts 
(Table 12).  
On day 1 after conditioning with 1.5 mA, GABA-CB1-wt mice showed more freezing 
in the shock context (context: p < 0.01), whereas total-CB1-ko, total-CB1-wt, GABA-
CB1-ko, Glu-CB1-ko and Glu-CB1-wt mice failed to do so (Table 13). On day 2, total-
CB1-wt mice (context: p < 0.05), GABA-CB1-ko mice (context: p < 0.01) and GABA-
CB1-wt mice (context: p < 0.05) displayed more freezing in the shock context 
compared to the grid context, but there was no significant difference for total-CB1-ko, 
Glu-CB1-ko and Glu-CB1-wt mice (Table 13). On day 7, total-CB1-ko mice (context x 
interval: p < 0.05), Glu-CB1-ko mice (context: p < 0.01), Glu-CB1-wt mice (context: p 
< 0.05), GABA-CB1-ko mice (context: p < 0.05) and GABA-CB1-wt mice (context: p < 
0.05) had higher levels of freezing in the shock context compared to the grid context, 
but total-CB1-wt mice showed no significant differences (Table 13) .  
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Figure 17: Background contextual fear conditioning. Freezing levels of total-CB1-ko mice (A-B), 
GABA-CB1-ko mice (C-D) and Glu-CB1-ko mice (E-F) and the respective wildtype littermates in the 
contextual fear conditioning paradigm on day 1, 2 and 7 after conditioning. Mice were conditioned with 
0.7 mA (A, C, E) or with 1.5 mA (B, D, F). Grey insets and square symbols highlight the freezing 
values in the shock context compared to the grid context with diamond symbols. Data are shown in 1-
min-intervals. Values are means +/- S.E.M. Arrows indicate significant main effects of genotype. 
Asterisks indicate post-hoc comparisons following significant genotype x interval interaction. ↑ p < 
0.05, ↑↑ p < 0.01 and ** p < 0.01. Effects close to significance are indicated by the given p value. 
Sample sizes are indicated for genotypes. Please see Table 8+9 for statistical details. 
 
If the development of the freezing response on the repeated test days was analysed 
separately for context, at 0.7 mA, total-CB1-ko mice and GABA-CB1-ko mice showed 
generally more freezing in the grid context than the wildtype control mice (genotype: 
p < 0.05 and p < 0.01, respectively) independently of the testing days (genotype x 
day: p = 0.3 and p = 0.7, respectively) but there was no significant difference in  
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Figure 18: Development of the fear response in the two contexts. Freezing levels of total-CB1-ko 
mice, GABA-CB1-ko mice and Glu-CB1-ko mice and the respective wildtype littermates in the shock 
context (A, B) or the grid context (C, D) following background contextual fear conditioning with 0.7 mA 
(A, C) or 1.5 mA (B, D), respectively over the three testing days. Values are means +/- S.E.M. Sample 
sizes are the same as in Fig. 17. Arrows indicate significant main effects of genotype. Asterisks 
indicate post-hoc comparisons following significant genotype x interval interaction. ↑ p < 0.05, ↑↑ p < 
0.01, ↑↑↑ p < 0.001 and ** p < 0.01. Please see Table 14+15 for statistical details. 
 
Glu-CB1-ko mice, compared with the wildtype littermates (Figure 18C, Table 14). On 
the other hand, Glu-CB1-ko mice revealed generally more freezing in the shock 
context (genotype: p < 0.01) which is not the case in total-CB1-ko and GABA-CB1-ko 
mice, compared to the wildtype mice (Figure 18A, Table 14).  
At 1.5 mA, total-CB1-ko mice, GABA-CB1-ko mice and Glu-CB1-ko mice showed 
generally more freezing in the grid context than the wildtype control mice (genotype: 
p < 0.001, p < 0.05 and p < 0.05, respectively) (Figure 18D, Table 15). In the shock 
context, no differences in the levels of freezing could be found in total-CB1-ko and 
GABA-CB1-ko mice, compared to their wildtype control mice, respectively, whereas 
there was augmented freezing in Glu-CB1-ko mice compared to the wildtype 
littermates (day x genotype: p < 0.01) (Figure 18B, Table 15). 
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Figure 19: Conditioning response to the auditory cue. Freezing levels of total-CB1-ko mice, 
GABA-CB1-ko mice and Glu-CB1-ko mice and the respective wildtype littermates for the auditory cue 
in the background contextual fear conditioning paradigm on day 8. The same mice as shown in Fig. 15 
were conditioned with 0.7 mA (A) or with 1.5 mA (B). Data are shown in 1-min-intervals. Values are 
means +/- S.E.M. Sample sizes are the same as in Fig. 17. Arrows indicate significant main effects of 
genotype. Asterisks indicate post-hoc comparisons following significant genotype x interval interaction. 
↑ p < 0.05, ↑↑ p < 0.01 and ** p < 0.01, *** p < 0.001. Effects close to significance are indicated by the 
given p value. Please see Table 8+9 for statistical details. 
 
Next, we tested whether mice of the three lines displayed different freezing behaviour 
to the tone used for fear conditioning. The animals were exposed to a neutral context 
and the conditioning tone was presented for 5 min.  
Being conditioned with 0.7 mA, total-CB1-ko (interval x genotype and genotype: p < 
0.001 and p < 0.05, respectively) showed higher freezing levels and Glu-CB1-ko 
(genotype: p < 0.092) mice showed a tendency to display more freezing to the tone, 
whereas there was no significant difference for GABA-CB1-ko mice, always 
compared to the wildtype control mice (Figure 19A, Table 8). 
Being conditioned with 1.5 mA, total-CB1-ko (Interval x genotype and genotype: p < 
0.05 each) showed higher freezing levels whereas there was no significant difference 
for GABA-CB1-ko mice and Glu-CB1-ko mice, always compared to the wildtype 
control mice (Figure 19B, Table 9). Additionally, we conditioned Glu-CB1 with 0.5 mA 
(these results are summarised in the Appendix section). Here, Glu-CB1-ko mice 
revealed higher freezing levels than their wildtype littermates when the tone was 
presented (Interval x genotype: p < 0.01) (Figure 35B, Table 17).  
Eventually, we checked whether the mice of the three lines revealed altered freezing 
behaviour in a new environment, which was the neutral context on day 8 before tone 
presentation. For 0.7 mA, there was no difference in freezing for total-CB1-ko, GABA-
CB1-ko and Glu-CB1-ko mice compared to the wildtype littermates (Figure 20A, 
Table 22). At 1.5 mA, no difference could be detected for total-CB1-ko and Glu-CB1-
ko mice, but GABA-CB1-ko mice showed augmented levels of freezing (genotype: p 
< 0.01), always compared to the wildtype animals (Figure 20B, Table 22).  
 
 
 
 
 
 
 
Results 
 52
 
 
Figure 20: Response of fear in a neutral context. Freezing levels of total-CB1-ko mice, GABA-CB1-
ko mice and Glu-CB1-ko mice and the respective wildtype littermates before the auditory cue in the 
contextual fear conditioning paradigm on day 8 after conditioning. Mice were conditioned with 0.7 mA 
(A) or with 1.5 mA (B). Data are shown in 1-min-intervals. Values are means +/- S.E.M. Sample sizes 
are the same as in Fig. 17. Arrows indicate significant main effects of genotype. ↑↑ p < 0.01. Please 
see Table 22 for statistical details. 
 
3.3 Emotionality and Anxiety 
3.3.1 Elevated plus-maze 
As an indicator of anxiety-related behaviour, the time and frequency with which a 
mouse explored an unprotected and aversive environment, i.e. the open arms, was 
assessed with the elevated plus-maze on two consecutive days.  
On day one, no significant differences for open-arm entries, open-arm time, closed-
arm entries and total-arm entries could be found for the genotypes of the three 
mouse lines, although total-CB1-ko showed a strong tendency to enter the open 
arms less often (p < 0.08) and to spend less time in the open arms (p < 0.09) 
whereas GABA-CB1-ko had a strong tendency to enter the open arms more 
frequently (p < 0.06), always compared to the respective wildtype controls (Figure 
21A+C, Table 23). For total arm entries and closed arm entries, i.e. parameters to 
control for locomotion, no differences could be observed for any of the three mouse 
lines (Figure 21B+D).  
On day two, no significant differences for open-arm entries, open-arm time, total-arm 
entries and closed-arm entries could be found for the genotypes of the three mouse 
lines, although total-CB1-ko showed a tendency to spend less time on the open arms 
(p < 0.097) (Figure 22A-D, Table 23). 
Using a chi square test, we next analysed how many mice per genotype explored the 
open arms at all. On day one, no differences could be found for the genotypes of the 
three mouse lines (Figure 23A, Table 24). On day two, however, significantly less 
total-CB1-ko mice (p < 0.05) and Glu-CB1-ko mice (p < 0.01) explored the open arms 
compared to the respective wildtype mice (Figure 23B, Table 24). 
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Figure 21: Elevated plus-maze behaviour on day 1. Behaviour on the elevated plus-maze of total-
CB1-ko mice, GABA-CB1-ko mice and Glu-CB1-ko mice and the respective wildtype littermates on 
day 1. Open-arm entries (A), open-arm time (B), total number of arm entries (C) and closed-arm 
entries (D) are shown. Bars represent means +/- S.E.M. Sample sizes are given in Table 23 
(Appendix). Effects close to significance are indicated by the given p value. Please see Table 23 for 
statistical details. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 54
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: Elevated plus-maze behaviour on day 2. Behaviour on the elevated plus-maze of total-
CB1-ko mice, GABA-CB1-ko mice and Glu-CB1-ko mice and the respective wildtype littermates on 
day 2. Open-arm entries (A), open-arm time (B), total number of arm entries (C) and closed-arm 
entries (D) are shown. Bars represent means +/- S.E.M. Sample sizes are given in Table 23 
(Appendix). Effects close to significance are indicated by the given p value. Please see Table 23 for 
statistical details. 
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Figure 23: Proportion of non-explorers of the open arms. Relative number of animals of total-CB1-
ko mice, GABA-CB1-ko mice and Glu-CB1-ko mice and the respective wildtype littermates which 
refrained from open arm exploration at all on day 1 (A) and on day 2 (B). Sample sizes are given in 
Table 24 (Appendix). * p < 0.05, ** p < 0.01 versus respective wildtype mice (chi-square test). Please 
see Table 24 for statistical details. 
3.3.2 Light/dark exploration 
To test the avoidance of animals to explore brightly lit environments, animals were 
exposed to the light/dark box for 15 min. The time spent in the lit compartment, the 
relative distance moved in the lit compartment normalised to the total distance moved 
and the entries into the lit compartment were analysed. No significant genotype 
differences could be ascertained for either parameter for total-CB1, GABA-CB1 and 
Glu-CB1 mice (Figure 24A-C, Table 25). 
 
Figure 24: Light/dark box. Light/dark box exploration of total-CB1-ko mice, GABA-CB1-ko mice and 
Glu-CB1-ko mice and the respective wildtype littermates. (A) Relative time the animals spent in the 
illuminated compartment (B) relative distance travelled in the illuminated part (C) entries made into the 
lit compartment are shown for the entire 15 min exposure in 3-min-intervals. Dotted lines in (A) and (B) 
indicate an equal distribution in both compartments (50%). Data are presented as means +/- S.E.M. 
Sample sizes are indicated for genotypes (WT / KO). Please see Table 25 for statistical details. 
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3.3.3 Defensive marble burying 
Marbles that are distributed in the home cage can be considered as an aversive 
stimulus to mice. Therefore, the number of marbles that are buried in the home cage 
of the mice was assessed with the marble burying test during a 15 min interval. No 
significant differences in the number of buried marbles could be found between the 
genotypes (Figure 25, Table 27). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Defensive marble burying test. Number of marbles buried during a 15 min session by 
total-CB1-ko mice, GABA-CB1-ko mice and Glu-CB1-ko mice and the respective wildtype littermates. 
Data are presented as means +/- S.E.M. Sample sizes are given in Table 27 (Appendix). Please see 
Table 27 for statistical details. 
3.3.4 Social interaction 
As a marker of anxiety-related behaviour, the time spent by a mouse in social 
interaction, i.e. sniffing, close following or grooming the partner, was tested in the 
three mouse lines under lowly or highly aversive lighting conditions, i.e. 0 lux and 500 
lux. At an illumination of 0 lux, we found no significant genotype differences for the  
Figure 26: Exploration of a novel juvenile mouse. Exploration of a novel juvenile mouse by total-
CB1-ko mice, GABA-CB1-ko mice and Glu-CB1-ko mice and the respective wildtype littermates at 0 
lux (A) or 500 lux (B). Values are means +/- S.E.M. Sample sizes are given in Table 26 (Appendix). ** 
p < 0.01 versus respective wildtype mice (unpaired t-test). Please see Table 26 for statistical details. 
 
three mouse lines (Figure 26A, Table 26). But at an illumination of 500 lux, the time in 
which total-CB1-ko (p < 0.01) and Glu-CB1-ko (p < 0.01) mice engaged in social 
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interaction with a juvenile mouse was significantly lower compared to their wildtype 
littermates whereas there was no significant difference between GABA-CB1-ko mice 
and the respective wildtype controls (Figure 26B, Table 26). 
3.3.5 Novel object exploration 
As a marker of anxiety-related behaviour, the time spent by a mouse in exploring a 
novel object was tested in the three mouse lines under two lighting conditions that 
were 30 lux and 500 lux. At an illumination of 30 lux, we found no difference for total-
CB1 mice, an increase of exploration for GABA-CB1-ko mice (p < 0.05) and a 
decrease of exploration in Glu-CB1-ko mice (p < 0.01) always compared with the 
respective wildtype control mice (Figure 27A, Table 26). At an illumination of 500 lux, 
total-CB1-ko (p < 0.01) and Glu-CB1-ko (p < 0.001) mice showed decreased levels of 
exploration whereas GABA-CB1-ko mice (p < 0.05) showed an increase of 
exploration of the novel object compared to their wildtype littermates, respectively 
(Figure 27B, Table 26). 
  
Figure 27: Exploration of a novel object. Exploration of a novel object by total-CB1-ko mice, GABA-
CB1-ko mice and Glu-CB1-ko mice and the respective wildtype littermates at 30 lux (A) or 500 lux (B). 
Values are means +/- S.E.M. Sample sizes are given in Table 26 (Appendix). * p < 0.05, ** p < 0.01, 
*** p < 0.001 versus respective wildtype mice (unpaired t-test). Please see Table 26 for statistical 
details. 
 
3.3.6 Open field test 
Mice were exposed to an open field arena for 30 min. The test was conducted under 
two illuminations, 0 lux and 700 lux, on two consecutive days.  
On day 1 at 0 lux, we found a significant difference in the development of rearing 
over the time of Glu-CB1-ko mice (genotype x interval: p < 0.05), indicating that the 
mutants showed a decrease in the number of rearing towards the end of exposure, 
and no significant difference for total-CB1-ko and GABA-CB1-ko mice, always 
compared to the respective wildtype littermates (Figure 28A, Table 28). There was an 
increase for the total distance moved of total-CB1-ko mice (genotype x interval: p < 
0.001) whereas no significant difference could be found for GABA-CB1-ko and Glu-
CB1-ko mice, always compared to the respective wildtype mice (Figure 28C, Table 
28). At the same time, we observed a decrease of immobility of total-CB1-ko mice 
(genotype x interval: p < 0.001) and no significant difference for GABA-CB1-ko and 
Glu-CB1-ko mice, always compared to the respective wildtype controls (Figure 28E, 
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Table 28). Distance moved close to margin is significantly decreased in total-CB1-ko 
mice and in Glu-CB1-ko mice (genotype or genotype x interval: p < 0.05 and p < 
0.05, respectively) but unchanged in the GABA-CB1-ko mice, always compared to 
the wildtype control mice, respectively (Figure 28G, Table 28).  
On day 1 at 700 lux, we found a decrease of rearing of total-CB1-ko mice (genotype: 
p < 0.05) whereas GABA-CB1-ko and Glu-CB1-ko mice showed no significant 
difference, always compared to the respective wildtype controls (Figure 28B, Table 
29). There was a decrease for the total distance moved of total-CB1-ko (genotype: p 
< 0.05) and a tendency of an increase of total distance moved for GABA-CB1-ko 
mice (genotype: p < 0.097) whereas no significant difference could be found for Glu-
CB1-ko mice, always compared to the respective wildtype controls (Figure 28D, 
Table 29). No differences were found for immobility in the three mouse lines (Figure 
28F, Table 29). Distance moved close to margin was significantly increased in total-
CB1-ko mice, Glu-CB1-ko mice (genotype: p < 0.05 each) and in GABA-CB1-ko mice 
(genotype x interval: p < 0.05) compared to the wildtype controls (Figure 28H, Table 
29).  
On day 2 at 0 lux, we found a decrease of rearing of total-CB1-ko and Glu-CB1-ko 
mice (genotype x interval and genotype: p < 0.05 each), but levels of rearing were 
not significantly different in GABA-CB1-ko mice, always compared with the respective 
wildtype control mice (Figure 29A, Table 30). Total distance moved was not 
significantly different in the three mouse lines, although there was a tendency of 
increased locomotion in the total-CB1-ko mice (genotype x interval: p = 0.08), 
compared to the wildtype controls (Figure 29C, Table 30). We observed an increase 
of immobility in Glu-CB1-ko mice (genotype: p < 0.05) but no significant differences in 
total-CB1-ko mice and GABA-CB1-ko mice, always compared with the wildtype mice, 
respectively (Figure 29E, Table 30). Distance moved close to the margin was 
significantly decreased in total-CB1-ko mice (genotype: p < 0.05), but did not reach 
significant differences in GABA-CB1-ko and Glu-CB1-ko mice, compared to the 
wildtype mice, respectively (Figure 29G, Table 30).  
On day 2 at 700 lux, we found a decrease of rearing of total-CB1-ko and Glu-CB1-ko 
mice (genotype: p < 0.001 and p < 0.05, respectively) but not in GABA-CB1-ko mice, 
always compared with the respective wildtype mice (Figure 29B, Table 31). There 
was a decrease for the total distance moved of total-CB1-ko and Glu-CB1-ko mice 
(genotype: p < 0.05 each) but not in GABA-CB1-ko mice, compared with the 
respective wildtype animals (Figure 29D, Table 31). Immobility was unaltered for the 
genotypes, although there was a tendency of increased immobility in total-CB1-ko 
and Glu-CB1-ko mice (genotype: p = 0.06 and p = 0.099, respectively) always 
compared to the respective wildtype littermates (Figure 29F, Table 31). Distance 
moved close to margin was significantly increased in Glu-CB1-ko mice (genotype: p 
< 0.05), whereas no significant difference could be found in total-CB1-ko and GABA-
CB1-ko mice, compared with the respective wildtype controls (Fig 29. H, Table 31).  
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Figure 28: Open field test on day 1. Open field behaviour of total-CB1-ko mice, GABA-CB1-ko mice 
and Glu-CB1-ko mice and the respective wildtype littermates on day 1 at 0 lux (A, C, E, G) or 700 lux 
(B, D, F, H). Vertical activity (i.e. rearing) (A-B), total distance moved (i.e. locomotion) (C-D), 
immobility (E-F) and relative distance moved along the margin walls (i.e. thigmotaxis) (G-H) are shown 
for the entire 30 min exposure in 3-min-intervals. Data are presented as means +/- S.E.M. Sample 
sizes are given in Table 34 and 35. Arrows indicate significant main effects of genotype. Asterisks 
indicate post-hoc comparisons following significant genotype x interval interaction. ↑ or ↓ p < 0.05, ↓↓ p 
< 0.01, and * p < 0.05, ** p < 0.01, *** p < 0.001. Effects close to significance are indicated by the 
given p value. Please see Table 28+29 for statistical details.  
 
Figure 29: Open field test on day 2. Open field behaviour of total-CB1-ko mice, GABA-CB1-ko mice 
and Glu-CB1-ko mice and the respective wildtype littermates on day 2 at 0 lux (A, C, E, G) or 700 lux 
(B, D, F, H). Rearing (A-B), locomotion (C-D), immobility (E-F) and relative distance moved along the 
margin walls (G-H) over 30 min are shown. Data are presented as means +/- S.E.M. Sample sizes are 
given in Table 34 and 35. Arrows indicate significant main effects of genotype. Asterisks indicate post-
hoc comparisons following significant genotype x interval interaction. ↑ or ↓ p < 0.05, ↑↑ p < 0.01 and * 
p < 0.05, ** p < 0.01. Effects close to significance are indicated by the given p value. Please see Table 
30+31 for statistical details. 
3.3.7 Open field habituation from day 1 to day 2 
We assessed the development of the behavioural performance from day 1 to day 2 
by means of ANOVA for repeated measurements for 0 lux. We found a tendency of 
increased immobility of Glu-CB1-ko (genotype: p = 0.088) but no significant 
difference for total-CB1-ko and GABA-CB1-ko mice compared to the wildtype control 
mice, respectively (Figure 30E, Table 32). No significant differences could be found 
for total distance moved in the three mouse lines (Figure 30C, Table 32). Glu-CB1-ko 
mice revealed a decrease in rearing over the two days (genotype: 0.05), but there 
was no difference for total-CB1-ko and GABA-CB1-ko mice, compared to the 
wildtype controls, respectively (Figure 30A, Table 32). However, in no case there was 
a significant interaction between genotype and day for immobility, total distance 
moved, and rearing indicating that the degree of habituation did not differ for the 
three mouse lines. 
We then tested with a paired t-test for every genotype whether habituation occurred 
(Table 34). For rearing, there was a significant decrease in Glu-CB1-ko mice (p < 
0.05) but not in Glu-CB1-wt mice as being the case in total-CB1-ko, total-CB1-wt, 
GABA-CB1-ko and GABA-CB1-wt mice. For locomotion, total-CB1-ko mice did not 
show a decrease whereas total-CB1-wt mice did show a decrease (p < 0.05, 
respectively) as it can be found in Glu-CB1-ko (p < 0.01), Glu-CB1-wt (p < 0.001), 
GABA-CB1-ko (p < 0.05) and GABA-CB1-wt (p < 0.001) mice. For immobility, a 
significant increase could be observed for total-CB1-wt (p < 0.01) mice and GABA-
CB1-wt mice (p < 0.001) whereas for total-CB1-ko mice (p < 0.058) and GABA-CB1-
ko mice (p < 0.056) the increase was close to significance and both Glu-CB1-ko (p < 
0.01) and Glu-CB1-wt mice (p < 0.01) showed increased levels of immobility always 
compared to the wildtype controls.  
By means of ANOVA for repeated measurements we analysed habituation of the 
three mouse lines over days for 700 lux. We found a significant decrease of rearing in 
total-CB1-ko mice, GABA-CB1-ko mice and Glu-CB1-ko mice over the course of the 
days as compared to the respective wildtype controls (genotype, genotype x day and 
genotype x day: p < 0.05 each), compared to the littermate controls (Figure 30B, 
Table 33). For total distance moved, a decrease was seen in Glu-CB1-ko mice 
(genotype x day: p < 0.05) and in total-CB1-ko mice (genotype: p < 0.05) but not in 
GABA-CB1-ko mice, compared to the respective wildtype controls (Figure 30D, Table 
33). For immobility, a significant increase was found in Glu-CB1-ko mice (genotype x 
day: p < 0.05) whereas total-CB1-ko and GABA-CB1-ko mice showed no significant 
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differences when being compared with the respective wildtype control animals 
(Figure 30F, Table 33).  
Using a paired t-test, we then tested for every genotype whether habituation occurred 
(Table 35). At 700 lux, significant decrease in rearing and total distance moved and a 
significant increase for immobility could be assessed for all genotypes. Only for total-
CB1-wt mice we found an increase of rearing under these conditions. 
Eventually, we examined habituation within the first open field exposure (Table 36). 
For total-CB1-ko, total-CB1-wt, GABA-CB1-ko, GABA-CB1-wt, Glu-CB1-ko and Glu-
CB1-wt mice we found a decrease of locomotion over time (p < 0.001 each) at 0 lux. 
We could see a corresponding increase of immobility for total-CB1-ko, total-CB1-wt, 
GABA-CB1-ko, GABA-CB1-wt, Glu-CB1-ko and Glu-CB1-wt mice (p < 0.001 each). 
At 700 lux, there was a decrease in locomotion only in total-CB1-wt, GABA-CB1-ko, 
GABA-CB1-wt, Glu-CB1-ko and Glu-CB1-wt mice (p < 0.001 each) but not for total-
CB1-ko mice (Table 37). In addition, we observed a significant increase of immobility 
in total-CB1-wt, GABA-CB1-ko, GABA-CB1-wt, Glu-CB1-ko and Glu-CB1-wt mice (p 
< 0.001 for each genotype, respectively) but not for total-CB1-ko mice. 
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Figure 30: Open field test habituation. Open field habituation of total-CB1-ko mice, GABA-CB1-ko 
mice and Glu-CB1-ko mice and the respective wildtype littermates form day 1 to day 2 under 0 lux (A, 
C, E) or 700 lux (B, D, F). Rearing (A-B), locomotion (C-D) and immobility (E-F) are shown. Data are 
presented as means +/- S.E.M. Sample sizes are given in Table 34 and 35. Arrows indicate significant 
main effects of genotype. Asterisks indicate post-hoc comparisons following significant genotype x 
interval interaction. ↓ p < 0.05 and ** p < 0.01, *** p < 0.001. Effects close to significance are indicated 
by the given p value. Please see Table 32+33 for statistical details. 
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4. Discussion 
 
In the present study, we compared electrophysiological, memory-related and 
emotional characteristics of three CB1-deficient mouse lines: A conventional knock-
out mouse line (total-CB1-ko mice) and two conditional knock-out mouse lines with a 
cell type specific deficiency of CB1 on GABAergic interneurons (GABA-CB1-ko mice) 
or glutamatergic neurons (Glu-CB1-ko mice). 
 
4.1 Synaptic transmission and plasticity in CB1-ko mice  
4.1.1 Effects of CB1 signalling on basal synaptic transmission 
CB1 is located on GABAergic and glutamatergic nerve terminals and can unfold an 
inhibitory effect on transmitter release (Freund et al., 2003). It is well studied that 
activation or block of CB1 can influence the synaptic transmission in a cellular 
pathway. Application of CB1 agonists reduced evoked EPSCs and IPSCs in dentate 
granule cells (Hajos and Freund, 2002). A reversible depression of both fEPSP and 
pop-spike can be seen after anandamide application (Terranova et al., 1995), 
although it had no effect in another study (Lees and Dougalis, 2004). Conversely, the 
CB1 antagonists SR141716 and AM251 can augment basal excitatory synaptic 
transmission (Slanina and Schweitzer, 2005). The latter study indicates that 
endocannabinoids might have a tonic activity to decrease excitatory 
neurotransmission.  
In the present study, comparison of the current-response relationship of the perforant 
path input to the granule cells of the dentate gyrus revealed no significant differences 
in shape of the fEPSP increase. For pop-spike amplitude, there was a difference in 
that GABA-CB1-ko mice showed increased amplitudes over a range of stimulating 
currents. This difference in the input-output relationship for pop-spike is quite 
remarkable as it indicates an alteration in basal cellular excitation to fire action 
potentials of GABA-CB1-ko mice in contrast to total-CB1-ko and Glu-CB1-ko mice 
but not in depolarisation of the cells as it is reflected in the fEPSP for the three mouse 
lines. What might be the reason for the specific enhancement of pop-spike amplitude 
in GABA-CB1-ko mice? One line of evidence points towards altered input properties 
of the medial septum. The projection of the medial septum to the hippocampus 
consists of two components: One is cholinergic afferents which contact both 
pyramidal and inhibitory cells in the hippocampus (Frotscher and Leranth, 1985). The 
other component is GABAergic neurons that seem to selectively contact interneurons 
(Freund and Antal, 1988). About 40% of medial septal projection neurons are 
cholinergic and about 30% are GABAergic (Amaral and Kurz, 1985;Kiss et al., 1990). 
Cholinergic afferent neurons from the septum increased the amplitude of IPSPs in 
inhibitory interneurons, with disinhibition in the pyramidal cell (Toth et al., 1997). 
Disinhibition of granule cells can also be established by septohippocampal 
GABAergic neurons selectively innervating inhibitory interneurons in the dentate 
gyrus (Frotscher et al., 1992). Electrical stimulation of the medial septum in vivo is 
reported to increase population spikes but not the fEPSPs generated in the dentate 
gyrus by the perforant path (Bilkey and Goddard, 1985;Fantie and Goddard, 1982). 
Application of the acetylcholine esterase inhibitor physostigmine (acetylcholine 
esterase degrades ACh in the synaptic cleft) raises the levels of ACh and leads to 
inhibition of fEPSP. Interestingly, the CB1 antagonist AM251 eliminated this inhibitory 
effect to reduce fEPSP in the hippocampus (Colgin et al., 2003). Furthermore, a 
recent study of Monory and colleagues seems to indicate a lack of CB1 mRNA in the 
septum of GABA-CB1-ko mice (Monory et al., 2006). On the whole, as an inhibitory 
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effect of CB1 is missing on the cholinergic and/or GABAergic projections, disinhibition 
in the dentate gyrus might be facilitated. This could lead to the increased input-output 
relationship of pop-spike as we observed it in the GABA-CB1-ko animals. Our finding 
raises the question why we failed to detect a similar effect in total-CB1-ko mice? The 
cholinergic input seems to be modulated by CB1 on glutamatergic neurons, too, for 
which the exact mechanism remains unclear (Tzavara et al., 2003b). Perhaps, 
glutamatergic CB1 counteracts the disinhibition effect and leaves the I/O curve 
unchanged in total-CB1-ko animals. 
Interestingly, an increase in synaptic strength, measured by input-output 
relationships, can be observed in the hippocampus of rats exposed to environmental 
enrichment or after learning a contextual fear conditioning task (Foster et al., 
1996;Sacchetti et al., 2001). This phenomenon suggests that basal synaptic 
transmission can be altered by learning events. Although we did not find improved 
memory, the anxiolytic phenotype of GABA-CB1-ko mice might correlate with 
increased excitability in the hippocampus (as it will be discussed in detail below). 
4.1.2 Effects of CB1 signalling on short-term synaptic plasticity 
We would like to briefly introduce the reader to the experimental phenomenon of 
short-term synaptic plasticity. When e.g. the perforant path is stimulated with pairs of 
stimuli, the amplitudes of fEPSP and pop-spike components of the first and second 
response can vary depending upon the time interval between the stimuli. When the 
second responses are larger than the first responses, the effect is referred to as 
paired-pulse facilitation (PPF). When the second responses are smaller than the first 
responses, the effect is termed paired-pulse depression (PPD). 
The analysis of fEPSPs generated by paired stimulation in granule cells has been 
shown that PPF develops almost instantaneously and that the amplitude of 
facilitation rapidly decreases with bigger intervals between stimuli. The reported 
duration of facilitation in granule cells in vivo varies tremendously depending upon 
the experimental conditions and range from about 40 ms to about 200 ms (Lomo, 
1971). Here, we could observe facilitation to about 100 ms inter-pulse-interval.  
The explanation of this phenomenon is as follows: Two stimuli given in a rapid 
succession produce two different synaptic responses. When the probability of 
transmitter release during the first response is high, the second response is relatively 
smaller than the first, and when the probability of release of the first is low, the 
second response is relatively larger than the first. PPF is thought to be caused by 
summation of residual calcium following the first response with even more calcium 
entering the presynapse on the second stimulation of the cell. This produces a larger 
second response. Hence, PPF is likely to be the consequence of enhanced 
transmitter release. Ideally, any process such as presynaptic inhibition that alters the 
probability of transmitter release should also alter PPF (Zucker, 1989). 
This is the first time we report about short-term plasticity phenomena in the dentate 
gyrus of CB1-ko mice in vivo. We could not find a difference of PPF of fEPSP in any 
of the three mouse lines. In line with our findings, no difference of PPF was detected 
in slices from hippocampal region CA1 of CB1-ko mice (Bohme et al., 2000). 
Furthermore, it was shown that activation of CB1 inhibits excitatory synaptic 
transmission in neonatal, but not adult rat hippocampus (Al Hayani and Davies, 
2000). Most studies measuring effects of activation or block of CB1 on transmitter 
release that found profound effects were done on a single cell level (Hirasawa et al., 
2004;Katona et al., 2001;Melis et al., 2004b). Perhaps, differences in transmitter 
release are too subtle as they could be detected with the here used extracellular field 
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potential recordings or they simply do not play a role in our adult mice in an in vivo 
preparation. 
If stimuli are applied that are of sufficient amplitude to produce a pop-spike, paired-
pulse stimulation leads to a diphasic change in granule cell response to the second 
pulse. At short intervals (10-40 ms) the granule cell responsiveness to the second 
stimulus is decreased, i.e. PPD occurs. The PPD is due primarily to the activation of 
interneurons producing GABA-mediated inhibition (Alger and Nicoll, 1982a;Alger and 
Nicoll, 1982b). The granule cell pop-spike evoked by the first pulse drives 
polysynaptic GABAergic feedback loops to generate granule cell hyperpolarisation 
via GABAA-receptors. Subsequent depolarisation of the granule cells arising from the 
second pulse is shunted by a residual inhibitory postsynaptic potential, reducing the 
probability of the granule cells reaching firing threshold and thus contributing to the 
decline of the pop-spike amplitude (Steffensen and Henriksen, 1991;Tuff et al., 
1983). Equivalent degrees of PPD evident in knockout and wildtype mice of the three 
lines suggest that CB1 is not implicated in the IPSPs induced by release of GABA 
from interneurons and activation of GABAA-receptors on the granule cells.  
At intermediate intervals (40-200 ms) granule cell response to the second stimulus is 
facilitated. An increase in PPF is indicative of a greater number of granule cells firing 
in response to the second stimulus compared to the first stimulus (Andersen et al., 
1971). Three mechanisms have been proposed to account for facilitation at 
intermediate interpulse intervals: Firstly, within specific time windows, the second 
pulse is delivered when the presynaptic terminals are still hyperpolarised. This leads 
to an increase in presynaptic calcium influx into the nerve terminal and augmentation 
of transmitter release for the second pulse (Fisher et al., 1997;Zucker, 1989). 
Secondly, PPD at longer IPIs is strongly diminished by activation of presynaptic 
GABAB-autoreceptors located on interneurons that serve to limit subsequent GABA 
release (Bordi et al., 1997;Brucato et al., 1992;Canning and Leung, 2000;Steffensen 
and Henriksen, 1991) which has the effect that firing of granule cells is less restricted 
and PPF can be accomplished. Thirdly, PPF is also influenced by activation of 
glutamatergic n-methyl-d-aspartate receptors (NMDA-R), and that their activation 
comprises a large part of the facilitation response (Joy and Albertson, 1993). These 
findings suggest that augmentation in glutamatergic and/or reductions in GABAergic 
mediated neurotransmission promote the facilitation effect.  
Activation of the NMDA-R increased the levels of 2-AG in primary cultures of rat 
neocortical neurons (Stella and Piomelli, 2001). Anandamide can inhibit NMDA-
dependent calcium influx in a cortical slice preparation. Interestingly, when the CB1 
receptor is blocked, anandamide still produced a stimulatory effect on NMDA-induced 
calcium responses and NMDA-stimulated currents in the slice, a process obviously 
independent of CB1 (Hampson et al., 1998). Bearing in mind that FAAH and AMT 
activity is increased in the hippocampus of CB1-ko mice (Maccarrone et al., 2002) 
which might lead to reduced anandamide levels in these mice, it might be that 
anandamide affects NMDA-R activity in total-CB1-ko and wildtype mice. This might 
explain the tendency of a decreased PPF in total-CB1-ko mice if we assume that less 
anandamide binds to NMDA-R in these mice compared to the wildtype animals. As 
further described below, anandamide can also activate the vanilloid receptor 1 (VR1) 
(Szallasi and Blumberg, 1999). Perfusion of anandamide increases PPD of pop-
spike, an effect that was not blocked by the CB1 antagonist AM281, but was blocked 
by the VR1 antagonist capsazepine (Al Hayani et al., 2001). However, we could not 
find a significant difference of PPF of pop-spike in all three mouse lines. Perhaps, the 
inhibitory effect of CB1 is taken over by a similar inhibition of transmitter release by 
presynaptic GABAB-receptors and thus changes in PPF of pop-spike do not occur. 
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4.1.3 Effects of CB1 signalling on long-term potentiation (LTP) 
It is known for a long time that application of CB1 agonists such as ∆9-THC, HU-210, 
WIN55,212-2, anandamide or 2-AG all inhibited LTP of hippocampal fEPSPs in vitro 
(Collins et al., 1995;Misner and Sullivan, 1999;Nowicky et al., 1987;Stella et al., 
1997;Terranova et al., 1995). On the other hand, mice devoid of CB1 exhibited 
enhanced LTP in vitro in the hippocampus (Bohme et al., 2000) and in the 
basolateral amygdala (Marsicano et al., 2002). Whether antagonists of CB1 lead to 
enhanced LTP is a matter of debate: In some studies, the CB1 antagonist SR141716 
failed to enhance LTP in the hippocampus (Terranova et al., 1995) and in the 
basolateral amygdala (Marsicano et al., 2002) of brain slices. However, other studies 
could show that the antagonists AM251 and SR141716 clearly increased the level of 
LTP in hippocampal CA1 region (Slanina et al., 2005) and in the prefrontal cortex 
(Auclair et al., 2000) in a slice preparation. As all of the pharmacological brain slice 
studies rely on an acute incubation, one reason for contradictory findings might be 
the duration of a pharmacological treatment: In a recent study by Hoffman and 
coworkers, no acute effect of the antagonist AM251 could be assessed but a 7-day 
treatment led to an increase of LTP levels in CA1 (Hoffman et al., 2007). 
Undoubtedly, endocannabinoid signalling occurs for a limited time window during or 
for a few minutes after LTP induction, as there is a lack of effect of antagonists after a 
certain time interval on LTP (Chevaleyre and Castillo, 2003;Ronesi et al., 
2004;Sjostrom et al., 2003). As CB1 is located on GABAergic and glutamatergic 
synapses, one could expect GABA and/or glutamate to be causally involved in 
alterations of LTP. 
Generally speaking, synaptic plasticity represents a mechanism by which 
environmental stimuli could alter responsiveness of neurons, such as the storage of 
information gained through experience. The durability of such changes in synaptic 
strength is extremely variable, such that synaptic efficacy can fluctuate with time 
scales ranging from milliseconds to years. LTP is defined as an enduring 
enhancement of synaptic efficacy, which occurs in a specific synapse following e.g. 
bursts of high-frequency electrical stimulation, and that can persist for hours to 
weeks. LTP can be subdivided based on the molecules involved in its induction and 
expression, as well as the synaptic locus of the change that underlies the alteration in 
efficacy. Some forms of plasticity are initiated and maintained by purely postsynaptic 
mechanisms, others by purely presynaptic mechanisms, and still others by 
mechanisms initiated in the postsynaptic neuron and are then communicated to the 
presynaptic neuron by retrograde messengers (Bliss and Collingridge, 1993;Tao and 
Poo, 2001). Retrograde messengers are molecules released from the postsynaptic 
neuron and alter the presynaptic neurotransmitter release. CB1 is located on the 
presynaptic terminal and postsynaptically synthesised endocannabinoids indeed 
function as a retrograde signal and are crucial to an alteration of synaptic efficacy 
(Alger, 2002;Wilson and Nicoll, 2002). In principal, any modulatory neurotransmitter 
capable of inhibiting synaptic transmission could disrupt LTP. As stated above, it is 
shown for many different CB1 agonists that they profoundly block LTP induction and 
maintenance. This LTP inhibiting action is likely not a unique action of cannabinoid 
drugs, but given the remarkably widespread presynaptic expression of CB1 
throughout the entire brain, it may be a common mechanism by which 
endocannabinoids regulate different forms of synaptic plasticity. It is of importance for 
our studies that LTP stimulation paradigms indeed increase the formation of 
endocannabinoids (at least in the hippocampal slice) and hence might play a role for 
the processes under investigation (Stella et al., 1997). 
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In this study, we found for the first time a CB1-dependent LTP enhancement in the 
dentate gyrus in an in vivo preparation. Increased LTP could be observed only in 
total-CB1-ko mice. This finding was quite unexpected as it was our hypothesis that 
either GABAergic or glutamatergic neurons lacking CB1 were responsible for 
enhanced LTP and that there would be also a difference in either GABA-CB1-ko mice 
or in Glu-CB1-ko mice.  
One explanation for our failure to detect any elevations of LTP in Glu-CB1-ko or 
GABA-CB1-ko mice might be that LTP in these animals was already saturated. We 
stimulated the perforant path using a theta-burst stimulation (TBS) protocol consisting 
of six series of six pulses of 400 Hz, with 200 ms inter-series interval. Theta-burst 
stimulation, that is short bursts of stimuli delivered at an interburst-frequency of 5 Hz, 
mimic the firing of pyramidal cells of rodents involved in exploratory behaviour and 
produces reliable, robust and saturated LTP (Staubli and Lynch, 1987). The theta-
burst paradigm, but not HFS, also exploits the temporal characteristics of firing of the 
GABAergic interneurons for effective induction of LTP (Davies et al., 1991). The 
powerful potentiation enabled through TBS perhaps prevents the observation of more 
subtle differences in GABA-CB1-ko and Glu-CB1-ko mice compared to the respective 
wildtype mice. It would be interesting to apply rather moderate LTP-inducing 
protocols in order to detect differences in GABA-CB1-ko mice or Glu-CB1-ko mice.  
Total-CB1-ko mice showed enhanced LTP compared to the respective wildtypes but 
the statistical significant difference was close. One reason for this finding might be 
that C57BL/6 mice, which is the background for all three knock-out mouse lines in 
this study, per se exhibit excellent levels of LTP induction and maintenance 
compared to other mouse strains both in vitro and in vivo (Jones et al., 
2001b;Matsuyama et al., 1997;Nguyen et al., 2000). Hence, we possibly reached a 
ceiling effect in GABA-CB1-ko and Glu-CB1-ko mice that obscures enhanced LTP in 
CB1-deficient mice. 
It was suggested that LTP has two components: Firstly an increase in the EPSP and 
secondly an increase in the ability of an equal-sized EPSP to fire an action potential. 
The latter is called the EPSP-spike (E-S) coupling component of LTP (Bliss and 
Lomo, 1973). Some studies postulate that the E-S coupling could be mediated by a 
persistent reduction of inhibitory input and hence a disinhibition of a glutamatergic 
neuron (Abraham et al., 1987;Chavez-Noriega et al., 1989). Our finding that only the 
pop-spike is enhanced fits to the results of Chevaleyre and Castillo who could 
demonstrate that neuronal excitability, measured as E-S coupling, is specifically 
blocked by CB1 antagonists and seems to be particularly increased following high-
frequency stimulation (Chevaleyre and Castillo, 2003). Our TBS-protocol resulted in a 
pure EPSP-spike (E-S) potentiation: Pop-spike potentiation was not accompanied by 
any maintained increase in fEPSP slope. This phenomenon was already described 
by other groups for mouse and rat (Jones et al., 2001b;Veinbergs et al., 
1998;Yanagihashi and Ishikawa, 1992). In the mouse, it seems to be much more 
difficult to induce LTP of fEPSP as also reported by Namgung and colleagues, who 
found LTP of fEPSP in only 38% and Bliss and Errington et al. who found LTP of 
fEPSP in 20% of the cases (corresponding to 100% for pop-spike) (Bliss and 
Errington, 1984;Namgung et al., 1995). We suggest that LTP of dentate granule cells 
spike generation, reflected in the pop-spike, was caused without potentiating the 
synaptic input in the present experiment.  
CB1 blockade may not generally improve synaptic plasticity but may rather shift the 
occurrence of LTP. In a patch-clamp study in pyramidal cells of the prefrontal cortex, 
application of the agonist WIN55212-2 led to a shift of synaptic plasticity in favour of 
long-term depression (LTD). On the other hand, the antagonist SR141716 favoured 
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LTP at the expense of LTD. Nevertheless, in both cases, there were still cells that 
were non-plastic or showed LTP or LTD, respectively (Auclair et al., 2000). Bearing in 
mind that not all total-CB1-ko mice showed enhanced LTP compared to the wildtype 
mice in our experiments, LTP does not seem to be increased in an all-or-none 
fashion but rather in a subgroup of animals being prone to the tetanic stimulation.  
The picture gets even more complex as the endocannabinoid anandamide, in 
contrast to the synthetic cannabinoid WIN55212-2, failed to inhibit theta-burst-LTP 
(Lees and Dougalis, 2004). Anandamide binds to and activates CB1 but also VR1 
(Smart et al., 2000), two receptors with opposite effects on excitation. Furthermore, 
low concentrations of ∆9-THC can even enhance the persistence of LTP (Nowicky et 
al., 1987).  
Thus, the physiological role of endocannabinoids with their lipophilic nature and rapid 
reuptake may be fairly different from the effect of synthetic cannabinoids and remains 
to be fully explained.  
We would like to make detailed suggestions to the reader what might be the 
underlying reason for LTP enhancement after blockade of CB1 and which transmitter 
systems might be involved. These suggestions can be found in the Appendix (section 
6.1). All in all, it remains to be enigmatic why enhanced LTP can be observed in total-
CB1-ko mice but not in Glu-CB1-ko and GABA-CB1-ko mice. Several candidates for 
transmitters exist of which the contribution cannot be ascertained yet. Future studies 
in different brain regions (e.g. CA1 of hippocampus, neocortex, and amygdala) might 
shed light onto altered levels of LTP in Glu-CB1-ko and GABA-CB1-ko mice. 
4.1.4 Pitfalls of LTP in anaesthetised mice 
We investigated the phenomenon of LTP in anaesthetised mice in vivo as it 
resembles physiological processes more closely than recordings done in brain slice 
preparations. Admittedly, we have to consider the effects of isoflurane anaesthesia 
on different transmitter systems in our in vivo preparation. Similar to many other 
anaesthetics, isoflurane potentiates the activity of the GABAA receptor, but also of 5-
HT3 and kainate receptors, whereas it blocks alpha-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors and nicotinic ACh receptors (Rudolph and 
Antkowiak, 2004). In addition, isoflurane anaesthesia increases the extracellular 
concentration of dopamine and its metabolites (Adachi et al., 2005). This simply 
highlights the fact that multiple transmitter systems are altered under isoflurane 
anaesthesia. Indeed, enhanced LTP in Thy-1-knockout mice could be observed in 
awake animals but not in an anaesthetised preparation (Errington et al., 1997) 
clarifying the difference between an awake and an anaesthetised state. Whether this 
is actually the case and has an effect on our results could be only revealed by 
measuring LTP in awake, freely behaving animals. 
4.1.5 Brain oscillatory activity influenced by CB1 activation 
Inhibitory interneurons in the hippocampus contact up to 1000 of pyramidal neurons, 
and this widespread connectivity is important in synchronising the firing of principal 
neurons (Freund and Buzsaki, 1996). Interneurons in the hippocampus form fast 
synapses and are thought to orchestrate synchronous oscillations in the gamma 
band that is a frequency of 20-80 Hz present in local field potentials (Banks et al., 
2000). Gamma oscillations are synchronised over long distances in the brain and are 
hypothesised to bind together sensory perceptions and to play a role in cognition 
(Singer, 1999). In vitro evidence suggests that exogenously applied cannabinoids 
can selectively suppress gamma oscillations (Hajos et al., 2000). 
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Another endogenous oscillation in the brain is theta rhythm that is waves with a 4-12 
Hz frequency present in local field potentials. Theta activity was originally described 
in the hippocampus to characteristically accompany exploratory behaviour 
(Vanderwolf, 1969) and has been suggested to serve as a temporal reference for 
coding relevant environmental information represented by place cells (O'Keefe and 
Recce, 1993).  
Theta rhythm might be of interest to us as it is associated with both mnemonic 
function and cholinergic neurotransmission. The medial septum and the diagonal 
band of Broca seem to play a prominent role in generating theta rhythm (Smythe et 
al., 1992;Vertes and Kocsis, 1997). The major septal neurons projecting to the 
hippocampus use ACh or GABA as neurotransmitters (Freund and Antal, 
1988;Frotscher and Leranth, 1985). Blockade of mAChR in the medial septum 
suppresses theta rhythm, as does GABAAR activation, and lesioning the respective 
neurons eliminated theta rhythm in the hippocampus (Givens and Olton, 1990;Yoder 
and Pang, 2005). Acetylcholine release in the hippocampus is increased during theta 
activity, and correlates with theta power (Keita et al., 2000). In general, rises in 
cholinergic transmission are found during novelty-related processes such as attention 
and learning (Everitt and Robbins, 1997). As learning and memory are powerfully 
influenced by the cholinergic input of the medial septum, it is widely believed that 
theta rhythm generated here is possibly a property enabling memory (Wiebe and 
Staubli, 2001;Winson, 1978) and the underlying neuronal plasticity (Holscher et al., 
1997). 
Besides of a role in memory processing, the medial septum seems to be essential for 
anxiety-related behaviour, too, as lesioning the septum disrupts anxiety-like 
behaviour in several tasks (Bannerman et al., 2004;Deacon et al., 2002;Degroot and 
Treit, 2003;Miller et al., 1986). Theta rhythm might couple together brain regions like 
the amygdala and the hippocampus in order to cope with an anxiety-provoking 
situation (Seidenbecher et al., 2003). Increased magnitude of theta oscillations on 
the open arms of an elevated plus-maze might indicate an anxiogenic phenotype in 
mice (Gordon et al., 2005).  
Cannabinoids can diminish the power of hippocampal activity in the theta (4-10 Hz), 
gamma (30-80 Hz) and fast ripple (100-200 Hz) band in the freely behaving rat, a 
process clearly activated by CB1 (Robbe et al., 2006), and endocannabinoids can 
interrupt theta rhythm in CA1 of the hippocampus (Reich et al., 2005). Nevertheless, 
the antagonist SR141716 has no effect on the network activity (Robbe et al., 2006). 
This suggests that at least a tonic level of endocannabinoids does not seem to be 
involved in the formation of network oscillations.  
Theta stimulation after a sensory stimulus in anaesthetised rodents is an established 
model to study e.g. cholinergic or GABAergic modulations in the hippocampus (Keita 
et al., 2000;Kinney et al., 1999;Yoder and Pang, 2005). We hypothesised that 
increased theta activity might be another factor explaining enhanced memory abilities 
in total-CB1-ko mice that are found by others. This was especially of interest as 
increased levels of ACh in CB1-ko mice could be shown in vitro (Kathmann et al., 
2001) and in vivo (Degroot et al., 2006) and cholinergic neurons are considered to 
regulate the magnitude of hippocampal theta rhythm (Lee et al., 1994;Monmaur et 
al., 1997). Nevertheless, we found no change of theta activity after a sensory 
stimulus over time in total-CB1-ko mice. Assuming increased levels of ACh in CB1-ko 
mice, our finding leads rather to the conclusion that no increased theta activity 
accompanies a boosted cholinergic system. However, we have to bear in mind that 
elevated levels of ACh in behaving CB1-ko mice were only seen if the animals were 
exposed to a stressful environment but not under basal conditions (Degroot et al., 
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2006). Therefore, our applied tail pinch that shall resemble a sensory stimulation was 
possibly not drastic enough to elicit enhanced ACh levels and thereby enhabced 
theta rhythm in the hippocampus. Also, if we assume that an alteration of theta 
rhythm is a prerequisite for anxiety-related behaviour, this fits well to our finding that 
changes of anxiety in total-CB1-ko mice are rather context-specific (as it is further 
discussed below), and tail-pinch-induced theta rhythm might not be the appropriate 
model to test this hypothesis. Lastly, we recorded local field potentials from the 
dentate gyrus which may not be the essential area for memory acquisition and 
retrieval processes. This may rather be restricted to CA1 of the hippocampus (Hall et 
al., 2001;Wiebe and Staubli, 1999). EEG recordings in behaving animals and in 
different areas of the hippocampus could enlighten these issues. 
Beside of ACh, serotonin might be involved in alterations of theta rhythm in the 
hippocampus. Although there is no data of serotonin levels for CB1-ko mice, it could 
be suggested that levels are rather increased as CB1 activation leads to a decrease 
of serotonin in the mouse neocortex (Nakazi et al., 2000). Furthermore, CB1 and 5-
HT3 are co-localised in CCK-positive-interneurons of the hippocampus, neocortex 
and amygdala and receptor activation has opposite effects on GABA release, with 5-
HT3 activation increasing and CB1 activation decreasing GABA release (Hermann et 
al., 2002;Morales and Backman, 2002). Eventually, a 5-HT3 receptor antagonist 
increases the frequency of theta rhythm in the hippocampal CA1 region in vivo 
(Staubli and Xu, 1995). This would rather suggest a decrease of theta rhythm in CB1-
ko mice through elevated levels of serotonin. 
Altogether, these findings might indicate that even if there is an increased level of 
serotonin or ACh in total-CB1-ko mice this does not lead to any alteration of 
hippocampal theta rhythm under our experimental conditions. 
 
4.2. Memory functions in CB1-ko mice 
4.2.1 Is there a genuine physiological role of CB1 in memory? 
Blockade of CB1 signalling has been found to enhance performance in several 
memory tasks. SR141716 improved social recognition memory of rats and attenuated 
recognition memory deficits displayed by aged rats and mice (Terranova et al., 1996). 
Rats trained in a radial 8-arm maze made fewer errors after treatment with the 
antagonist SR141716 if the delay between sessions was in the range of hours 
(Lichtman, 2000) and showed increased performance in the elevated T-maze 
(Takahashi et al., 2005). Also, chickadees, after an intrahippocampal infusion of 
SR141716, showed enhanced long-term memory for the location of hidden food 
(Shiflett et al., 2004). However, there is one study finding no memory alteration in a 
Morris water maze task after SR141716 application (Da and Takahashi, 2002). 
Furthermore, SR141716 failed to enhance performance in a variety of operant 
conditioning paradigms (Brodkin and Moerschbaecher, 1997;Hampson and 
Deadwyler, 2000;Mallet and Beninger, 1998;Mansbach et al., 1996). This is probably 
because these tasks are strongly dependent on working or short-term memory where 
subjects have to retain the information in the range of 10 s and long-term memory 
processes do not play an essential role here1. Finally and conversely, administration 
                                      
1 Another difficulty may be that the antagonist SR141716 has properties of an inverse agonist (Mato 
et al., 2002;Terranova et al., 1996b). That is, some effects of the antagonist appear to be produced in 
the absence of any ongoing endogenous cannabinoid release, prompting the hypothesis that 
cannabinoid receptors can exist in a constitutively active state in which they undergo some degree of 
coupling to their effector mechanisms (Pertwee, 2005a). However, SR141716 is over 7000-fold more 
potent as a CB1 antagonist than as an inverse agonist and this suggests that it may have limited 
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of the antagonist AM251 into the rat hippocampus after training disrupted memory of 
an inhibitory avoidance task in a subsequent session and let the authors suggest that 
endocannabinoids contribute to facilitate memory consolidation (de Oliveira et al., 
2005).  
The phenotype of CB1-ko mice, as being reported in the literature, is partly in line 
with memory improvement after CB1 antagonist application. CB1-ko mice exhibited 
an enhanced performance in the active avoidance paradigm (Martin et al., 2002) and 
in an object recognition task (Maccarrone et al., 2002;Reibaud et al., 1999). 
However, unexpected was the finding that CB1-ko mice did neither show improved 
performance in a long-term appetitively-motivated operant conditioning task nor in the 
extinction of this task (Holter et al., 2005). Furthermore, CB1-ko mice have been 
reported to exhibit similar acquisition rates in the Morris water maze as wild-type 
littermates (Varvel and Lichtman, 2002). In addition, adult CB1-ko mice even showed 
a deficit in long-term social memory, skill learning on a rotarod and in an operant 
conditioning paradigm (Bilkei-Gorzo et al., 2005). Finally, CB1-ko mice revealed 
increased perseverance during reversal learning in a water maze task and showed a 
deficit to unlearn the task (Varvel and Lichtman, 2002). CB1-deficient mice exhibited 
less extinction of fear memory after a tone-footshock conditioning procedure 
(Marsicano et al., 2002) which is confirmed by administration of CB1 antagonist 
SR141716 that leads to a decrease of extinction of conditioned fear (Chhatwal et al., 
2005;Marsicano et al., 2002;Niyuhire et al., 2007;Pamplona et al., 2006;Suzuki et al., 
2004) and in a passive avoidance task (Niyuhire et al., 2007). Thus, the 
endocannabinoid system may aid extinction of aversive memories. Extinction is 
believed to involve active suppression of previously learned associations (Lattal and 
Abel, 2001). If the endocannabinoid system were involved in extinction processing, 
then disrupting CB1 genetically or pharmacologically may pretend improved memory 
in some models because it prolongs retention of the respective information.  
Given the extent to which the endocannabinoid system appears to modulate short-
term and long-term forms of synaptic plasticity and as we could find elevated levels of 
LTP in total-CB1-ko mice, it should not be surprising that this system may have a 
tonic activity in mnemonic processes. Curiously, although an improvement of memory 
was not seen in a first study (Varvel et al., 2006a), FAAH-ko mice, that possess 
approximately 10-fold elevated brain levels of anandamide, and mice treated with the 
FAAH inhibitor OL-135 acquired a water maze task faster than the respective 
controls in a follow-up study (Varvel et al., 2006b). Particularly, this study provides a 
dramatic example of how manipulations that elevate the endocannabinoid tone can 
lead to different results compared to exogenously applied agonists. Interestingly, an 
enriched environmental exposure that is known to improve hippocampus-dependent 
memory results in 10-fold elevations in hippocampal endocannabinoid content (Wolf 
and Matzinger, 2003). Perhaps, endocannabinoids are rather essential for cognition 
and unfold a cognitive enhancing effect. 
 What would then account for the observation that exogenous cannabinoids like ∆9-
THC can inhibit LTP and learning (Nowicky et al., 1987;Varvel et al., 2005)? The 
concentration of exogenously administered cannabinoids is likely to be greater at 
CB1 than the concentration of the highly labile endogenous cannabinoids suggesting 
                                                                                                                      
inverse agonist activity in vivo (Sim-Selley et al., 2001). Furthermore, SR141716 seems to bind to 
another receptor, as it was biologically active in mice deficient for CB1 which led to the hypothesis of 
“CB3” (Hajos et al., 2001). If "CB3” is crucial for effects on learning and memory is a matter of debate, 
as CB1-ko mice showed no impairment of working memory in a water maze task after application of 
different CB1 agonists (Varvel and Lichtman, 2002). 
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that exogenous cannabinoids are likely to do more than simply mimic the function of 
endocannabinoids. It could be that learning and memory relies on precise spatial and 
temporal ordering for information storage and recall in a tightly integrated neural 
circuit, and indeed LTP on a subset of synapses can be elicited by endocannabinoids 
(Carlson et al., 2002). Global activation of CB1 of all types of neurons and in several 
brain regions might disrupt this precision and lead to memory impairment. 
All things considered, it is fairly controversial whether CB1 is essentially implicated in 
learning and memory and if so in which aspects of it. To investigate a possible 
contribution of CB1, we performed a set of learning and memory tasks especially in 
order to point out the type of receptor system (i.e. CB1 on GABAergic or 
glutamatergic neurons) that might be needed for such effects. 
 
4.2.2 Water maze  
We could not see any differences in acquisition for the total-CB1-ko mice and the 
Glu-CB1-ko mice indicating that CB1 is dispensable for learning the water maze task. 
However, we have to be cautious in drawing definite conclusions as Varvel and 
colleagues failed to find improved acquisition in a first study with FAAH-ko mice but 
found better acquisition in a second study. This was probably due to a general slower 
acquisition phase in the second study (that was performed in a bigger water maze 
tank) that made any differences apparent (Varvel et al., 2006a;Varvel et al., 2006b). 
These researchers used the latency to locate the platform as a measure of memory. 
For our experiments, we have to assert that the acquisition of the task occurred very 
rapidly within two days and there are no differences for the latency to swim to any 
platform. In the water maze spatial discrimination task, as it was applied by us, 
accuracy to reach the stable platform is the essential measure for learning abilities, 
which is dependent on an intact hippocampus (Arns et al., 1999). As the latency to 
reach the platform is very short, levels of stress due to water exposure are minimised 
in our test compared to the conventional Morris water maze procedure. This allowed 
us to isolate true cognitive effects of endocannabinoids from more indirect effects due 
to stress coping. 
Our results confirm water maze studies from different laboratories which indicate no 
effect of CB1 antagonism once mice have learned the position of the platform, i.e. 
CB1 activation seems not to be involved in memory retrieval. Moreover, there is no 
deficit in learning performance, i.e. acquisition, of the Morris water maze in CB1-ko 
mice (Da and Takahashi, 2002;Varvel et al., 2001;Varvel and Lichtman, 2002). 
However, knockout mice showed what these authors call “perseverance” in the 
reversal test. They continued to return to the location where the platform had been 
previously located and spent more time returning to the position where the platform 
was formerly located, which interfered with them finding the new platform position 
(Varvel et al., 2005;Varvel and Lichtman, 2002). The same phenomenon could be 
observed in chickadees that received an intrahippocampal injection of SR141716. 
Here, the birds showed better memory of a location with hidden food but this memory 
was still observable when it extinguished again in the control group (Shiflett et al., 
2004). In another study, rats were exposed to unpredictable stress. These animals 
show decreased levels of 2-AG and CB1 receptor density in the hippocampus and 
have impaired reversal learning (i.e. increased perseveratory behavior) in the water 
maze task. Reversal learning worsened by application of the CB1 agonist HU-210 
(however, it improved if a low dose was given) (Hill et al., 2005)2. These cognitive 
                                      
2 We would like to stress here that only the latency to swim to the platfrom was affected, which does 
not mean that hippocampus-dependent spatial memory was indeed impaired but rather the locomotive 
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impairments might be a consequence of deficient endocannabinoid signalling. 
Endocannabinoids may be needed to inhibit a previously learned behaviour such as 
in extinction or in reversal learning. 
We assessed reversal learning by replacing the stable platform with the floating 
platform in the water maze. The animals were enforced not to swim to the old 
location of the stable platform anymore in order to find the safe platform. As the 
stable platform was changing its position from trial to trial, it was difficult for the 
mouse to efficiently learn to always reach the stable platform. Thus, a chance level of 
50 % right choices was defined as a reasonable performance for the reversal 
training. In our hands, total-CB1-ko mice showed the same rate of reversal learning 
contradicting the finding of Varvel and colleagues. Glu-CB1-ko mice showed even 
enhanced abilities for reversal learning. It was suggested that the endocannabinoid 
system plays a key role in the extinction of memory, i.e. an unlearning that the former 
stable platform is not safe anymore in our case. Extinction seems to be affected by 
block of CB1 in aversive tasks (Marsicano et al., 2002), but no effect is apparent in 
appetitively-motivated tasks (Holter et al., 2005;Niyuhire et al., 2007). What might be 
the reason that we did not see any effect on reversal learning in the total-CB1-ko 
mice? Varvel et al. compared a massed extinction protocol, in which the extinction 
trials were given over days, with a spaced extinction procedure, in which the 
extinction trials were given over weeks. They pointed out that there were only 
extinction deficits for the spaced extinction protocol (Varvel et al., 2005). According to 
this paradigm, our experimental protocol with 10 trials per day and an intertrial-
interval of 3 min might resemble a highly massed extinction protocol which might not 
be suitable to detect any differences in extinction in total-CB1-ko mice. Also, as the 
latency to reach the platform is very short, our water maze task is perhaps not 
aversive enough to detect an effect on extinction. Oddly enough, we were able to see 
facilitated reversal learning in the Glu-CB1-ko mice. Obviously, lack of CB1 on 
glutamatergic neurons eases the behavioural flexibility to relearn or learn a new 
platform location. Recently, it was found that administration of the CB1 antagonist 
AM251 alleviated perseverance in a set-shifting task in rats (Hill et al., 2006a), 
indicating the possibility that blockade of CB1 can indeed enhance behavioural 
flexibility under certain circumstances. Behavioural flexibility, or a decrease in 
perseverance, is most often described in the water maze task. The hippocampus 
seems to be an essential structure enabling a reversal learning in that damaging the 
hippocampus or its afferent/efferent fibre bundles leads to a perseverant behaviour 
(Morris et al., 1986b;Whishaw and Jarrard, 1995). Similarly, the process of extinction, 
i.e. an ‘unlearning’ of the expression of the original memory (Myers and Davis, 2002), 
might be enhanced in Glu-CB1-ko mice which is however not supported by our own 
results from the contextual fear conditioning experiments (please see below). Still, an 
alteration in glutamatergic transmission in the hippocampus possibly allows Glu-CB1-
ko to relearn the new location of the safe platform more rapidly. It remains to be 
tested whether GABA-CB1-ko mice reveal any alterations in reversal learning and 
whether CB1 of GABAergic neurons plays a role for behavioural flexibility. 
 
4.2.3 Object and social recognition  
There is good evidence that CB1 deletion improves recognition memory. Especially, 
both young (1 month) and adult (4 months) CB1-ko mice showed better memory in 
the object recognition task (Maccarrone et al., 2002;Reibaud et al., 1999). 
                                                                                                                      
performance and the behavioural coping with cold-water stress of the animals. A more appropriate 
measure would have been the time spent searching in the target quadrant. 
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Additionally, administration of the antagonist SR141716 improved memory of young 
(2-3 months) and old (10-12 months) rats and mice in the social recognition test 
(Terranova et al., 1996). Having said that, only young CB1-ko mice (6-8 weeks) 
showed a better performance in the social recognition test in another study, whereas 
adult (3-5 months) and old (14-17 months) CB1-ko mice showed a memory deficit 
when compared to their wildtype littermates (Bilkei-Gorzo et al., 2005) which has 
been interpreted by the authors as accelerated aging in these animals. Altogether, 
this points towards a nootropic effect of CB1 antagonism at a certain age and that the 
endocannabinoid system may negatively influence some mnemonic processes.  
Admittedly, in the present study we could neither observe improved memory in the 
object recognition task nor in the social recognition task. There is rather the trend that 
memory performance is attenuated in total-CB1-ko mice and Glu-CB1-ko mice, as 
the former fail to show social recognition memory after 24 h and the latter fail to show 
social recognition memory both after 1 and 24 h. There is no indication for any better 
memory performance in our three knockout mouse lines. Partly, this might be due to 
a decrease in exploration time as it is seen in the Glu-CB1-ko mice for the first 
encounter of a novel object or juvenile (as it will be further discussed in section 
4.3.4). A certain amount of exploration might be needed for an effective gathering of 
information to build up the recognition memory at least for the object recognition as 
accuracy in olfactory discrimination requires only milliseconds of exploration (Uchida 
and Mainen, 2003) and even decreased exploration does not lead to impaired social 
recognition memory (Richter et al., 2005). Hence, instead of memory, we think that 
rather motivational or emotional properties are altered in total-CB1-ko and Glu-CB1-
ko mice.  
On the other hand, it was suggested that improved memory in CB1-ko mice might be 
due to increased ACh efflux in the hippocampus (Chaperon and Thiebot, 1999). 
Enhanced ACh levels in CB1-ko mice can be only found under stressful conditions 
(Degroot et al., 2006). At least the object recognition task, which is one of the few 
tasks for which memory improvement was clearly shown (Maccarrone et al., 
2002;Reibaud et al., 1999), was carried out under very lowly stressful conditions in 
our hands whereas the aversive conditions of the social recognition task (i.e. 
illumination of 500 lux) were possibly too drastic. Perhaps this did not lead to a 
sufficient or superior elevation of ACh levels, respectively, in order to enhance 
memory.  
 
4.2.4 Open field habituation 
Habituation, a form of non-associative learning, can be measured by examining 
exploratory behaviour in a novel environment such as an open field and is reflected 
by decreased locomotion. It was shown that deletion of the CB1 receptor significantly 
improved habituation learning in the open field and those authors argue that CB1-ko 
mice display a prolonged memory retention (Degroot et al., 2005). On the other hand, 
intrahippocampal infusion of the CB1 antagonist AM251 in the rat after the training 
session in the open field did not lead to a decrease of locomotion in the second trial 
(de Oliveira et al., 2005). This suggests that consolidation of open field exploration 
memory is not influenced by hippocampal endocannabinoids. However, the latter 
study could show a memory-disrupting effect in an inhibitory avoidance task3. These 
findings point towards the direction that the endocannabinoid system requires some 
degree of averseness or alertness in order to be recruited.  
                                      
3 In this test, the animal receives a foot shock as soon as it steps down from a platform in a training 
session. In the test session, the latency the animal requires to step down from the platform is 
measured as an index of memory. 
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Taking this into consideration, we tested mice in the open field under two different 
lighting conditions, i.e. 0 lux or 700 lux and accordingly lowly aversive or highly 
aversive testing conditions. We could show that the level of habituation is dependent 
on the illumination of the open field. At 700 lux, all genotypes of the three mouse 
lines revealed habituation indicated by a decrease in locomotion and rearing from 
day 1 to day 2. In total-CB1-ko mice and in Glu-CB1-ko mice there was a more 
pronounced decrease in locomotion and rearing compared to their wildtype 
littermates. At 0 lux, the situation gets a bit more complex in that total-CB1-ko mice 
showed no decrease in locomotion whereas GABA-CB1-ko mice and Glu-CB1-ko 
mice did show a decrease in locomotion from day 1 to day 2 and only Glu-CB1-ko 
mice showed a decrease in rearing. Additionally, we checked for habituation within 
the first session on day 1. At 0 lux, mice of all three lines were able to habituate 
within a session which is reflected in a decrease of locomotion. At 700 lux, total-CB1-
ko mice failed to habituate whereas GABA-CB1-ko mice and Glu-CB1-ko mice and 
the respective wildtype animals were able to habituate. However, total-CB1-ko mice 
started at a lower level of locomotion already. No genotype differences could be 
revealed for the three mouse lines for within session habituation.  
All in all, we can confirm a greater habituation in total-CB1-ko mice and Glu-CB1-ko 
mice only under highly aversive (i.e. 700 lux) conditions. However, it is questionable 
whether this truly reflects an enhanced cognitive ability. As we see similar habituation 
within the first session for the genotypes and a lack of habituation of total-CB1-ko 
mice from day 1 to day 2 under 0 lux, we rather believe that the observed effects are 
due to altered levels of anxiety (as being described below in section 4.3.4)4.  
 
4.2.5 Contextual fear conditioning  
It is generally accepted that processing of contextual information in a fear 
conditioning paradigm may rely on the hippocampus and the amygdala (Desmedt et 
al., 2003;Kim and Fanselow, 1992;Selden et al., 1991) whereas processing of distinct 
stimuli (such as a tone) requires the amygdala but not the hippocampus (Phillips and 
LeDoux, 1994). When rats were treated with the CB1 antagonist AM251 either before 
the training or before the test session of a background contextual fear conditioning 
task, freezing was decreased in the AM251-treated rats in the shock context session 
48 h later, indicating that expression of contextual fear is impaired by blocking CB1. 
At the same time, freezing to the tone was increased in AM251-treated rats (Arenos 
et al., 2006). This finding supports the notion that CB1 does not have the same role 
in contextual and cue-specific fear conditioning. A study by Mikics and colleagues 
studied background contextual fear-conditioning in CB1-ko mice (Mikics et al., 2006). 
They could show that the conditioned fear response was abolished by the disruption 
of CB1 and was reduced by the CB1 antagonist AM251 in wildtype mice whereas it 
was increased by the agonist WIN-55,212-2 when administered before the testing 
session. These findings demonstrate again that blockade of CB1 impairs contextual 
                                      
4 The fact that we found contradictory effects of habituation memory compared to Degroot and 
colleagues may be due to the housing conditions of our mice, too. Individually housed mice display 
reduced habituation and show an hyperactive phenotype (Voikar et al., 2005). Furthermore, the 
experimental conditions could explain a lack of habituation: Mice tested during the dark phase of a 
light-dark cycle (like our mice) are more aroused by the testing environment than those tested during 
the light phase, as evidenced by increased ambulation during the dark phase (Valentinuzzi et al., 
2000). 
Discussion 
 77
memory and, quite unexpectedly, activation of CB1 promotes the expression of 
conditioned fear.5 
Other studies present a different picture of CB1 function. In a trace eyeblink 
conditioning task that is dependent on an intact hippocampus and cerebellum, CB1-
ko mice revealed the same performance as the wildtype mice. The very same result 
could be observed after application of the antagonist SR141716 before the training 
session (Kishimoto and Kano, 2006). Moreover, application of the CB1 agonist 
WIN55212-2 before a contextual fear conditioning task reduced the freezing levels 
and thus impaired memory in rats. Here, the antagonist SR151716 had no effect 
when given alone (Pamplona and Takahashi, 2006). These authors could show that 
administration of WIN55212-2 had only an effect when given before conditioning, 
whereas Mikics et al. applied the agonist before the memory test, indicating a 
differential effect on acquisition and retrieval of aversive memories to environmental 
cues.  
Finally, regarding the extinction process, WIN55212-2, when given before the 
extinction session, facilitated extinction of fear-potentiated startle, and the 
anandamide reuptake inhibitor AM404 enhanced extinction, too (Chhatwal et al., 
2005), whereas SR147778 or SR141716, both CB1 antagonists, blocked extinction in 
a cued or contextual fear conditioning task (Chhatwal et al., 2005;Marsicano et al., 
2002;Pamplona et al., 2006;Suzuki et al., 2004).  
Altogether, some studies suggest that CB1 blockade has no effect on acquisition of 
contextual fear memory whereas others show attenuated acquisition of contextual 
fear memory after blockade of CB1. Generally, the process of extinction seems to be 
blocked by antagonism of CB1 function. 
We also used background contextual fear conditioning to examine the response of 
the three mouse lines to aversive contextual cues. We tested our three mouse lines 
on three days (day 1, day 2 and day 7 after conditioning) in two different contexts, the 
shock context and a grid context. By using two contexts, we checked for the 
specificity of memory for the conditioning environment and discrimination of fear 
conditioning cues. The two contexts differed in several aspects that were mainly their 
shape, illumination and the present odour, but shared the grid floor as a common 
feature (an overview is given in Table 2, page 38). Furthermore, we tested the mice 
with two shock intensities, with 0.7 mA being a standard and moderate shock 
intensity whereas 1.5 mA was a highly aversive shock intensity that was expected to 
promote generalised fear (Shaban et al., 2006). 
In general, animals showed high freezing levels in both contexts indicating that the 
conditioning protocol is appropriate to induce a conditioned fear response. If only 
considering day 1 (as most of the cited studies do), at 0.7 mA, effects seem to be 
puzzling: Total-CB1-ko mice did not show any freezing differences in the shock 
context and the grid context whereas GABA-CB1-ko mice froze more in the grid 
context and Glu-CB1-ko mice had a significant higher freezing response in the shock 
context. The picture becomes clearer if we compare the development over days and 
consider both shock intensities: Total-CB1-ko mice showed increased freezing in 
both contexts, but especially at 1.5 mA, they outperformed wildtype mice with 
increased freezing in the grid context. GABA-CB1-ko mice always revealed elevated 
freezing levels in the grid context whereas Glu-CB1-ko mice nearly always showed 
                                      
5 We would like to point out here, that in the study of Mikics and colleagues, each mouse received a 
pairing with 10 shocks of 3 mA which is an extremely drastic conditioning protocol. It is quite 
astonishing that the CB1-ko mice show such a poor contextual memory which might be explained with 
the genetic background of these mice which is the CD1 strain.  
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enhanced freezing in the shock context. Finally, in the neutral context on day 8, 
freezing to the tone that was previously presented for conditioning pointed out 
increased freezing in total-CB1-ko mice and to some extent in Glu-CB1-ko mice.  
To begin with, we showed that total-CB1-ko and, as shown for the first time here, 
Glu-CB1-ko mice froze more to the tone following conditioning with 0.7 mA and 0.5 
mA, respectively, which is very consistent with previous reports in which 
pharmacological blockade of CB1 or genetic deletion of CB1 increased freezing to an 
auditory cue during a memory testing session (Arenos et al., 2006;Cannich et al., 
2004;Kamprath et al., 2006;Marsicano et al., 2002;Niyuhire et al., 2007). We propose 
that this is due to an impaired habituation (which is a nonassociative learning 
process), as it is elegantly shown for CB1-ko mice already (Kamprath et al., 2006). 
We can furthermore specify that it is CB1 located on glutamatergic neurons that has 
profound effects on short-term extinction. 
The finding that total-CB1-ko, GABA-CB1-ko and Glu-CB1-ko mice differently froze in 
the two types of context may be explained by two possibilities, namely that the 
balance between reconsolidation and extinction is altered or that the acquisition of 
contextual information and its representation is modulated.  
Firstly, memory testing causes memory reactivation and initiates two dissociable but 
opposite processes: Reconsolidation, i.e. a stabilisation of the expression of the 
original memory, and extinction, i.e. a weakening or rather ‘unlearning’ of the 
expression of the original memory (Myers and Davis, 2002;Nader, 2003). It remains 
difficult to differentiate between these two processes, but brief reminders to a 
conditioning context may lead to reconsolidation, whereas longer reminders may 
result in memory extinction, which tends to inhibit the expression of the original 
memory (Suzuki et al., 2004). Total-CB1-ko and especially Glu-CB1-ko mice either 
show less extinction or these mice possess a stronger tendency for reconsolidation. 
Application of the CB1 agonist WIN55212-2 into the amygdala after reactivation of 
the conditioned fear response reduced fear memory when animals were reexposed 
to the conditioned stimulus, suggesting that reconsolidation is diminished or 
extinction is facilitated (Lin et al., 2006). On the other hand, the application of AM404, 
an inhibitor of endocannabinoid reuptake, prior to extinction training enhances 
extinction in a fear-potentiated startle paradigm and the antagonist SR141716 
blocked extinction (Chhatwal et al., 2005). Very convincingly, FAAH-ko mice or mice 
treated with the FAAH inhibitor OL-135 showed facilitated extinction in the water 
maze task (Varvel et al., 2006b). Thus, activation of CB1 could facilitate extinction on 
the one hand and block reconsolidation on the other hand. CB1 activation leads to 
activation of MAPK among others (Derkinderen et al., 2003). CB1-ko mice have 
decreased levels of phosphorylated MAPK and calcineurin in the basolateral 
amygdala, and higher levels of phosphorylated MAPK and calcineurin were observed 
in the central amygdala after fear conditioning (Cannich et al., 2004). Block of MAPK 
in the basolateral amygdala reduces extinction in an acoustic startle paradigm (Lu et 
al., 2001). Altogether, this may indicate that indeed the extinction process is altered 
in total-CB1-ko and Glu-CB1-ko mice. Most remarkably, calcineurin is specifically 
expressed in glutamatergic neurons but not in GABAergic interneurons in the 
hippocampus (Sik et al., 1998). This might be a reason for the specific extinction 
deficit in total-CB1-ko and Glu-CB1-ko mice in terms of short-term extinction of 
auditory-cued fear but not GABA-CB1-ko mice taking into consideration the potential 
role of calcineurin in extinction (Lin et al., 2003a;Lin et al., 2003b). Moreover, the 
effect on extinction seems to be specific for aversive learning tasks as no effects on 
extinction could be found in appetitively-motivated memory tasks (Holter et al., 
2005;Niyuhire et al., 2007). 
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Supporting this view, strong impairment of short-term and long-term extinction of 
auditory-cued fear memory has been reported in CB1-ko mice (Marsicano et al., 
2002). The protocol employed resulted in elevated levels of endocannabinoids in the 
basolateral amygdala (Marsicano et al., 2002) and the dorsal hippocampus 
(Kamprath et al., 2006) of wildtype mice, regions known to control extinction of 
aversive memories, which indicates that specifically endocannabinoids might 
facilitate extinction of aversive memories. In contrast to the tone, we observed no 
extinction over days for the shock context in total-CB1-ko and GABA-CB1-ko mice 
and Glu-CB1-ko mice and the respective wildtype animals, with the only exception of 
Glu-CB1-ko mice showing extinction at a 0.7 mA shock current. This is probably due 
to the short reexposure of the mice to the shock context (that was 5 min) as only a 
reexposure to the context for 30 min led to an extinction of the fear response (Suzuki 
et al., 2004).  
After conditioning with 1.5 mA, mice of the three lines revealed a very intense 
freezing response in the shock and the grid context which can be described as a 
ceiling effect. We believe that the absence of context discrimination is partly due to a 
generalised freezing response as it is seen by others (Shaban et al., 2006). This is 
especially true for GABA-CB1-ko mice that have increased levels of freezing also in 
the neutral context before tone presentation on day 8.  
As a second explanation for the differing freezing behaviour of the three mouse lines, 
and to see it from a different angle, total-CB1-ko mice showed increased freezing in 
both contexts whereas Glu-CB1-ko mice generally revealed higher levels of freezing 
in the shock context. Most curiously, GABA-CB1-ko mice had increased freezing 
levels in the grid context but not in the shock context as compared to the wildtype 
littermates. What might lead to the dissociation between the contexts in the mouse 
lines? Three hypotheses could explain this discrepancy. On the one hand, total-CB1-
ko mice and GABA-CB1-ko mice could have generalized the conditioned fear to any 
novel environment. Here, generalization is a process of judging different sensory 
stimuli as being similar enough to predict e.g. a footshock (Shepard, 1987) which 
consequently leads to a loss of memory specificity. Even the unavoidable 
manipulations inherent in fear conditioning testing (i.e. animal handling, carriage, to 
be placed in a context, particular time of the day) might induce enough fear to 
become sufficient to elicit the freezing response. The generalization of the fear 
response may be linked to the overall behavioral suppression of fear-conditioned 
mice. This emotional suppression then leads to a loss of discrimination between 
contexts and can be observed in rats and mice also by other groups (Baldi et al., 
2004;Balogh and Wehner, 2003;Fanselow, 1980;Laxmi et al., 2003;Radulovic et al., 
1998;Shaban et al., 2006).  
A mechanism that more specifically explains the generalization phenomenon is 
sensitization. Sensitization is a non-associative learning process characterized by a 
general increase in responsiveness to potentially harmful stimuli after an aversive 
experience (Groves and Thompson, 1970;Kamprath and Wotjak, 2004). In contrast to 
contextual fear conditioning, where the freezing response would be tested towards 
the conditioning context, in sensitization the freezing response would be tested 
towards an unrelated stimulus, or, as in our case, to an unrelated neutral context. 
Learning about the association between a tone and a potential footshock, i.e. the 
associative component, and sensitization to a tone after having received an 
inescapable footshock, i.e. the non-associative component, occur at the same time 
and can be basically dissociated (Kamprath and Wotjak, 2004) for auditory cued fear 
conditioning. Most interestingly, CB1-ko mice are impaired in habituation of the fear 
response to a tone after sensitization by a footshock (Kamprath et al., 2006). In our 
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hands, total-CB1-ko and GABA-CB1-ko mice seem to reveal such a sensitized fear 
as they show increased freezing levels in the grid context compared to the wildtype 
littermates, beside of per se high freezing levels in the shock context.  
If it is indeed enhanced generalization or more specifically increased sensitization 
that we observe in total-CB1-ko and GABA-CB1-ko mice, then we should expect that 
they also show enhanced freezing levels in the neutral context on day 8 before tone 
presentation. Admittedly, this is not the case after conditioning with 0.7 mA, and total-
CB1-ko, Glu-CB1-ko and GABA-CB1-ko mice have similar freezing levels compared 
to their wildtype controls. This rules out the possibility that generalization or 
sensitization to any new environment explains our findings. However, after 
conditioning with 1.5 mA, GABA-CB1-ko mice indeed reveal increased freezing in the 
neutral context possibly indicating increased sensitization under more aversive 
conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: A two-process model of context representation as it is adopted from Rudy et al. (2004). 
A context consists of a set of cues. Contextual fear conditioning can be supported by associations 
emphasising an individual feature of the context (as it is the grid floor in our example) and leading to a 
representation of this feature for the fear memory. On the other hand, conditioning can be supported 
by associations of contextual cues into a conjunction and a representation of the entire conjunction in 
the brain is stored as the fear memory. Under normal circumstances, conjunctive representation 
inhibits feature representation. 
 
A third explanation for our findings is, therefore, that mice could differentially use a 
subset of the conditioned cues to recall the aversive association. Rudy and co-
workers proposed a model that explains how contextual fear memory can be 
represented in the brain (Rudy et al., 2004) as it is shown in Figure 31. Here, physical 
elements of a context can be stored as either (1) a set of independent features in 
association with an event or (2) as features bound into a conjunctive representation 
encoding the co-occurrence with an event and supporting pattern completion. Rudy 
and colleagues further put forward the hypothesis that a conjunctive representation 
relies on the amygdala and the hippocampus whereas for a feature representation 
only the amygdala is needed. Under normal circumstances, a conjunctive 
representation inhibits a feature representation. If the hippocampus is blocked or an 
interaction between the hippocampus and the amygdala is impaired for other 
reasons, then a feature representation might take over to represent a context. Thus, 
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the interplay between the hippocampus and the amygdala is important for the kind of 
context representation (Figure 32).  
Both contexts, the shock context and the grid context, contained the grid floor that 
was used for conditioning of the animals with a footshock. GABA-CB1-ko mice might 
learn about the contexts by using a feature learning strategy, abstracting a small 
number of contextual elements that is the grid floor in our experimental condition. 
Perhaps they then make a stronger association between the grid floor as part of the 
context and the aversive stimulus during training and thus loose the ability to 
discriminate between contexts as could be also observed by others (Klemenhagen et 
al., 2006). If this is true, then GABA-CB1-ko mice favour a feature representation and 
rely on the grid floor as a cue. One could also argue for a pattern completion 
strategy, in that they consider the grid floor as a dominant cue that enables them to 
access the whole context memory. Also, one could bring forward the argument that 
total-CB1-ko mice and especially GABA-CB1-ko mice reveal declined safety learning, 
i.e. they cannot distract from the shock memory by combining the new cues (e.g. 
shape of the grid context, odour in the grid context) with a safe environment (Rogan 
et al., 2005) and learn that it is harmless. In contrast to that, Glu-CB1-ko mice prefer 
a conjunctive representation relying more on the context as a whole to learn and 
remember about the shock context and to specifically freeze more herein.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: Schematic representation of the brain regions involved in the contextual fear 
conditioning task. An emotionally neutral encounter is presented in association with an aversive 
stimulus. Processed information of the encounter is fed from neocortical regions to the hippocampus 
and the amygdala. The amygdala is receiving direct information on the averseness at the same time. 
An intense interplay between the hippocampus and the amygdala ensures the conjunction of context 
information that is represented in the hippocampus with the emotional load of the information that is 
represented in the amygdala. Neuronal connections of the amygdala are highlighted in grey. 
 
We pointed out earlier already that the medial septum, which uses ACh and GABA as 
neurotransmitters for its projection to the hippocampus (Freund and Antal, 
1988;Frotscher and Leranth, 1985), seems to play a prominent role in generating 
theta rhythm (Smythe et al., 1992;Vertes and Kocsis, 1997). Elevated levels of ACh 
specifically promote contextual fear conditioning at the expense of conditioning to a 
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tone (Calandreau et al., 2006). CB1-ko mice reveal heightened levels of ACh 
(Degroot et al., 2006;Kathmann et al., 2001b) which might influence the generation 
and distribution of theta rhythm in the hippocampus. Eventually, enhanced levels of 
theta oscillations in the hippocampus could be found in mice with increased anxiety-
related behaviour on the elevated plus maze (Gordon et al., 2005). More specifically, 
Seidenbecher and colleagues showed that during normal exploration and during 
presentation of an unconditioned tone, there was no evidence of theta rhythm in the 
amygdala, despite strong theta in the hippocampus. However, elicitation of 
conditioned fear with a context or a tone is associated with theta activity and theta 
synchronisation in the amygdala and the hippocampus (Seidenbecher et al., 2003). 
These findings suggest that theta oscillations that are possibly enhanced by ACh can 
be propagated to downstream targets, from the hippocampus to the amygdala. This 
might reflect an increase in neuronal communication that promotes the retention of 
the fear memory in favour of a conjunctive representation. If a synchronisation of the 
two brain structures is not assured anymore, one could speculate that this would 
bring forward a feature representation that requires the amygdala only. The fact that 
we did not find any differences in theta rhythm in the dentate gyrus of anaesthetised 
total-CB1-ko mice does not contradict this hypothesis as it is specifically the CA1 
region but not the dentate gyrus of the hippocampus that is involved in a contextual 
fear conditioning task (Hall et al., 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33: Model of different brain regions involved in the contextual fear conditioning task in 
GABA-CB1-ko and Glu-CB1-ko mice according to Rudy et al. (2004). A feature learning strategy is 
accomplished in GABA-CB1-ko mice that rely on a direct input of sensory information coming from the 
neocortex (left). In Glu-CB1-ko mice, a conjunctive learning strategy is favoured and contextual 
information is associated in the hippocampus and then fed into the amygdala. 
 
Importantly, GABAergic interneurons play a pivotal role in the generation of theta and 
gamma rhythm (Bartos et al., 2007;Buzsaki, 2002). It is impossible to state here 
which CB1-bearing neurons in the brain (GABAergic neurons in the septum, 
GABAergic neurons in the hippocampus, GABAergic neurons in the amygdala, 
cholinergic neurons in the septum, or glutamatergic neurons in the hippocampus 
projecting to the amygdala) are particularly involved in the observed phenotypes. 
However, it is tempting to speculate that a lack of theta synchronisation or gamma 
oscillations might be a reason for the amygdala-dependent feature representation in 
the GABA-CB1-ko mice, and a more strengthened synchronisation of theta rhythm 
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might underlie the hippocampus/amygdala-dependent conjunctive representation in 
the Glu-CB1-ko mice (Figure 33). 
In conclusion, deletion of CB1 does not play a pivotal role in exploration-based 
memory tasks like the object recognition test, social recognition test and open field 
habituation test. However, in aversive learning paradigms, the endocannabinoid 
system plays a role in reversal learning as could be seen in Glu-CB1-ko mice in the 
water maze task, and differentially affects learning of a context in the contextual fear 
conditioning paradigm in all three mouse lines. We would like to make some 
speculative suggestions referring to transmitter systems and brain structures involved 
in these processes in the Appendix (section 6.2). 
 
4.3 Modulation of emotionality in CB1-ko mice 
4.3.1 Effects of CB1 signalling on emotionality 
Blockade of CB1 with an antagonist increased anxiety-like behaviour in rodents 
(Akinshola et al., 1999;Arevalo et al., 2001;McGregor et al., 1996;Navarro et al., 
1997;Patel and Hillard, 2006) whereas other studies could show an anxiolytic effect 
of antagonist administration (Akinshola et al., 1999;Haller et al., 2002;Rodgers et al., 
2003).  
Data from mice with a deletion of CB1 were similarly inconsistent. CB1-ko mice 
showed decreased (Degroot and Nomikos, 2004), unaltered (Aguado et al., 
2005;Ledent et al., 1999;Maccarrone et al., 2002;Marsicano et al., 2002) or 
increased (Martin et al., 2002;Uriguen et al., 2004) anxiety-related behavior in a 
variety of tests of unconditioned fear such as the open field, shock probe burying, 
elevated plus-maze, social interaction, and the light/dark test.6 
On the other hand, CB1 activation with the agonists WIN55212-2 or CP 55940 or 
potentiation of endocannabinoid signalling with the degradation inhibitor URB532 and 
URB597 or the endocannabinoid reuptake inhibitor AM404 reduced anxiety-related 
behavior in rats or mice (Bortolato et al., 2006;Kathuria et al., 2003;Patel and Hillard, 
2006). The fact that endocannabinoids affect anxiety-related behaviour is pivotal and 
suggests an involvement of the endocannabinoid system under normal physiological 
conditions.  
One reason for the apparent discrepancies might be differences in environmental 
factors. It has been shown that CB1-ko mice only showed an anxiogenic-like 
phenotype under conditions of high stress: Light in the elevated plus-maze (that was 
200 lux compared to 0.5 lux, respectively) and the familiarity of the testing 
environment (novel cage compared to home cage, respectively) (Haller et al., 2004a). 
In another study, FAAH-ko mice or mice treated with the FAAH-blocker URB597 
revealed no difference to the control mice from the background strain on the elevated 
plus maze under standard laboratory conditions (i.e. normal overhead light) but 
showed an anxiolytic phenotype under high-light conditions for the open arms (i.e. 
overhead lights turned off and two 60-W light bulbs illuminating open arms and 
casting a shadow on the closed arms) (Naidu et al., 2007). These findings would 
explain why the same drug or the same knockout animal has different effects or 
displays different behaviors, respectively, under different conditions because 
behavioural effects of CB1 blockade depend on the averseness or stressfulness of 
the testing environment.  
                                      
6 Curiously, SR141716A still decreased anxiety-related behavior in CB1-ko mice, suggesting another 
target of the drug which might be “CB3” (Haller et al., 2002). There was no such an effect with the 
antagonist AM251, suggesting that this is a truly specific CB1 antagonist (Haller et al., 2004b). 
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The context dependency is indirectly supported by the “one-trial sensitization” 
phenomenon described by Rodgers and colleagues in the plus-maze. An anxiolytic 
effect of the antagonist SR141716 is revealed in mice previously exposed to the plus 
maze apparatus (Rodgers et al., 2003). Thus, the anxiolytic effect of SR141716 is 
more pronounced when animals have increased basal levels of anxiety. Another 
study could show an anxiolytic effect of the CB1 antagonist AM251 in the highly 
aversive step-down inhibitory avoidance task but no effect in the lowly aversive open 
field habituation task (de Oliveira et al., 2005;de Oliveira et al., 2006). 
We tried to figure out if at all and under which conditions mice of the three lines 
revealed anxiety-related behaviour. Taken from the studies cited above, our 
hypothesis was the following: In tests where an animal is exposed to an aversive 
situation, the endocannabinoid system is activated and eventually leads to an 
attenuation of the anxiety state. This condition permits the mouse not to remain in a 
state of anxiety but to access its behavioral repertoire and apply adequate behaviour 
in the respective situation. Indeed, augmented levels of endocannabinoids can 
suppress an anxious reaction when rats are exposed to a predator odour (Hill et al., 
2006b). Obviously, endocannabinoids are able to dampen activation of stress-related 
brain circuits, e.g. the HPA axis (Patel et al., 2004;Patel et al., 2005b) and may act as 
a buffer system in the stress response (Di et al., 2003;Tasker, 2004). 
 
4.3.2 Elevated plus-maze and light/dark box 
Grossly, we can divide the applied emotionality tests used in this study into two 
categories: Choice and no-choice tests of a confrontation with an aversive 
environment. In the light/dark test and plus-maze test, the animal can choose 
whether to stay in the safe compartment or whether to explore the unsafe and 
brightly illuminated or elevated areas of the maze, respectively. Here, no significant 
differences are found for total-CB1, GABA-CB1 and Glu-CB1 mice. Even so, there 
was a tendency of total-CB1-ko mice to show an anxiogenic response and in GABA-
CB1-ko mice to show an anxiolytic response in the plus-maze test. This makes sense 
as the elevated plus maze includes two additional anxiety-provoking parameters, 
height and totally open area (Crawley et al., 1997) as compared to the light/dark test. 
However, the tendency of a mouse, either wildtype or knockout, to stay in the safe 
areas and to avoid the unsafe areas will not require the endocannabinoid system and 
an effect of CB1 deletion cannot be ascertained. Indeed, this is in keeping with 
pharmacological blockade of CB1, after which no effect on anxiety could be seen in 
the plus-maze and the light/dark box (Rodgers et al., 2003;Rutkowska et al., 2006).  
 
4.3.3 Defensive marble burying 
On the other hand, we employed test situations with a no-choice condition to avoid 
an aversive surrounding in terms of exposure to bright light or glass marbles, 
respectively, that were the social interaction test, the novel object exploration test, the 
open field test and the marble burying test.  
We found no differences in the marble burying test as it could be observed by others 
(Hodgson et al., 2007). Assuming that the marbles constitute an aversive situation 
this would contradict our hypothesis that mice with an anxiogenic phenotype bury 
more marbles. It has been argued that marble burying is a better measure of 
obsessive-compulsive behaviour: Rather than responding to an aversive object, the 
test is thought to reflect spontaneous digging behaviour (with buried marbles just 
being a quantification of the digging behaviour) where habituation does not occur and 
selective serotonin reuptake inhibitors are highly effective (Gyertyan, 1995;Njung'e 
and Handley, 1991). In the end, the marble burying test might not be an appropriate 
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test to investigate emotionality in our mouse lines. It has been furthermore suggested 
that burying is proportional to a subjects’ tendency to explore (Londei et al., 1998). 
As we conducted the test in darkness, the situation might have been not aversive 
enough, as it could have been observed for the social recognition and object 
recognition test (please see below). However, as the marbles were spread over the 
whole cage, there was no opportunity for the animal to avoid contact to the marbles, 
which might have lead to a severe state of anxiety in both wildtype and knockout 
animals. We can exclude this possibility as it has been shown that mice did not avoid 
the marbles when given the opportunity to do so in a two-compartment box (Njung'e 
and Handley, 1991)7. Altogether, marbles do not seem to be as aversive as e.g. 
brightly lit environments. Ultimately, digging of bedding material, whether being a test 
for obsessive compulsive disorder or not, is not different in the investigated mouse 
lines under low light conditions. Future studies are planned to figure out whether this 
finding holds true for a brightly lit environment, too. 
 
4.3.4 Social interaction, novel object interaction and open field 
The case is very different for the social interaction test, the novel object exploration 
test and the open field test. We conducted these tests under two conditions, bright 
light or dim light/darkness, that is highly aversive or lowly aversive for rodents, 
respectively. For example, the startle response in rats was markedly increased under 
bright light conditions compared to dark conditions, an effect that was disrupted by 
anxiolytic drugs (Walker and Davis, 1997a). Furthermore, exploration of a novel 
space, a novel object or a conspecific mouse under bright light conditions was 
reduced, and this effect could be prevented by administration of a benzodiazepine as 
an anxiolytic drug (Crawley and Goodwin, 1980;File and Hyde, 1978). 
Under low light, we found moderate or no differences for the genotypes. Glu-CB1-ko 
mice showed less novel object exploration and decreased thigmotaxis in the open 
field, i.e. an anxiogenic and anxiolytic phenotype, respectively. GABA-CB1-ko, in 
contrast, showed more novel object exploration compared to the wildtype littermates, 
i.e. an anxiolytic phenotype. Total-CB1-ko mice had decreased levels of thigmotaxis 
in the open field task similar to Glu-CB1-ko mice indicating an anxiolytic phenotype.8 
This highlights that under the lowly aversive conditions the endocannabinoid system 
gets moderately activated as can be observed in some test parameters.  
Our results become very clear and unambiguous under the highly aversive condition. 
Here, we could show that total-CB1-ko and Glu-CB1-ko mice showed a decrease of 
exploration of a novel object or juvenile and revealed increased thigmotaxis in the 
open field test emphasizing an anxiogenic phenotype. GABA-CB1-ko mice still have 
increased exploratory activity in the object exploration test, a tendency of increased 
locomotion in the open field and a minor increase in thigmotaxis in the open field 
rather pointing towards an anxiolytic phenotype. We hypothesize that under the 
highly aversive conditions the endocannabinoid system gets fully activated and 
unfolds its anxiety-modulating effect. Our findings support the anxiogenic phenotype 
of CB1-ko mice and the anxiolytic phenotype of FAAH-ko mice that is only seen 
under high levels of stress associated with the environmental conditions (Haller et al., 
                                      
7 There is another study clearly demonstrating the avoidance of glass marbles in the zone containing 
the marbles, although only for C57BL/6J mice but not in two other mouse strains (Nicolas et al., 2006). 
8 We would like to emphasise here that a decrease of thigmotaxis is not due to a general 
augmentation of locomotion as we analysed the relative rate of thigmotaxis by normalizing the 
distance moved along the walls by the total distance moved. We did not consider the distance moved 
in the center of the open field as this area is arbitrarily defined and is too small for an appropriate 
measurement that could consistently reflect an anxiety-like behaviour in our laboratory. 
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2004b;Naidu et al., 2007). Our findings make sense from a physiological point of 
view, as corticosterone, that is released during stress, has similar levels in CB1-ko 
mice and wildtype mice under basal conditions but there is increased levels of 
corticosterone after a stressful experience in CB1-ko mice (Uriguen et al., 
2004;Wade et al., 2006) so that CB1-ko mice are perhaps more prone to stress by 
that.  
We cannot fully exclude the possibility that total-CB1-ko mice and Glu-CB1-ko mice 
possess a disturbance in their visual system (e.g. a deterioration of the retina) so that 
they are not able to detect a novel object or a novel juvenile mouse under bright light 
conditions. This is rather unlikely to our minds: The novel juvenile exploration not only 
relies on approaching the juvenile mouse by the adult test mouse but also vice versa 
by approaches of the juvenile mouse towards the adult mouse. Secondly, although 
we tested total-CB1-ko and Glu-CB1-ko mice in the water maze under moderate 
illumination (50 lux) we could not detect any differences for acquisition of the task 
suggesting that the visual acuity of the mice is unaltered. 
Behavioural consequences of endocannabinoid system activation become even 
more pronounced in a second trial in our experiments. Experienced total-CB1-ko 
mice and Glu-CB1-ko mice now show an anxiogenic phenotype in the plus-maze. 
Differences are known to exist in the nature of the anxiety response in plus-maze 
naïve and plus-maze experienced rodents. After an initial apparatus exploration it 
seems that rodents acquire, consolidate and retrieve some kind of memory related to 
exploration of potentially dangerous areas of the maze that is the open arms and 
consequently avoid these areas (Carobrez and Bertoglio, 2005). In particular, test 
experienced animals do not longer respond to the anxiolytic effect of 
benzodiazepines (Holmes and Rodgers, 1999). Obviously, in exploration-based tests 
(e.g. elevated plus-maze, open field) that rely on a conflict of approach and 
avoidance of a novel environment, learning shifts the balance towards avoidance (as 
there is no reason to search for food, shelter, escape anymore) (Belzung and 
Griebel, 2001;Millan, 2003). However, the antagonist SR141716 displayed a 
significant anxiolytic effect in maze-experienced mice (Rodgers et al., 2003). One 
explanation of this finding might be that only in the second trial on the plus-maze, the 
endocannabinoid system is adequately activated and the antagonist can unfold its 
complete efficacy. Nevertheless, we cannot support the anxiolytic effect of a deletion 
of CB1 on trial two with our mouse lines but see the opposite effect namely that total-
CB1-ko and Glu-CB1-ko mice reveal an anxiogenic phenotype if the number of mice 
not exploring the open arms at all are considered. However, we have to remark 
critically here that the mice treated with the antagonist in Rodger’s experiment were 
undrugged in the first trial, whereas our mice were deficient of CB1 in both trials, 
which may change the outcome of the second trial. Perhaps, Rodger’s mice were 
rather affected in memory retrieval of the first plus-maze trial which resets their 
emotional response so that it resembles an anxiolytic phenotype. In the same way, 
total-CB1-ko mice and Glu-CB1-ko display drastically less locomotion and rearing in 
the open field under bright light conditions and both mice have increased levels of 
thigmotaxis during a second exposure. We suggest a similar memory of the aversive 
situation as it is perhaps the case for the plus-maze test. 
In conclusion, CB1 on glutamatergic and GABAergic nerve cells has an antagonistic 
effect on anxiety which we refer to as the “Yin and the Yang effect” of CB1 on anxiety 
(Figure 34). Total-CB1-ko and Glu-CB1-ko mice show an axiogenic phenotype under 
highly aversive conditions and at the same time lack CB1 on glutamatergic neurons. 
We hypothesize that in wildtype animals downregulation of glutamatergic 
transmission via CB1 can unfold an anxiolytic phenotype. Otherwise, GABA-CB1-ko 
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mice rather show an anxiolytic phenotype. This mouse line misses CB1 on 
GABAergic neurons preferentially in the forebrain. Hence, in wildtype mice, 
downregulation of GABAergic transmission by activation of CB1 might manifest an 
anxiogenic phenotype and deletion of CB1 on GABAergic neurons consequently 
leads to the anxiolytic phenotype in the GABA-CB1-ko mice. We would like to make 
some speculative suggestions referring to transmitter systems and brain regions 
involved in these processes in the Appendix (section 6.3 and 6.4). 
 
 
 
Figure 34: The Yin and Yang of CB1 on emotionality. Activation of CB1 has antagonistic effects on 
anxiety. Depicted is the distribution of CB1 on either glutamatergic neurons or GABAergic nerve cells. 
CB1 on glutamatergic cells reveals an anxiolytic effect whereas CB1 on GABAergic neurons appears 
to be anxiogenic. The converse phenotype can be observed in the Glu-CB1-ko and GABA-CB1-ko 
mice as CB1 is missing on the respective neuronal populations. Under highly aversive conditions, CB1 
on glutamatergic terminals outweighs the effects of CB1 on GABAergic terminals with the 
consequence that total-CB1-ko mice display an anxiogenic-like phenotype under those circumstances. 
 
All in all, activation of CB1 has a major influence on anxiety, critically depending on 
the severity of a potential threat and the neuronal subpopulation (i.e. glutamatergic or 
GABAergic neurons) with respective neuronal circuits participating in certain fearful 
situations. 
 
4.4 Pitfalls of the CB1-ko animal model 
Genetic deletion of CB1 offers several advantages over the pharmacological 
blockade, most importantly an increased receptor specificity (i.e. no concomitant 
block/activation of VR1 or occurrence of inverse agonist properties of the CB1 
antagonist SR141716 in our case) and a completeness of receptor inactivation. 
Another advantage is that the lack of receptor and its associated function is not 
restricted to the moment of the experiment (and then could unfold its effect at an 
earlier or later moment) but is persistent. Eventually, by using conditional knockout 
mice, it is possible to target specific neuronal populations or developmental stages. 
However, one has to be cautious about the drawbacks of genetically modified mice. 
Genetic mutations or deletions can lead to molecular or cellular changes that have 
been interpreted as an attempt of the organism to compensate for the missing or 
malfunctioning gene product (Nelson and Young, 1998;Pich and Epping-Jordan, 
1998;Routtenberg, 2002). Potential drawbacks in CB1-ko mice shall be highlighted in 
the next two paragraphs.  
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CB1 on  
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4.4.1 Compensatory mechanisms in CB1-ko mice 
CB1-ko mice develop apparently normally in the absence of the CB1 receptor 
(Harkany et al., 2007). They are fertile, care for their offspring, and do not show any 
obvious behavioral abnormalities. However, the elimination of CB1 may still alter the 
development of the animals, leading to behavioral changes that are not the direct 
result of acute disruption of endocannabinoid transmission. CB1-ko mice show some 
gross abnormalities in that they have reduced body weights, tend to have 
spontaneous seizures in their home cages (G. Marsicano, C.T. Wotjak, personal 
communication; Zimmer et al., 1999), swam poorly during a first exposure to the 
water maze pool (Varvel and Lichtman, 2002), have a higher mortality rate, and have 
a decrease in the number of cells in the hippocampus (Bilkei-Gorzo et al., 
2005;Zimmer et al., 1999). On the other hand, young (6-8 weeks old) CB1-ko mice 
are not impaired in learning and memory test as it has been shown for adult and old 
CB1-ko mice (Bilkei-Gorzo et al., 2005). Therefore, if there are compensatory 
changes that affect behaviour, then they set in rather late in ontogeny. 
There is some evidence that CB1-ko animals exhibit changes in neurochemical and 
hormonal states. The study of Maccarrone and colleagues compared 1-month-old 
and 4-month-old CB1-ko mice with the respective wildtype animals. They could show 
that there are no changes in endogenous anandamide and 2-AG brain contents as 
well as in AMT and FAAH activity in the 1-month-old animals. In contrast, the 4 
month old CB1-ko animals, that resemble our animals with a range of age of 3-5 
months, showed a decrease in hippocampal and striatal anandamide content and an 
increase in hippocampal and cortical AMT and FAAH activity (Di Marzo et al., 
2000;Maccarrone et al., 2002). On the other hand, in a different study, no age-
dependent differences in the tissue levels of anandamide and 2-AG or the density of 
CB1 could be found in 2 month old or 6-12 month old CB1-ko mice (Wang et al., 
2003).  
In contrast to acute pharmacological blockade with SR141716 or AM251, genetic 
inactivation of CB1 did not modulate basal steady-state hippocampal ACh efflux (this 
happened only under stress-inducing conditions) (Degroot et al., 2006;Kathmann et 
al., 2001b). Furthermore, genetic deletion of CB1 did not result in increased basal 
corticosterone levels in some studies (Wade et al., 2006;Wenger et al., 2003) 
whereas application of the antagonist SR141716 or genetic deletion of CB1 clearly 
increases levels of corticosterone in other studies (Barna et al., 2004;Cota et al., 
2006;Wade et al., 2006). Neuropeptide mRNA levels of dynorphin and substance P 
are increased in the striatum of CB1-ko mice. In addition, locomotion was drastically 
reduced in CB1-ko mice (level of illumination of the open field in this study is not 
denoted), but motor coordination on the rotarod was not impaired (Steiner et al., 
1999). This led the authors to the conclusion that initiation of movement is affected in 
CB1-ko mice. However, we could show that the inhibition of locomotion in CB1-ko 
mice is dependent on the averseness of the test situation and is not seen under low 
stress conditions. Morover, GABA-CB1-ko mice show a recombination of CB1 in the 
striatum whereas Glu-CB1-ko mice do not. At the same time, GABA-CB1-ko mice 
show no differences in locomotion in the open field. Thus, it is rather unlikely that the 
striatum as a central player of locomotion is the main cause of the observed 
phenotype. 
By and large, these data indicate that brain region-specific adaptive and 
compensatory changes may occur in endocannabinoid metabolism of CB1-ko mice. 
However, it is questionable whether they significantly contribute to the phenotypes 
observed in the present study. 
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4.4.2 Genetic background of CB1-ko mice 
Inbred C57BL/6 substrains and the outbred CD1 strain of mice have been utilised as 
genetic background for the generation of CB1-ko mice. These strains of mice have 
been used to develop four independent CB1-ko mouse lines, with Zimmer et al., 
Robbe et al. and Marsicano et al. using C57BL/6 substrains and Ledent et al. using 
the CD1 strain (Ledent et al., 1999;Marsicano et al., 2002;Robbe et al., 2002;Zimmer 
et al., 1999). Particularly, as the Ledent line has been crossed to an outbred CD1 
genetic background, individual mutant animals from this strain can be expected to 
have a more heterogeneous genetic background.  
In pharmacological, electrophysiological or behavioral experiments, results can be 
very different due to different genetic make-up of the used mouse strain. Most 
importantly for our study, it seems to be very distinct that CD1 mice show declined 
LTP maintenance and declined non-spatial learning whereas C57Bl/6 mice show 
excellent learning capabilities and LTP maintenance (Gerlai, 2002). Therefore, it 
might be much easier to find LTP and memory enhancing effects in mutant CD1 
mice, and it is difficult to compare knockout animals of these two strains as a 
background. To avoid a ceiling effect, it might be more appropriate to use a mouse 
strain that can improve poor performance and the C57BL/6 mouse strain might not 
be the best tool for this purpose. Discrepancies between CD1 and C57BL/6 mice are 
also found in tests of memory (Gerlai, 2002) and anxiety (Bouwknecht and Paylor, 
2002) and have to be kept in mind if knockout animals with different background 
mouse strains are compared. Anyhow, experiments with mutant mice have to be 
confirmed by acute pharmacological treatment which would, furthermore, allow 
addressing the question on to the different involvement of CB1 in different phases of 
the learning process (i.e. acquisition, consolidation, retrieval, extinction). In the 
present study, however, pharmacological treatment was not indicative as it fails to 
discriminate between CB1 on GABAergic versus glutamatergic neurons and hence 
could not help us to answer the questions under study. 
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5. Conclusion 
 
The present study suggests that CB1 is involved in long-term synaptic plasticity 
although it could not be ascertained which neuronal population (i.e. glutamatergic or 
GABAergic nerve cells) accomplished LTP enhancement. The endocannabinoid 
system does not have a general nootropic effect. CB1 activation seems to specifically 
affect learning and memory of aversive learning tasks while leaving exploration-
based learning tests unaffected. For the first time, a dissociation of contextual fear 
memory representation could be observed that is affected by cell-type specific CB1 
ablation. CB1 activation plays a pivotal role in coping with stressful and potentially 
threatening situations. A “Yin and Yang principle” of CB1 on emotionality is evident in 
that CB1 on GABAergic neurons unfolds an anxiogenic effect and CB1 on 
glutamatergic nerve cells reveals an anxiolytic effect as it is shown for the first time in 
this study. These effects are most prominent under very stressful and aversive 
testing conditions. The exact neuroanatomical and neurophysiological processes 
behind our findings remain to be investigated. 
Our findings emphasise the importance of conditional mutant mice to investigate the 
endocannabinoid system. With pharmacological tools, we would not have been able 
to distinguish between CB1 on glutamatergic and GABAergic neurons which was 
only possible with a specific ablation of CB1 on these neuronal populations in 
conditional mutant mice. 
Taken into consideration that a variety of anxiety disorders are characterised by 
altered processing of trauma-related and stressful contextual fear memories and by 
impairments in fear extinction (e.g. posttraumatic stress disorder, panic disorder, and 
social phobia), the data of the present study imply a dysregulation of the 
endocannabinoid system to play an important role in such pathological states. 
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6. Appendix 
 
6.1 Factors for LTP enhancement 
We would like to introduce the reader to some possible mechanisms by which LTP 
enhancement could be assured. 
6.1.1 Factors for LTP enhancement I: GABA 
It is controversial whether the enhancement of LTP is a direct consequence of an 
unrestrained excitatory transmission between principal neurons, or whether it occurs 
indirectly as a reduction of inhibitory transmission onto pyramidal or granule cells so 
that glutamatergic transmission can pass off more efficiently.  
Stimulation of hippocampal afferent fibers activates excitatory synapses on principal 
cells, but also local populations of GABAergic interneurons, which exert potent 
inhibitory actions on principal cells (Thompson, 1994). Release of endocannabinoids 
in the hippocampus might be related to reduced inhibition. More precisely, the 
perforant path-granule cell LTP is normally accompanied by long-term potentiation of 
a feed-forward inhibitory pathway (Kairiss et al., 1987) and induction of NMDA-R-
dependent LTP in the dentate gyrus is facilitated by a reduction of GABAergic IPSCs 
(Wigstrom and Gustafsson, 1983;Wigstrom and Gustafsson, 1985). LTP of 
GABAergic interneurons may arise from changes at both excitatory synapses on to 
interneurons and inhibitory synapses on to pyramidal cells. Activation of CB1 would 
block GABAergic interneurons that restrain their target glutamatergic pyramidal 
neurons. Endocannabinoids would then be the natural disinhibitor of local synaptic 
plasticity in the hippocampus.  
In two single-cell recording studies, a high spatial and temporal precision of 
endocannabinoid action onto GABAergic interneurons could be demonstrated. As 
stated above, a brief stimulus train, that did not induce LTP under normal conditions, 
was then delivered during a DSI period, when GABAergic transmission is suppressed 
after depolarisation of a principal neuron. It now could induce NMDA-R-dependent 
LTP (Carlson et al., 2002). The same effect holds true for I-LTD in that induction of I-
LTD can prime excitatory synapses, so that LTP of excitatory transmission can 
subsequently be induced by stimuli that were previously subthreshold for LTP 
induction. The priming effect is spatially very specific for a small dendritic area 10 µm 
away from the stimulating electrode (Chevaleyre and Castillo, 2004). Accordingly, 
endocannabinoids can facilitate LTP induction through a heterosynaptic interaction 
with GABAergic synapses. These studies also suggests that the effect of 
endocannabinoids to facilitate LTP induction occurs in a highly spatially restricted 
way as released endocannabinoids travel ≤ 20µm (Wilson and Nicoll, 2001). The 
results are also remarkable as they do not contradict the many reports that 
(endo)cannabinoids antagonise LTP, because exogenously applied 
(endo)cannabinoids globally affect all cells and types of cannabinoid receptors, 
including those on glutamatergic and GABAergic synapses. Thus, a loss of 
endocannabinoid control on GABA release, like in CB1 knock-out mice, could rather 
increase inhibition, which likely counteracts LTP. The fact that this effect can not be 
supported by our study is perhaps due to the global activation of large hippocampal 
areas in our experimental in vivo preparation. 
Remarkably, endocannabinoids may also decrease GABA reuptake and thus 
augmented GABA levels after HFS could hinder LTP (Al Hayani and Davies, 
2002;Maneuf et al., 1996). This suggests, that endocannabinoids released after 
depolarization may impair the induction of LTP through upregulation of GABAergic 
transmission.  
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Disinhibition does not have to be mediated within the hippocampus but may be 
mediated from GABAergic septohippocampal afferents that selectively inhibit 
hippocampal interneurons and thus disinhinbit pyramidal cells (Toth et al., 1997). 
Remarkably, each hippocampal inhibitory cell contacts 500-1200 pyramidal cells 
(Buhl et al., 1994), thus the effect might be very striking in disinhibiting a large 
population of neighbouring pyramidal cells. Disinhibition could eventually lead to a 
facilitated induction of LTP. As total-CB1-ko and GABA-CB1-ko mice miss CB1 on 
GABAergic neurons this could mean that disinhibition occurs in these mice and 
ultimately enhances LTP. 
On the other hand, and quite astonishingly, it is not mandatory that LTP of an afferent 
excitatory input to an interneuron necessarily improves the inhibition in a target cell of 
the respective interneuron. For example, when LTP is induced in an interneuron, 
IPSP in a postsynaptic pyramidal neuron may be depressed rather than potentiated, 
because of presynaptic effects (Stelzer and Shi, 1994). It is known that GABAB 
autoreceptors, located on the interneuron terminals that synapse on pyramidal cells 
and unfold postsynaptic hyperpolarisation via GABAA receptors, can be activated 
during LTP induction, depress the release of GABA and lead to a prolongation of 
EPSPs, thereby creating facile conditions to trigger LTP (Davies et al., 1991;Mott and 
Lewis, 1991;Pacelli et al., 1989). GABAB antagonists can block theta-burst-LTP 
(Davies et al., 1991) or lead to suppressed LTP (Brucato et al., 1996). The effect of 
autoreceptor-mediated reduction of GABA is more sensitive to LTP induced through 
theta-burst stimulation that we also applied in our study (Staubli et al., 1999).  
In conclusion, increased GABA levels could decrease LTP or paradoxically increase 
LTP or have simply no net effect at all as the increase of GABA due to the lack of 
CB1 is decreased to the net level due to GABAB-receptor activation. If these 
mechanisms play a role in total-CB1-ko and GABA-CB1-ko mice, where CB1 is 
missing on interneurons, it remains to be elucidated why LTP enhancement can only 
be observed in total-CB1-ko mice.  
6.1.2 Factors for LTP enhancement II: Glutamate 
Another obvious mechanism for the action of CB1 on LTP is a modulation of 
glutamatergic transmission during LTP induction. A straightforward hypothesis would 
state that the lack of CB1, having an inhibitory effect on glutamatergic transmission, 
leads to an enhancement of LTP. 
Whether endocannabinoids suppress excitatory glutamatergic transmission is a 
matter of debate. CB1 agonists can decrease EPSPs in hippocampal pyramidal 
neurons (Al Hayani and Davies, 2000;Ameri and Simmet, 2000;Hajos and Freund, 
2002;Misner and Sullivan, 1999) or no inhibition of excitatory synaptic transmission in 
the hippocampus could be found (Al Hayani and Davies, 2000;Paton et al., 
1998;Terranova et al., 1995). Most importantly, suppression of glutamatergic 
transmission after application of the CB1 agonist WIN55,212-2 could be shown in the 
amygdala, neocortex, cerebellum and hippocampus in GABA-CB1-ko mice but no 
such suppression has been detected in mice lacking CB1 on glutamatergic neurons, 
that are similar to our Glu-CB1-ko mice, or in CB1-ko mice (Domenici et al., 
2006;Kawamura et al., 2006). This unequivocally shows that it is indeed CB1 on 
glutamatergic neurons causing the effect and not a secondary process. 
Inhibition of COX-2, that is an endocannabinoid degrading enzyme, which 
consequently boosts levels of 2-AG, decreases basal excitatory transmission in the 
hippocampus. Slanina and colleagues could further show that, again by blocking 
COX-2, hippocampal LTP of fEPSP is greatly restricted. On the other hand, block of 
CB1 with the antagonists SR161714A or AM251 increased levels of LTP. 
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Interestingly, only moderate or theta-burst stimulation for LTP induction lead to 
increased levels of LTP after CB1 block. If strong HFS protocols were applied, no 
difference could be found anymore (Slanina et al., 2005;Slanina and Schweitzer, 
2005).  
These data, obtained in the slice preparation, cannot be directly conferred to our in 
vivo preparation. Our LTP-inducing protocol is a moderate theta-burst protocol with 
36 stimuli altogether (compared to 216 pulses usually applied for in vivo experiments 
in mouse or rat (Jones et al., 2001a), hence contradicting the finding of Slanina et al., 
as we did not find any changes in Glu-CB1-ko mice. However, for LTP induction, we 
used a current with asymptotic pop-spike amplitude compared to baseline current 
used in the study of Slanina et al. In conclusion, it might be that our protocol for LTP 
induction is too drastic and differences get blurred between knockout and wildtype 
animals. The question again arises why we are able to find increased LTP levels only 
in total-CB1-ko animals but not in Glu-CB1-ko and GABA-CB1 ko mice?  
As stated already above, enhanced LTP could not always be mimicked by application 
of the CB1 antagonist (Marsicano et al., 2002) suggesting some other factor being 
involved in the increase. Curiously, the antagonist AM251 even inhibited the 
induction of LTP in a recent study (de Oliveira et al., 2006) whereas only a chronic 
but not acute administration of the antagonist AM251 increased levels of LTP 
(Hoffman et al., 2007). Which other transmitter may account for this discrepancy? 
6.1.3 Factors for LTP enhancement III: Acetylcholine 
If it is not the GABAergic or glutamatergic transmission leading to enhanced LTP 
then another additional factor must be required for this effect. One possibility is the 
cholinergic system. ACh has been accorded an important role in supporting learning 
and memory processes in the hippocampus (Parent and Baxter, 2004). Cholinergic 
projection neurons that innervate the forebrain (including the hippocampus) arise in 
the medial septum and the nucleus basalis of Meynert. As mentioned above, the 
projection of the medial septum to the hippocampus consists of two components: 
One is cholinergic afferents which contact both pyramidal and inhibitory cells in the 
hippocampus (Frotscher and Leranth, 1985). The other component are GABAergic 
neurons that seem to selectively contact interneurons (Freund and Antal, 1988). 
Interneurons of the hippocampus feed back to the medial septum and innervate 
cholinergic and non-cholinergic neurons herein (Amaral DG and Witter MP, 1995). 
CB1 is present in cholinergic projecting neurons in the medial septum and the 
nucleus basalis of Meynert (Lu et al., 1999;Nyiri et al., 2005) and FAAH is found in 
these cells as well (Harkany et al., 2003) indicating that cholinergic neurons might 
utilize endocannabinoids for the control of efficacy of cholinergic input and are itself 
under the control of endocannabinoids. The cannabinoid receptor agonists 
anandamide, WIN55,212-2 and CP55940, decrease acetylcholine release from 
electrically stimulated hippocampal slices (Gifford et al., 1997a;Gifford et al., 
2000;Gifford and Ashby, Jr., 1996), whereas the antagonists SR141716 and AM281 
increase the ACh release in mouse and rat suggesting that ACh output is tonically 
inhibited by endocannabinoids (Freund et al., 2003;Gifford et al., 1997b;Gifford et al., 
2000;Kathmann et al., 2001b;Redmer et al., 2003;Steffens et al., 2003). The CB1 
antagonist AM251 eliminated the effect of the ACh esterase inhibitor physostigmine 
to reduce fEPSP in the hippocampus (Colgin et al., 2003). Also, the hippocampus of 
CB1-ko mice showed enhanced release of ACh in response to electrical stimulation 
(Kathmann et al., 2001a) although another study found no difference for CB1-ko 
animals under basal conditions (Degroot et al., 2006;Wade et al., 2006). Eventually, 
CB1 agonists reduce acetylcholine levels in the neocortex and hippocampus in vivo 
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but only at relatively high doses (mg/kg) whereas lower doses (µg/kg) cause the 
opposite effect elevating the acetylcholine level (Acquas et al., 2000;Gessa et al., 
1998)9. 
Importantly, cholinergic agonists facilitated LTP (Blitzer et al., 1990;Burgard et al., 
1993) and endogenous ACh, that activates muscarinic ACh receptors, lowers the 
threshold for LTP induction (Ovsepian et al., 2004). Interestingly, specific activation of 
the M1-mAChR leads to enhanced LTP and the same receptor triggers release of 
endocannabinoids and DSI (Kim et al., 2002;Shinoe et al., 2005). Thus, increased 
ACh levels may participate in the facilitation of LTP in total-CB1-ko mice. So far, it is 
unknown whether ACh levels are altered in GABA-CB1-ko and Glu-CB1-ko mice 
which could consequently contribute to enhance LTP.  
6.1.4 Factors for LTP enhancement IV: Cholecystokinin (CCK) 
CCK is one of the most abundant neuropeptides in the brain (Fink et al., 1998). CB1 
is located on the axon terminals of a specific GABAergic cell population characterised 
by the expression of CCK. About 80% of CCK-positive interneurons coexpress CCK 
and CB1. Altogether, about 40% of all hippocampal interneurons express CB1 
(Marsicano and Lutz, 1999). Indeed, cannabinoid agonists inhibit CCK release in the 
hippocampal slice (although CCK release is unchanged in the frontal cortex after 
agonist application, where CB1 and CCK are coexpressed, too) (Beinfeld and 
Connolly, 2001). Hence, a reduction of GABAergic transmission by CB1 activation 
might be paralleled by a reduction of CCK. Another line of evidence showed that 
deficiency of CCK receptor decreased LTP, and CCK receptor agonists increased 
LTP in the hippocampus (Balschun and Reymann, 1994;Nomoto et al., 1999;Yasui 
and Kawasaki, 1995). So far, no study investigated levels of CCK in vitro or in vivo in 
CB1-ko animals, however this discloses another possibility of enhanced LTP in total-
CB1-ko mice if these mice would indeed reveal enhanced levels in CCK 
transmission. However, the fact that we did not see any differences in LTP in GABA-
CB1-ko mice does not support a major role of CCK in LTP enhancement (provided 
that CCK levels are actually increased in GABA-CB1-ko mice).  
6.1.5 Factors for LTP enhancement V: Vanilloid receptor 1 
The transient receptor potential vanilloid subtype 1 channel (TRPV1 or vanilloid 
receptor 1 VR1) is a calcium-permeable non-selective cation channel that was cloned 
                                      
9 The biphasic dose-dependent effect on cholinergic neurotransmission might be explained by a dose-
dependent engagement of excitatory or inhibitory pathways of the forebrain. Suppressing, high-dose 
effects seem to be locally mediated in the hippocampus, whereas low-dose excitatory effects seem to 
be mediated in the septum (Tzavara et al., 2003b). WIN55,212-2 is much more potent in reducing 
GABAergic than glutamatergic neurotransmission (Hajos and Freund, 2002). Thus, the higher 
sensitivity of septal CB1 circuits could be attributed to GABAergic septal neurons in controlling 
cholinergic neurotransmission. Indeed, blockade of septal GABAergic activity leads to cholinergic 
stimulation (Moor et al., 1998). Interestingly, a primary reduction of cholinergic activity in the septum 
can also induce a moderate increase in hippocampal ACh via deactivation of a negative 
autoregulatory loop (Wu et al., 2000). The inhibitory effect of WIN55,212-2 mediated locally in the 
hippocampus and observed with higher doses, could result from activation of low-sensitivity CB1 
localized on cholinergic terminals or in projections that modulate ACh release. Hence, although ACh 
levels are increased in CB1-ko mice according to one study (Kathmann et al., 2001b), this does not 
exclude the possibility of a dysregulated septal-hippocampal network. Altogether, this suggests that 
there may be an endogenous and tonic CB1-mediated inhibition of ACh release. Given that the 
septohippocampal pathway is important for learning and memory, it is reasonable to think that 
excitation of this cholinergic pathway is one of the means by which the lack of CB1 might enhance 
LTP and memory.  
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in 1997 (Szallasi and Blumberg, 1999). The channel is activated by both chemical 
(capsaicin, the red hot chilli pepper ingredient) and physical (noxious heat and low 
pH) stimuli (Caterina and Julius, 2001). VR1 is expressed in neocortex, 
hippocampus, amygdala, hypothalamus, thalamus, substantia nigra, cerebellum 
among others (Mezey et al., 2000). VR1 and CB1 are co-expressed on pyramidal 
neurons of the hippocampus and in the molecular layer on the dentate gyrus as could 
be shown by immunohistochemistry (Cristino et al., 2006;Mezey et al., 2000). In 
contrast to CB1, VR1 is expressed on postsynaptic dendritic spines and cell somata 
(Toth et al., 2005). The identity of endogenous activators of VR1 remains currently 
unclear. Endocannabinoids can activate VR1 as could have been shown for 
anandamide and n-arachidnoyldopamine (NADA) (Al Hayani et al., 2001;Di Marzo et 
al., 2002a;Zygmunt et al., 1999), thus the term “endovanilloids” may be appropriate 
for these messengers in the future, too. However, VR1 has opposing effects on 
cellular excitability in that cation and calcium influx through VR1 channel lead to 
excitation and to an activation of calcium-dependent kinases. Thus, opposite to 
actions of CB1, they can increase glutamatergic transmission (Marinelli et al., 2006). 
There seems to be interplay between VR1 and CB1. For example, although 
WIN55,212-2 and 2-AG increase the paired-pulse ratio for population spike in CA1 
(i.e. less paired-pulse depression), anandamide and also capsaicin have the opposite 
effect and decrease the paired-pulse ratio (i.e. increased paired-pulse depression), 
an effect being blocked with the VR1 antagonist capsazepine (Al Hayani et al., 2001). 
This suggests that these effects are mediated via VR1 and that its activation leads to 
an increase in inhibitory GABAergic transmission in the hippocampus. Interestingly, 
in slices prepared from wildtype mice, the CB1 agonist WIN55,212-2 inhibited evoked 
EPSCs and evoked IPSCs whereas in slices from CB1-ko mice, WIN55,212-2 no 
longer inhibited IPSCs, but still inhibited EPSCs (Hajos et al., 2001). The inhibition of 
excitatory transmission was mimicked by the VR1 agonist capsaicin, and was 
blocked by the VR1 antagonist capsazepine whereas depression of inhibitory 
currents is not (Hajos and Freund, 2002) indicating that VR1 plays a major role for 
glutamatergic neurotransmission. 
The discrepancy whether CB1 activation reduces glutamatergic transmission could 
be resolved if one emanates from an interplay with VR1 and it might be that these 
effects are mediated by VR1 or the so far undiscovered “CB3”. We suggest that the 
latter possibility is more likely because VR1 forms a non-selective cation channel 
(Caterina and Julius, 2001) and a lack of VR1 leads to reduction of LTP in the 
hippocampus (Marsch et al., 2007). On the other hand, neither basal synaptic 
transmission nor LTP were modulated by the VR1 agonists capsaicin or 
resiniferatoxin (Lees and Dougalis, 2004). Furthermore, cannabinoid action on 
hippocampal glutamatergic terminals is clearly mediated via pertussis toxin-sensitive 
G-proteins (Misner and Sullivan, 1999), hence VR1 which is an ion channel might not 
be involved. Lastly, a slice study in prefrontal cortex indicated that bath application 
with cannabinoids facilitated LTD, at the expense of LTP. Conversely, blockade of 
CB1 with the antagonist SR141716 led to increased levels of LTP (Auclair et al., 
2000). It remains to be investigated whether CB1 and VR1 may interact and if 
endocannabinoids switch to the role of “endovanilloids” in total-CB1-ko mice. 
However, LTP enhancement by activation of VR1 does not seem to occur in our 
three mouse lines. 
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6.1.6 Factors for LTP enhancement VI: Glucocorticoids 
Yet another hypothesis for enhanced LTP in total-CB1-ko mice comes from the 
finding that these mice show alterations in the hypothalamus-pituitary-adrenal (HPA) 
axis function (Cota et al., 2006;Wade et al., 2006). 
Blockade of mineralocorticoid receptors (MRs) suppresses the ability to induce LTP, 
whereas blockade of glucocorticoid receptors (GRs) leads to an increase LTP in the 
hippocampus in vivo (Avital et al., 2006). It is important to know that MRs are 
preferentially activated at low corticosterone concentrations. When high 
corticosterone levels are present, MRs saturate and GRs take over (Reul and de 
Kloet, 1985). Antagonists of CB1 increased corticosterone levels in mice (Patel et al., 
2004;Wade et al., 2006). Furthermore, there is a basal increase of corticosterone and 
ACTH in CB1-ko mice (Barna et al., 2004;Cota et al., 2006) although another study 
could not find any difference between CB1-ko mice and the respective wildtype mice 
(Wade et al., 2006). Furthermore, stressed CB1-ko mice show enhanced levels of 
ACTH and corticosterone as well (Cota et al., 2006;Wade et al., 2006). Perhaps 
altered levels of corticosterone in the brain of total-CB1-ko mice lead to permanently 
increased occupancy of MR in the hippocampus and further on to enhanced LTP. 
Imagining that the respective occupancy of MR and GR and their opposite effects on 
LTP is in a fragile balance this could also explain our observation that only some 
total-CB1-ko mice have increased levels of LTP whereas others show levels similar 
to wildtype mice. Whether dysregulated occupancy of MR and GR may also take 
place in Glu-CB1-ko and GABA-CB1-ko mice remains to be investigated. 
6.1.7 Factors for LTP enhancement VII: The “cannabinoid receptor type 3 
(CB3)” 
Although CB1-ko mice lost responsiveness to most cannabinoids, ∆9-THC still 
produced nociception in the tail-flick test of analgesia (Zimmer 1999). Anandamide 
produced the full range of behavioural effects (the so called “mouse tetrad” consisting 
of antinociception, catalepsy, reduced locomotion and hypothermia) in CB1-ko mice 
(Di Marzo et al., 2000). However, compounds that potently stimulate VR1 are also 
very potent and efficacious in the tetrad and can be elicited e.g. with capsaicin (Di 
Marzo et al., 2002b). Furthermore, anandamide-stimulated GTPγS activity can be 
elicited in brain membranes from CB1-ko mice (Breivogel et al., 2001). The CB1 
agonist WIN55,212-2 reduced both IPSCs and EPSCs in wildtype mice, and most 
surprisingly the agonist still reduced EPSCs in CB1 knock-out mice, hence the 
receptor is found on excitatory (pyramidal) axonal terminals. The effect could be 
blocked by the antagonist SR 141716 and the VR1 antagonist capsazepine in CB1-
ko mice (Hajos et al., 2001). Thus, deletion of CB1 clearly altered the action of the 
cannabinoid agonists on inhibitory transmission, but left its effect on glutamate 
release unchanged. This might suggest that there is a third cannabinoid receptor 
“CB3” present on excitatory terminals in the hippocampus that inhibits glutamate 
release. However, Hoffman et al. could show that the effect of WIN55,212-2 could not 
be seen in mice of the C57BL/6J strain. As the above mentioned study relies on mice 
with a CD1 background, the authors suggest that “CB3” is present in hippocampi of 
CD1 mice but not in C57Bl/6J mice (Hoffman et al., 2005). Intricately, in very recent 
two studies, no effects of WIN55,212-2 on glutamatergic transmission in CB1-ko 
mice, neither on a C57Bl/6J background nor on a CD1 background, could be shown 
at all (Kawamura et al., 2006;Takahashi and Castillo, 2006). The reason for the 
discrepancy to the study of Hajos et al. and Hoffman et al. remains unknown. Most of 
the electrophysiological studies support the idea that CB1 is the exclusive 
cannabinoid receptor responsible for cannabinoid-dependent presynaptic modulation 
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at inhibitory and excitatory synapses in the brain (Azad et al., 2003;Gerdeman et al., 
2002;Melis et al., 2004a;Robbe et al., 2002;Whalley et al., 2004). We believe that 
“CB3”, if it exists at all, does not play a role in our three mouse lines.  
6.1.8 Factors for LTP enhancement VIII: Effects of CB1 activation on neuronal 
growth and neuroneogenesis 
One of the cellular mechanisms of learning and memory and synaptic plasticity is the 
formation of new synapses or the remodelling of existing ones (Martin et al., 
2000;Toni et al., 1999). An enhancement of synaptogenesis and increase in the 
number of cells in a brain area such as the hippocampus could cause enhancement 
of learning and memory and LTP, too.  
Analysis of neuronal progenitor cell proliferation indicate that endocannabinoids 
promote cell proliferation in a CB1-dependent manner, and this proliferation is 
impaired in CB1-ko animals (Aguado et al., 2005), although another study showed a 
clear increase in the number of cells after administration of the CB1 antagonist 
AM251 in vivo (Hill et al., 2006b). Assuming that neurogenesis might contribute to the 
generation of new functional neurons with the ability to be integrated in hippocampal 
circuits, this would paradoxically favour a weakening of the hippocampal network in 
CB1-ko mice. Neurogenesis in the dentate gyrus and the subventricular zone is 
indeed impaired in CB1-ko mice (Jin et al., 2004), implying that endocannabinoids 
promote basal levels of neurogenesis in vivo. In addition, in 3-5 month old CB1-ko 
mice, the number of cells is decreased in the CA1 and CA3 region (but not 
significantly in the dentate gyrus) of the hippocampus (Bilkei-Gorzo et al., 2005). 
Furthermore, treatment of rats with the CB1 agonist WIN55212-2 over 20 days lead 
to an increase of dendritic arborisation in CA3, dentate gyrus and subiculum of the 
hippocampus and an increase in the number of cells could be observed in the 
dentate gyrus after treatment (Lawston et al., 2000). Finally, chronic treatment of rats 
with the agonist HU210 promotes neurogenesis in vitro and in vivo, and interestingly 
this effect is accompanied with an anxiolytic phenotype in these animals (Jiang et al., 
2005). Altogether, one could argue that there might be a decrease in the dendritic 
arborisation and/or cell number in the hippocampus of CB1-ko mice. 
There is some evidence that supports the other view. Using a mouse neuroblastoma 
cell line as an in vitro model to study receptor-mediated neurite remodelling, it could 
be shown that the CB1 agonist HU-210, causes neurite retraction in a concentration-
dependent manner in these cells. CB1 antisense oligonucleotides blocked this effect 
indicating that it was indeed CB1 dependent (Zhou and Song, 2001). In a primary cell 
culture model of hippocampal neurons, anandamide as well as synthetic 
cannabinoids (WIN55212-2, ∆9-THC) inhibited recruitment of new synapses by 
activation of CB1, and decreased levels of cAMP and hence proteinkinase A 
activation within a time frame of 2 h (Kim and Thayer, 2001). Eventually, anandamide 
inhibited the neuronal differentiation in vitro and in vivo, whereas the antagonist 
SR141716 enhanced neurogenesis (Rueda et al., 2002).  
In conclusion, beside of direct effects on synaptic transmission, the activation of CB1 
potentially up or downregulates the number of functional synapses and cells in 
certain brain areas. This could especially explain effects found after an acute or 
chronic pharmacological treatment (Hoffman et al., 2007). Whether this is a genuine 
role of the endocannabinoid system and whether it is of importance in the here 
investigated mutant mouse lines for synaptic plasticity remains to be elucidated.  
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6.2 Transmitters involved in the memory enhancing effects mediated by CB1 
It is very speculative to state which neurotransmitter might lead to memory 
enhancement but we would like to make a few suggestions here. 
GABA and glutamate: Most obviously, as CB1 is located on presynapses of 
GABAergic and glutamatergic neurons, its activation reduces GABA and glutamate 
transmission release in vitro and in vivo (Domenici et al., 2006;Katona et al., 
1999;Katona et al., 2006;Marsicano et al., 2003;Monory et al., 2006). 
Pharmacological studies indicate that administration of GABAA-receptor antagonist 
bicuculline after application of ∆9-THC specifically alleviates memory impairments in 
mice (Varvel et al., 2005) and that bicuculline alone can facilitate retention of memory 
after intrahippocampal administration (Zarrindast et al., 2002). Increase of GABA 
levels enhances spatial learning in the water maze (O'Connell et al., 2001). There is 
a vast research line highlighting the involvement of glutamatergic transmission in 
learning and memory (Riedel et al., 2003). For example, blocking the NMDA receptor 
causes severe memory deficits in a Morris water maze task (and also decrease in 
LTP) in rats (Morris et al., 1986a).  
Cholecystokinine: Because reduction of GABA by CB1 activation is paralleled by a 
reduction of CCK (Beinfeld and Connolly, 2001), it is interesting to note that blockade 
of CCK receptors impairs learning of a 8-arm radial maze task (Harro and Oreland, 
1993).  
Acetylcholine: ACh can lead to memory enhancement. ACh has been accorded an 
important role in supporting learning and memory processes by the hippocampus 
(Parent and Baxter, 2004). Cholinergic projections of the nucleus basalis 
magnocellularis and of the medial septum to the cerebral cortex and the 
hippocampus have been regarded as critical for memory (Dutar et al., 1995). A 
recent study showed that CB1-ko mice exhibited an increased ACh release in the 
hippocampus (Katmann 2001), although there is evidence that there is no change 
under basal conditions but increased levels if CB1-ko mice are stressed (Degroot et 
al., 2006;Wade et al., 2006). Inhibition of ACh activity has been associated with 
cannabinoid-induced impairment of memory (Braida and Sala, 2000). Furthermore, 
enhancement of social recognition memory with the CB1 antagonist SR141716 can 
be reversed by simultaneous administration of the mACh-receptor antagonist 
scopolamine (Terranova et al., 1996) and coadministration of subthreshold doses of 
the SR141716 and the ACh-esterase inhibitor donepezil significantly enhanced 
memory (Wise et al., 2007), suggesting an interaction between the cholinergic and 
cannabinergic system. 
 
6.3 Transmitters involved in emotional effects mediated by CB1 
It is highly speculative to propose which neurotransmitter might lead to modulation of 
anxiety in our mouse lines but we would like to make a few suggestions here. 
GABA and glutamate: Endocannabinoids seem to play a prominent role in 
modulating anxiety and unfold an anxiolytic effect (Bortolato et al., 2006;Kathuria et 
al., 2003). Generally, CB1 is predominantly localised on axon terminals of GABAergic 
and glutamatergic neurons, and the lack of CB1 potentially enhances the levels of 
GABA and glutamate in the hippocampus, amygdala and other regions of the brain 
(Freund et al., 2003). Thus, the modulation of either inhibitory or excitatory 
transmitter systems may be involved in the regulation of emotional behaviour. 
Especially, activation of the GABAergic system is known to reduce levels of anxiety 
for a long time (Mohler et al., 2004). It is interesting to know that application of a 
GABAA-receptor agonist into the medial septum has an anxiolytic effect (Degroot and 
Treit, 2003). Similarly to GABA, glutamate is an ubiquitous transmitter in the brain 
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and has profound effects on anxiety (Bergink et al., 2004;Swanson et al., 2005), 
however this critically depends on the glutamtergic receptor subset and brain region 
under study. Especially, if GABA levels would be raised in GABA-CB1-ko mice, this 
could elegantly explain the anxiolytic phenotype in these mice. 
Colecystokinine: In addition, endocannabinoids might also influence the release of 
anxiogenic neuropeptides, such as corticotropin-releasing hormone (CRH) and 
Cholecystokinine (CCK) (Beinfeld and Connolly, 2001;Weidenfeld et al., 1994). Both 
CRH and CCK neurotransmission were shown to play a role in anxiety (Chen et al., 
2006;de Kloet et al., 2005;Fink et al., 1998;Schulkin et al., 2005). CCK-expressing 
interneurons co-express CB1 (Marsicano and Lutz, 1999). In addition, the 
postsynaptic membranes that are contacted by CCK-containing GABAergic 
interneurons are rich in α2 subunit of the GABAA receptor (Nyiri et al., 2001), which 
was shown to mediate the anxiolytic effect of benzodiazepines (Low et al., 2000). 
Nevertheless, as we rather observe an anxiolytic phenotype in GABA-CB1-ko mice, it 
is unlikely that CCK is the main factor that induces states of anxiety. 
Serotonin: Another candidate for effects on anxiety is serotonin. CB1 and 
serotonergic 5-HT1B- and 5-HT3-receptor are coexpressed on neurons of the 
hippocampus, striatum and neocortex (Hermann et al., 2002). Also, enhancing levels 
of anandamide with the FAAH inhibitor URB 597 increases firing activity of 
serotonergic neurones in the dorsal raphe nucleus (Gobbi et al., 2005). This is all the 
more interesting as the anxiolytic effect of the anandamide transport inhibitor AM 404 
can be antagonised by a 5HT1A-receptor antagonist suggesting a synergistic role of 
the 5HT1A- and the CB1 receptor activation in emotional reactivity (Braida et al., 
2007). Hence, if CB1 is missing in the brain and can not support the activation of the 
serotonergic system, perhaps this could induce the anxiogenic phenotype seen in 
total-CB1-ko and Glu-CB1-ko mice. 
Acetylcholin: Finally, CB1-ko mice have elevated levels of ACh under high stress 
conditions (Degroot et al., 2006) and activation of postsynaptic muscarinic receptors 
leads to a facilitated release of endocannabinoids (Fukudome et al., 2004;Ohno-
Shosaku et al., 2003) and eventually endogenous levels of ACh or AChR agonists in 
the hippocampus are anxiolytic in a set of behavioural tests (Degroot et al., 
2001;Degroot and Treit, 2003;File et al., 2000;Hess and Blozovski, 1987;Smythe et 
al., 1998). We can not support an upregulated cholinergic tone as total-CB1-ko 
conversely show an anxiogenic phenotype but increased and anxiolytic levels of ACh 
might play a role for GABA-CB1-ko mice. 
 
6.4 Brain regions involved in emotional effects in relation to CB1 
What might be the cellular and anatomical substrate of the altered emotional 
behavior in our mouse lines? Anxiety states and anxiety-related behavior appear to 
be regulated by a distributed but highly interconnected system of brain structures 
including the septohippocampal system (McNaughton, 1997), the basolateral 
amygdala (Campbell and Merchant, 2003), the bed nucleus of the stria terminalis 
(BNST) (Walker et al., 2003), hypothalamic regions (Singewald et al., 2003), the 
medial prefrontal cortex and the anterior cingulate cortex (Duncan et al., 1996), as 
well as hindbrain regions such as the periaqueductal grey, locus coeruleus and 
dorsal raphe nuclei (Singewald et al., 2003). At the same time, CB1 is richly 
expressed in most of these brain regions (Herkenham et al., 1990).  
The amygdala is a key station in the neural circuitry that processes emotions and 
mediates stress and fear responses to aversive sensory stimuli. The amygdala 
consists of the basolateral amygdala that in turn projects to the central nucleus of the 
amygdala and to the BNST. These structures, in turn, project to a common set of 
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target areas, mainly hypothalamus and brainstem, that mediate the autonomic and 
behavioral responses to aversive stimuli (Walker et al., 2003). There is sparse 
distribution of CB1 in the BNST (Herkenham et al., 1991) and CB1-bearing 
interneurons are localized in the basolateral complex of the amygdala (Katona et al., 
2001;McDonald and Mascagni, 2001). Indeed, the presentation of anxiogenic stimuli 
increases anandamide and 2-AG concentrations in the amygdala (Marsicano et al., 
2002). In addition, stress-induced amygdala activation is potentiated by blockade of 
CB1 receptors in rodents (Patel et al., 2005a), further implicating CB1 in the 
processing and integration of emotionally salient information. Endocannabinoids 
could modify the output of the amygdala in two complementary ways: Firstly, they 
could depress glutamate release from axon terminals originating in the cortex (Azad 
et al., 2003;Domenici et al., 2006), which richly innervate the basolateral amygdala. 
Pyramidal cells in the basolateral amygdala, receiving excitatory sensory inputs, may 
need to remove an inhibitory control to be able to fire and create associations 
between emotionally relevant and neutral stimuli, as in the fear conditioning 
paradigm. Secondly, by reducing GABA release from basolateral interneurons, they 
might disinhibit GABA cells in the adjacent so-called intercalated nuclei, whose 
GABAergic neurons generate feedforward inhibition to the central nucleus and 
consequently decrease the activity of GABAergic neurons in the central nucleus of 
the amygdala, which constitutes the structure’s primary efferent pathway towards 
autonomic and endocrine centers of the brain (Pare et al., 2004;Royer et al., 1999). 
Indeed, it has been shown that endocannabinoids induce LTD-I of inhibitory 
GABAergic neurotransmission in the basolateral amygdala, and this effect is even 
more pronounced in mice lacking the endocannabinoid-degrading enzyme FAAH 
(Azad et al., 2004). Also, the central nucleus and the basolateral nucleus of the 
amygdala project to cholinergic nuclei in the forebrain (Jolkkonen et al., 2002). 
Bearing in mind that cholinergic neurons of the forebrain express CB1 and FAAH 
(Harkany et al., 2003;Lu et al., 1999;Nyiri et al., 2005), it is tempting to speculate that 
cholinergic output to the cortex is modulated by the central amygdala. We could show 
that CB1 inactivation causes an anxiety-like response in total-CB1-ko and Glu-CB1-
ko mice, which might be enabled by an altered processing in the amygdala. On the 
other hand, the basolateral amygdala also projects to the BNST. The startle reflex 
can be enhanced by bright light, a factor that we and others found to be important for 
an anxiogenic response (Crawley, 1981;File and Hyde, 1978;Naidu et al., 2007). 
Most interestingly, blocking AMPA receptors in the BNST but not the central 
amygdala abolished light-enhanced startle (Walker and Davis, 1997b). Thus, the 
BNST might be an essential brain structure involved in our effects on anxiety, too. 
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6.2 Tables of statistical analysis 
 
Table 3: Statistical analysis of electrophysiological recordings  
(2-way ANOVA for repeated measurements) 
 
 
Table 4: Statistical analysis of hippocampal theta activity  
(2-way ANOVA for repeated measurements) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Intensity F(9, 207) = 51.2,  
p < 0.001 
F(1.3, 28.8) = 24.2, 
p < 0.001 
F(2.1, 47.8) = 36.8, 
p < 0.001 
Intensity x genotype  F(9, 207) = 0.23,  
p = 0.99 
F(1.3, 28.8) = 1.0, 
p = 0.35 
F(2.1, 47.8) = 0.34, 
p = 0.72 
I/O curve, fEPSP slope 
Genotype F(1, 23) = 0.21,  
p = 0.65 
F(1, 21) = 0.39, p = 
0.54 
F(1, 23) = 1.49, p = 
0.24 
Intensity F(2.7, 63.6) = 83.9, 
p < 0.001 
F(2.2, 57.9) = 83.4, 
p < 0.001 
F(2.3, 53.2) = 78.2, 
p < 0.001 
Intensity x genotype  F(2.7, 83.9) = 0.33, 
p = 0.78 
F(2.2, 57.9) = 3.8, 
p < 0.05 
F(2.3, 53.2) = 0.75, 
p = 0.50 
I/O curve, pop-spike 
amplitude 
Genotype F(1, 24) = 0.42,  
p = 0.52 
F(1, 26) = 14.7,  
p < 0.001 
F(1, 23) = 3.7,  
p = 0.067 
Interval F(2.1, 50.9) = 27.1, 
p < 0.001 
F(2.3, 56.8) = 10.1, 
p < 0.001 
F(1.2, 28.5) = 4.2, 
p < 0.05 
Interval x genotype  F(2.1, 50.9) = 2.0, 
p = 0.14 
F(2.3, 56.8) = 0.54, 
p = 0.61 
F(1.2, 28.5) = 0.96, 
p = 0.36 
PPS of fEPSP, 10-100 ms 
intervals 
Genotype F(1, 24) = 0.76, 
 p = 0.39 
F(1, 25) = 0.001,  
p = 0.98 
F(1, 23) = 0.144,  
p = 0.71 
Interval F(3.8, 91.3) = 1.7, 
p = 0.16 
F(2.8, 72.9) = 4.4, 
p < 0.05 
F(3.3, 75.1) = 21.0, 
p < 0.001 
Interval x genotype  F(3.8, 91.3) = 0.45, 
p = 0.76 
F(2.8, 72.9) = 1.0, 
p = 0.38 
F(3.3, 75.1) = 1.0, 
p = 0.41 
PPS of pop-spike, 40-100 
ms intervals 
Genotype F(1, 24) = 4.0,  
p < 0.058 
F(1, 26) = 0.8, 
 p = 0.37 
F(1, 23) = 0.19, 
 p = 0.67 
Time F(1.5, 33.3) = 3.9, 
p < 0.05 
F(2.5, 41.7) = 10.4, 
p < 0.001 
F(2.9, 64.6) = 3.6, 
p < 0.05 
Time x genotype F(1.5, 33.5) = 0.34, 
p = 0.66 
F(2.5, 41.7) = 0.76, 
p = 0.5 
F(2.9, 64.6) = 0.77, 
p = 0.5 
LTP of fEPSP slope, 1 h 
post tetanus 
Genotype F(1, 22) = 0.63, 
 p = 0.44 
F(1, 17) = 0.05, 
p = 0.82 
F(1, 22) = 0.54, 
 p = 0.47 
Time F(2.3, 53.2) = 16.8, 
p < 0.001 
F(2.9, 61.0) = 13.2, 
p < 0.001 
F(3.9, 85.8) = 13.3, 
p < 0.001 
Time x genotype F(2.3, 53.2) = 0.83, 
p = 0.46 
F(2.9, 61.0) = 1.3, 
p = 0.29 
F(3.9, 85.8) = 0.47, 
p = 0.75 
LTP of pop-spike 
amplitude, 1 h post 
tetanus 
Genotype F(1, 23) = 4.2,  
p < 0.05 
F(1, 21) = 0.56,  
p = 0.46 
F(1, 22) = 2.5,  
p = 0.13 
Parameter Statistical Parameter total-CB1 
Interval F(3.07, 92.1) = 9.7, 
p = 0.001  
Genotype x Interval F(3.07, 92.1) = 
0.38, p = 0.78  
Theta power after tail 
pinch 
Genotype F(1, 30) = 0.13, 
 p = 0.72  
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Table 5: Statistical analysis of water maze spatial discrimination task  
(2-way ANOVA for repeated measurements) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6: Statistical analysis of object and social recognition I  
(Two-tailed t-test between genotypes) 
 
 
 
 
 
 
 
 
 
Parameter Statistical Parameter total-CB1 Glu-CB1 
Day F(2.5, 30) = 5.6,  
p < 0.01 
F(2.6, 36.8) = 5.2, 
p < 0.01 
Genotype x day F(2.5, 30) = 2.4,  
p = 0.097 
F(2.5, 36.8) = 1.5, 
p = 0.2 
Accuracy: acquisition 
Genotype F(1, 12) = 0.19, 
 p = 0.67 
F(1, 15) = 0.005, 
 p = 0.95 
Day F(3, 36) = 5.9,  
p < 0.01 
F(3, 45) = 7.9, 
 p < 0.001 
Genotype x day F(3, 36) = 0.19,  
p = 0.9  
F(3, 45) = 1.3,  
p = 0.3  
Accuracy: retrieval 
Genotype F(1, 12) = 0.001,  
p = 1 
F(1, 15) = 11.2,  
p < 0.01 
Day F(1.6, 19.7) = 41.5, 
p < 0.001 
F(1.2, 17.8) = 40.2, 
p < 0.001  
Genotype x day F(1.6, 19.7) = 0.42, 
p = 0.62 
F(1.2, 17.8) = 2.4, 
p = 0.14 
Latency: acquisition 
Genotype F(1, 12) = 0.16,  
p = 0.7 
F(1, 15) = 2.0,  
p = 0.18 
Day F(3, 36) = 0.64,  
p = 0.6 
F(3, 45) = 1.8, 
 p = 0.15 
Genotype x day F(3, 36) = 2.1,  
p = 0.11  
F(3, 45) = 0.8, 
 p = 0.5  
Latency: retrieval 
Genotype F(1, 12) = 0.16,  
p = 0.7 
F(1, 15) = 1.1, 
 p = 0.3 
Test Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Genotype t(29) = 0.94,  
p = 0.36 
t(28) = 0.50,  
p = 0.62 
t(22) = 0.15,  
p = 0.88  
Object recognition, 3 h 
Sample size Wt = 14  
Ko = 17 
Wt = 17 
Ko = 13 
Wt = 11 
Ko = 13 
Genotype t(51) = 0.75,  
p = 0.46 
t(28) = 0.73,  
p = 0.47 
t(22) = 0.11,  
p = 0.92  
Object recognition, 24 h 
Sample size Wt = 25 
Ko = 28 
Wt = 17 
Ko = 13 
Wt = 11 
Ko = 13 
Genotype t(22) = 0.4,  
p = 0.69 
t(22) = 0.08,  
p = 0.93 
t(21) = 2.1,  
p < 0.05  
Social recognition, 1 h  
Sample size Wt = 11 
Ko = 13 
Wt = 12 
Ko = 12 
Wt = 13 
Ko = 10 
Genotype t(22) = 1.56,  
p = 0.13 
t(21) = 0.05,  
p = 0.96 
t(21) = 0.35,  
p = 0.73  
Social recognition, 24 h 
Sample size Wt = 11 
Ko = 13 
Wt = 12 
Ko = 11 
Wt = 13 
Ko = 10 
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Table 7: Statistical analysis of object and social recognition II.  
(One-sample t-test with column mean different from 0.5-chance level) 
 
Table 8: Statistical analysis of contextual fear conditioning, 0.7 mA  
(2-way ANOVA for repeated measurements) 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Context F(1, 28) = 16.8,  
p < 0.001 
F(1, 28) = 31.49,  
p < 0.001 
F(1, 22) = 0.13,  
p = 0.72 
Context x genotype F(1, 28) = 0.15,  
p = 0.7 
F(1, 28) = 0.58,  
p = 0.45 
F(1, 22) = 0.50,  
p = 0.49 
Interval x genotype F(2.8, 79) = 0.79,  
p = 0.5 
F(2.6, 73.1) = 0.75,  
p = 0.5 
F(2.6, 57.2) = 2.25,  
p = 0.30 
Context x interval x genotype F(3.3, 92.4) = 0.17,  
p = 0.93 
F(2.8, 79.0) = 1.9,  
p = 0.14 
F(2.7, 59.4) = 0.53,  
p = 0.65 
Day1 
Genotype F(1, 28) = 1.1,  
p = 0.31 
F(1, 28) = 3.5,  
p = 0.07 
F(1, 22) = 8.7,  
p < 0.05 
Context F(1, 27) = 1.48,  
p = 0.23 
F(1, 28) = 10.0,  
p < 0.01 
F(1, 22) = 0.81,  
p = 0.38 
Context x genotype F(1, 27) = 0.23,  
p = 0.64 
F(1, 28) = 2.7,  
p = 0.11 
F(1, 22) = 5.48,  
p < 0.05 
Interval x genotype F(3.3, 89.6) = 2.99,  
p < 0.05 
F(2.9, 80.0) = 0.29,  
p = 0.83 
F(3.1, 68.9) = 4.8,  
p < 0.005 
Context x interval x genotype F(3.0, 81.2) = 0.57,  
p = 0.64 
F(3.1, 86.8) = 0.56,  
p = 0.65 
F(2.8, 61.8) = 0.98,  
p = 0.41 
Day 2 
Genotype F(1, 27) = 5.23,  
p < 0.05 
F(1, 28) = 3.9,  
p = 0.058 
F(1, 22) = 1.7,  
p = 0.2 
Context F(1, 25) = 0.001,  
p = 0.99 
F(1, 28) = 1.99,  
p = 0.17 
F(1, 22) = 5.9,  
p < 0.05 
Context x genotype F(1, 25) = 2.4,  
p = 0.13 
F(1, 28) = 2.1, 
 p = 0.16 
F(1, 22) = 3.7, 
 p = 0.067 
Interval x genotype F(3.1, 76.7) = 6.6,  
p < 0.001 
F(2.8, 79.7) = 0.14,  
p = 0.93 
F(2.6, 47.1) = 0.17, 
 p = 0.89 
Context x interval x genotype F(3.5, 87.0) = 0.38,  
p = 0.99 
F(2.7, 87.0) = 0.42,  
p = 0.72 
F(2.6, 57.0) = 0.8,  
p = 0.5 
Day 7 
Genotype F(1, 25) = 1.9,  
p = 0.18 
F(1, 28) = 3.5, 
 p = 0.072 
F(1, 22) = 1.8,  
p = 0.19 
Interval F(4, 108) = 19.2,  
p < 0.001 
F(2.5, 68.7) = 16.6,  
p < 0.001 
F(2.6, 56.7) = 8.7, 
 p < 0.001 
Interval x Genotype F(4, 108) = 8.2,  
p < 0.001 
F(2.5, 68.7) = 0.39,  
p = 0.72 
F(2.6, 56.7) = 0.62,  
p = 0.58 
Day 8 
Genotype F(1, 27) = 6.9,  
p < 0.05 
F(1, 28) = 0.55,  
p = 0.47 
F(1,22 ) = 3.1,  
p = 0.092 
 
 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
wt t(13) = 1.87,  
p = 0.08,  
n = 14 
t(16) = 4.5,  
p < 0.001,  
n =17 
t(9) = 2.36,  
p < 0.04,  
n = 10  
Object recognition, 3 h 
ko t(16) = 2.9,  
p < 0.01,  
n = 17 
t(12) = 2.1,  
p < 0.05,  
n = 13 
t(13) = 2.3,  
p < 0.05,  
n = 14  
wt t(24) = 1.95,  
p = 0.06,  
n = 25 
t(16) = 0.04,  
p = 0.97, 
 n = 17 
t(9) = 1.6,  
p = 0.14,  
n = 10  
Object recognition, 24 h 
ko t(27) = 1.0,  
p = 0.32,  
n = 28 
t(12) = 0.75,  
p = 0.47, 
 n = 13 
t(13) = 1.2, 
 p = 0.23,  
n = 14  
wt t(10) = 4.88,  
p < 0.001,  
n = 11 
t(11) = 1.63,  
p = 0.13,  
n = 12 
t(12) = 5.99,  
p < 0.001,  
n = 13  
Social recognition, 1 h  
ko t(12) = 3.18,  
p < 0.01,  
n = 13 
t(11) = 2.12,  
p < 0.05,  
n = 12 
t(9) = 0.17,  
p = 0.87, 
 n = 10  
wt t(10) = 3.50,  
p < 0.005,  
n = 11 
t(11) = 2.75,  
p < 0.01,  
n = 12 
t(12) = 0.96,  
p = 0.35,  
n = 13  
Social recognition, 24 h 
ko t(12) = 0.18, 
p = 0.86, 
n = 13 
t(10) = 2.52, 
p < 0.05, 
n = 11 
t(9) = 2.03,  
p = 0.33, 
 n = 10  
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Table 9: Statistical analysis of contextual fear conditioning, 1.5 mA  
(2-way ANOVA for repeated measurements) 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Context F(1, 21) = 0.02,  
p = 0.90 
F(1, 22) = 9.6,  
p < 0.005 
F(1, 22) = 11.5,  
p < 0.01 
Context x genotype F(1, 21) = 1.2,  
p = 0.29 
F(1, 22) = 7.69,  
p < 0.01 
F(1, 22) = 6.5,  
p < 0.05 
Interval x genotype F(2.99, 62.7) = 8.0,  
p < 0.001 
F(2.7, 60.1) = 0.33,  
p = 0.78 
F(2.7, 58.8) = 0.08,  
p = 0.96 
Context x interval x genotype F(2.5, 51.7) = 0.39,  
p = 0.73 
F(2.40, 52.75) = 2.04, 
 p = 0.13 
F(2.2, 49.2) = 4.0,  
p < 0.05 
Day1 
Genotype F(1, 21) = 8.36,  
p < 0.01 
F(1, 22) = 3.4,  
p = 0.079 
F(1, 22) = 1.5,  
p = 0.23 
Context F(1, 21) = 4.2,  
p < 0.05 
F(1, 22) = 14.1,  
p < 0.001 
F(1, 20) = 10.9,  
p < 0.01 
Context x genotype F(1, 21) = 4.9,  
p < 0.05 
F(1, 22) = 0.45,  
p = 0.5 
F(1, 20) = 0.5,  
p = 0.5 
Interval x genotype F(2.7, 56.1) = 1.4,  
p = 0.24 
F(2.3, 50.2) = 1.2,  
p = 0.3  
F(2.5, 49.6) = 0.5,  
p = 0.6 
Context x interval x genotype F(2.6, 55.3) = 0.74, 
 p = 0.52 
F(2.3, 51.1) = 0.05,  
p = 0.96 
F(2.9, 58.0) = 0.94, p = 
0.43 
Day 2 
Genotype F(1, 21) = 8.3,  
p < 0.01 
F(1, 22) = 4.9,  
p < 0.05 
F(1, 20) = 2.2,  
p = 0.15 
Context F(1, 21) = 0.12,  
p = 0.73 
F(1, 22) = 9.7,  
p < 0.005 
F(1, 21) = 14.8 ,  
p < 0.001 
Context x genotype F(1, 21) = 2.1,  
p = 0.17 
F(1, 22) = 0.2,  
p = 0.6 
F(1, 21) = 0.9,  
p = 0.3 
Interval x genotype F(2.3, 48.4) = 3.8, p < 
0.05 
F(2.7, 58.5) = 0.2,  
p = 0.87 
F(4, 84) = 1.4,  
p = 0.2 
Context x interval x genotype F(2.8, 58.8) = 3.1, p < 
0.05 
F(2.9, 64.6) = 0.6,  
p = 0.63 
F(4, 84) = 0.6,  
p = 0.67 
Day 7 
Genotype F(1, 21) = 2.04,  
p = 0.17 
F(1, 22) = 0.55,  
p = 0.47 
F(1, 21) = 7.2,  
p < 0.01 
Interval F(2.9, 61.1) = 9.6, p < 
0.001 
F(2.2, 49.1) = 3.1,  
p < 0.05 
F(4, 84) = 5.6,  
p < 0.001 
Interval x Genotype F(2.9, 61.1) = 3.5, p < 
0.05 
F(2.2, 49.1) = 0.14,  
p = 0.89 
F(4, 84) = 0.76,  
p = 0.56  
Day 8 
Genotype F(1, 21) = 5.0,  
p < 0.05 
F(1, 22) = 1.2,  
p = 0.28 
F(1, 21) = 2.3,  
p = 0.14 
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Table 10: Statistical analysis of contextual fear conditioning (0.7 mA) separated for 
context  
(2-way ANOVA for repeated measurements) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Interval F(3.2, 88.5) = 5.6, 
p < 0.001 
F(2.3, 63.6) = 4.5, 
p < 0.01  
F(2.6, 57.9) = 2.7, 
p < 0.05  
Interval x genotype F(3.2, 88.5) = 0.8, 
p = 0.53 
F(2.3, 63.6) = 0.7, 
p = 0.5 
F(2.6, 57.9) = 0.7, 
p = 0.5 
Day 1 neutral context 
Genotype F(1, 28) = 1.2,  
p = 0.29  
F(1, 28) = 4.7,  
p < 0.05 
F(1, 22) = 3.6,  
p = 0.07 
Interval F(2.8, 79.8) = 6.4, 
p < 0.001 
F(4, 112) = 5.1,  
p < 0.001 
F(2.4, 52.6) = 2.0, 
p = 0.1 
Interval x genotype F(2.8, 79.8) = 0.3, 
p = 0.8 
F(4, 112) = 1.5, 
 p = 0.2 
F(2.4, 52.6) = 1.2, 
p = 0.3 
Day 1 shock context 
Genotype F(1, 28) = 0.8, 
 p = 0.4 
F(1, 28) = 1.2, 
 p = 0.28 
F(1, 22) = 5.9,  
p < 0.05 
Interval F(4, 112) = 11.7,  
p < 0.001  
F(2.9, 82.4) = 2.6, 
p = 0.057 
F(2.9, 63.7) = 1.8, 
p = 0.15 
Interval x genotype F(4, 112) = 1.1,  
p = 0.4 
F(2.9, 82.4) = 0.4, 
p = 0.7 
F(2.9, 63.7) = 1.1, 
p = 0.35 
Day 2 neutral context 
Genotype F(1, 28) = 5.5,  
p < 0.05 
F(1, 28) = 7.0,  
p < 0.01 
F(1, 22) = 0.0001, 
p = 0.9 
Interval F(2.7, 74.1) = 7.2, 
p < 0.001 
F(2.8, 77.2) = 5.3, 
p < 0.005 
F(2.4, 53.6) = 0.9, 
p = 0.4 
Interval x genotype F(2.7, 74.1) = 2.1, 
p = 0.1 
F(2.8, 77.2) = 0.4, 
p = 0.7 
F(2.4, 53.6) = 5.4, 
p < 0.005 
Day 2 shock context 
Genotype F(1, 27) = 3.4,  
p = 0.075 
F(1, 28) = 0.8,  
p = 0.4 
F(1, 22) = 4.3,  
p < 0.05 
Interval F(4, 112) = 10.9, 
 p < 0.001 
F(2.6, 75.5) = 8.5, 
p < 0.001 
F(2.9, 64.7) = 1.0, 
p = 0.4 
Interval x genotype F(4, 112) = 1.9, 
 p = 0.1 
F(2.6, 75.5) = 0.2, 
p = 0.9 
F(2.9, 64.7) = 1.8, 
p = 0.2 
Day 7 neutral context 
Genotype F(1, 28) = 1.8,  
p = 0.2 
F(1, 28) = 6.7, 
 p < 0.01 
F(1, 22) = 0.001,  
p = 0.99 
Interval F(2.9, 72.7) = 5.5, 
p < 0.01 
F(2.7, 74.7) = 7.8, 
p < 0.001 
F(2.6, 57.8) = 0.6, 
p = 0.6 
Interval x genotype F(2.9, 72.7) = 3.9, 
p < 0.01 
F(2.7, 74.7) = 0.4, 
p = 0.8 
F(2.6, 57.8) = 0.2, 
p = 0.9 
Day 7 shock context 
Genotype F(1, 25) = 0.1,  
p = 0.7 
F(1, 28) = 0.3,  
p = 0.6 
F(1, 22) = 3.8,  
p = 0.063 
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Table 11: Statistical analysis of contextual fear conditioning (1.5 mA) separated for 
context  
(2-way ANOVA for repeated measurements) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Interval F(2.9, 61.1) = 8.3, 
p < 0.001 
F(4, 88) = 7.9,  
p < 0.001 
F(3.0, 65.3) = 3.6, 
p < 0.05 
Interval x genotype F(2.9, 61.1) = 4.8, 
p < 0.005 
F(4, 88) = 1.5,  
p = 0.2 
F(3.0, 65.3) = 1.6, 
p = 0.19 
Day 1 neutral context 
Genotype F(1, 21) = 16.4, p < 
0.001 
F(1, 22) = 9.5,  
p < 0.005 
F(1, 22) = 6.5,  
p < 0.05 
Interval F(2.5, 53.5) = 5.6, 
p < 0.005 
F(2.3, 50.9) = 3.0, 
p < 0.05 
F(2.1, 46.1) = 3.5, 
p < 0.05 
Interval x genotype F(2.5, 53.5) = 2.8, 
p < 0.05 
F(2.3, 50.9) = 0.5, 
p = 0.6 
F(2.1, 46.1) = 1.6, 
p = 0.2 
Day 1 shock context 
Genotype F(1, 21) = 2.8, 
 p = 0.11 
F(1, 22) = 0.02,  
p = 0.9 
F(1, 22) = 0.001,  
p = 0.98 
Interval F(4, 84) = 6.0,  
p < 0.001 
F(2.6, 58.2) = 4.1, 
p < 0.01 
F(2.3, 48.0) = 1.5, 
p = 0.24 
Interval x genotype F(4, 84) = 2.3, 
 p = 0.061 
F(2.6, 58.2) = 0.5, 
p = 0.67 
F(2.3, 48.0) = 0.8, 
p = 0.45 
Day 2 neutral context 
Genotype F(1, 21) = 16.1,  
p < 0.001 
F(1, 22) = 2.8,  
p = 0.11 
F(1, 21) = 2.4,  
p = 0.14 
Interval F(2.2, 46.5) = 6.9, 
p < 0.005 
F(1.6, 36.1) = 5.3, 
p < 0.01 
F(2.8, 55.6) = 4.1, 
p < 0.01 
Interval x genotype F(2.2, 46.5) = 0.11, 
p = 0.91 
F(1.6, 36.1) = 1.0, 
p = 0.36 
F(2.8, 55.6) = 0.9, 
p = 0.45 
Day 2 shock context 
Genotype F(1, 21) = 1.3, 
 p = 0.3 
F(1, 22) = 3.4,  
p = 0.078 
F(1, 20) = 0.7,  
p = 0.4  
Interval F(2.6, 54.9) = 7.2, 
p < 0.001 
F(2.7, 58.6) = 6.5, 
p < 0.001 
F(2.8, 57.8) = 0.4, 
p = 0.7 
Interval x genotype F(2.6, 54.9) = 5.9, 
p < 0.005 
F(2.7, 58.6) = 0.5, 
p = 0.7 
F(2.8, 57.8) = 0.97, 
p = 0.4 
Day 7 neutral context 
Genotype F(1, 21) =13.3 ,  
p < 0.001 
F(1, 22) = 0.5,  
p = 0.5 
F(1, 21) = 1.9, 
 p = 0.18 
Interval F(2.4, 50.5) = 3.1, 
p < 0.05 
F(2.8, 62.1) = 10.5, 
p < 0.001 
F(2.8, 59.0) = 2.3, 
p = 0.09 
Interval x genotype F(2.4, 50.5) = 0.2, 
p = 0.9 
F(2.8, 62.1) = 0.27, 
p = 0.8 
F(2.8, 59.0) = 1.2, 
p = 0.3 
Day 7 shock context 
Genotype F(1, 21) = 0.04,  
p = 0.8 
F(1, 22) = 0.13,  
p = 0.7 
F(1, 21) = 8.8,  
p = 0.01 
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Table 12: Statistical analysis of contextual fear conditioning (0.7 mA) in terms of 
context comparison separately per genotype  
(2-way ANOVA for repeated measurements) 
 
Table 13: Statistical analysis of contextual fear conditioning (1.5 mA) in terms of 
context comparison separately per genotype  
(2-way ANOVA for repeated measurements) 
 
 
 
 
 
 
 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
ko: context F(1, 14) = 9.3,  
p < 0.01 
F(1, 12) = 11.6,  
p < 0.005 
F(1, 12) = 0.7, 
 p = 0.4 
ko: context x interval F(4, 56) = 1.5,  
p = 0.2 
F(4, 48) = 3.6,  
p < 0.01 
F(1.8, 21.3) = 1.0, 
p = 0.4 
wt: context F(1, 14) = 7.5,  
p < 0.05 
F(1, 16) = 21.7,  
p < 0.001 
F(1, 10) = 0.05,  
p = 0.8 
Day 1  
wt: context x interval F(4, 56) = 1.2,  
p = 0.3 
F(2.4, 38.3) = 2.1, 
p = 0.09 
F(2.1, 20.8) = 0.8, 
p = 0.5 
ko: context F(1, 13) = 0.9,  
p = 0.4 
F(1, 12) = 1.2,  
p = 0.3 
F(1, 12) = 5.7,  
p < 0.05 
ko: context x interval F(4, 52) = 0.2,  
p = 0.9 
F(4, 48) = 0.7,  
p = 0.6 
F(4, 48) = 0.2,  
p = 0.9 
wt: context F(1, 14) = 0.7,  
p = 0.4 
F(1, 16) = 12.0,  
p < 0.005 
F(1, 10) = 1.0, 
 p = 0.3 
Day 2 
wt: context x interval F(4, 56) = 1.3,  
p = 0.3 
F(4, 64) = 0.4,  
p = 0.7 
F(2.1, 20.9) = 1.2, 
p = 0.3 
ko: context F(1, 13) = 1.5, 
 p = 0.2 
F(1, 12) = 0.001,  
p = 0.99 
F(1, 12) = 8.5,  
p < 0.01 
ko: context x interval F(4, 52) = 0.6,  
p = 0.6 
F(4, 48) = 0.2,  
p = 0.93 
F(2.3, 27.2) = 0.3, 
p = 0.8 
wt: context F(1, 12) = 1.0,  
p = 0.3 
F(1, 16) = 4.1,  
p = 0.059 
F(1, 10) = 0.2,  
p = 0.7 
Day 7 
wt: context x interval F(4, 48) = 1.3,  
p = 0.3 
F(2.3, 36.7) = 0.4, 
p = 0.7 
F(2.4, 24.0) = 0.7, 
p = 0.5 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
ko: context F(1, 10) = 0.8,  
p = 0.4 
F(1, 13) = 0.1,  
p = 0.7 
F(1, 9) = 0.24,  
p = 0.64 
ko: context x interval F(1.9, 19.3) = 0.3, 
p = 0.7 
F(2.1, 27.9) = 1.7, 
p = 0.2 
F(1.8, 16.1) = 5.2, 
p < 0.05 
wt: context F(1, 11) = 0.4,  
p = 0.5 
F(1, 9) = 9.1,  
p < 0.01 
F(1, 13) = 26.7,  
p < 0.001  
Day 1  
wt: context x interval F(2.4, 26.5) = 0.3, 
p = 0.8 
F(2.0, 18.3) = 1.8, 
p = 0.2 
F(2.2, 28.8) = 0.53, 
p = 0.61 
ko: context F(1, 10) = 0.02,  
p = 0.9 
F(1, 13) = 8.5, 
 p < 0.01 
F(1, 9) = 4.6,  
p = 0.06  
ko: context x interval F(3.0, 30.4) = 0.3, 
p = 0.9 
F(2.6, 34.3) = 0.3, 
p = 0.8 
F(4, 36) = 2.7,  
p = 0.05 
wt: context F(1, 11) = 6.7,  
p < 0.05 
F(1, 9) = 5.7,  
p < 0.05 
F(1, 11) = 6.9,  
p = 0.05  
Day 2 
wt: context x interval F(2.1, 23.3) = 1.1, 
p = 0.4 
F(1.8, 16.4) = 0.09, 
p = 0.9 
F(4, 44) = 0.06,  
p = 0.99 
ko: context F(1, 10) = 1.9,  
p = 0.2 
F(1, 13) = 4.6,  
p < 0.05 
F(1, 9) = 9.8,  
p = 0.01 
ko: context x interval F(1.8, 17.7) = 3.6, 
p < 0.05 
F(4, 52) = 0.2, 
 p = 0.9 
F(4, 36) = 1.2,  
p = 0.3 
wt: context F(1, 11) = 0.5,  
p = 0.5 
F(1, 9) = 4.9,  
p < 0.05 
F(1, 12) = 5.0,  
p = 0.05 
Day 7 
wt: context x interval F(4, 44) = 0.5,  
p = 0.8 
F(4, 36) = 0.8, 
 p = 0.5 
F(4, 48) = 0.3,  
p = 0.87 
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Table 14: Statistical analysis of the development of contextual fear conditioning 
over days (0.7 mA) separately per context  
(2-way ANOVA for repeated measurements) 
 
Table 15: Statistical analysis of the development of contextual fear conditioning 
over days (1.5 mA) separately per context  
(2-way ANOVA for repeated measurements) 
 
 
Table 16: Statistical analysis of contextual fear conditioning over days in terms 
of context discrimination  
(3-way ANOVA for repeated measurements) 
 
 
 
 
 
 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Day F(2, 56) = 15.6,  
p < 0.001 
F(2, 56) = 8.3,  
p < 0.001 
F(2, 44) = 42.7, 
 p < 0.001 
Day x genotype F(2, 56) = 1.4,  
p = 0.3 
F(2, 56) = 0.3, 
 p = 0.7 
F(2, 44) = 2.1,  
p = 0.1 
Neutral context 
Genotype F(1, 28) = 4.7,  
p < 0.05 
F(1, 28) = 10.7,  
p < 0.01 
F(1, 22) = 0.7,  
p = 0.4 
Day F(2, 50) = 0.9,  
p = 0.4 
F(2, 56) = 4.4,  
p < 0.05 
F(2, 44) = 10.7,  
p < 0.001 
Day x genotype F(2, 50) = 0.7,  
p = 0.5 
F(2, 56) = 0.05,  
p = 0.95 
F(2, 44) = 0.05,  
p = 0.9 
Shock context 
Genotype F(1, 25) = 1.5,  
p = 0.2 
F(1, 28) = 1.5,  
p = 0.2 
F(1, 22) = 9.5,  
p < 0.01 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Day F(2, 42) = 8.4,  
p < 0.001 
F(2, 44) = 0.9, 
 p = 0.4 
F(2, 42) = 10.3,  
p < 0.001 
Day x genotype F(2, 42) = 1.4,  
p = 0.3 
F(2, 44) = 1.5,  
p = 0.2 
F(2, 42) = 0.24, 
 p = 0.79 
Neutral context 
Genotype F(1, 21) = 29.5,  
p < 0.001 
F(1, 22) = 6.7,  
p < 0.05 
F(1, 21) = 5.0,  
p < 0.05 
Day F(1.5, 32.3) = 1.9, 
p = 0.2 
F(2, 44) = 2.7,  
p = 0.079 
F(2, 40) = 7.5, 
 p < 0.005 
Day x genotype F(1.5, 32.3) = 1.1, 
p = 0.3 
F(2, 44) = 1.0,  
p = 0.4 
F(2, 40) = 4.9,  
p < 0.01 
Shock context 
Genotype F(1, 21) = 1.8, 
 p = 0.2 
F(1, 22) = 0.8,  
p = 0.4 
F(1, 20) = 2.5,  
p = 0.13 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Context x genotype F(1, 25) = 1.1, 
 p = 0.3 
F(1, 28) = 3.9,  
p < 0.05 
F(1, 22) = 7.8,  
p < 0.01 
Day x genotype F(2, 50) = 1.1,  
p = 0.4 
F(2, 56) = 0.04,  
p = 0.96 
F(2, 44) = 1.0,  
p = 0.4 
Context x day x genotype F(2, 50) = 1.0, 
 p = 0.4 
F(2, 56) = 0.4,  
p = 0.7 
F(2, 44) = 0.4,  
p = 0.7 
0.7 mA 
Genotype F(1, 25) = 3.3,  
p = 0.081 
F(1, 28) = 6.6,  
p < 0.05 
F(1, 22) = 5.0,  
p < 0.05 
Context x genotype F(1, 21) = 6.6,  
p < 0.05 
F(1, 22) = 4.2, 
p < 0.05 
F(1, 20) = 0.3,  
p = 0.58 
Day x genotype F(2, 42) = 1.8,  
p = 0.2 
F(2, 44) = 1.0, 
 p = 0.4 
F(2, 40) = 1.1,  
p = 0.34 
Context x day x genotype F(2, 42) = 0.3,  
p = 0.7 
F(2, 44) = 1.7,  
p = 0.2 
F(2, 40) = 4.6,  
p < 0.05 
1.5 mA 
Genotype F(1, 21) = 13.1,  
p < 0.005 
F(1, 22) = 5.5,  
p < 0.05 
F(1, 20) = 4.7,  
p < 0.05 
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Table 17: Statistical analysis of contextual fear conditioning, 0.5 mA  
(2-way ANOVA for repeated measurements) 
Parameter Statistical Parameter Glu-CB1 
Context F(1, 19) = 1.97,  
p = 0.18 
Context x genotype F(1, 19) = 0.51,  
p = 0.49 
Interval x genotype F(2.37, 45.0) = 0.14,  
p = 0.9 
Context x interval x genotype F(2.80, 53.1) = 0.41, 
 p = 0.73 
Day1 
Genotype F(1, 19) = 1.37,  
p = 0.26 
Context F(1, 19) = 0.12,  
p = 0.7 
Context x genotype F(1, 19) = 0.56,  
p = 0.46 
Interval x genotype F(2.9, 55.2) = 1.0, 
 p = 0.42 
Context x interval x genotype F(3.1, 59.1) = 3.9, 
 p < 0.01 
Day 2 
Genotype F(1, 19) = 0.84,  
p = 0.37 
Context F(1, 19) = 3.5,  
p = 0.076 
Context x genotype F(1, 19) = 0.16,  
p = 0.7 
Interval x genotype F(2.1, 40.7) = 1.8, 
 p = 0.5 
Context x interval x genotype F(2.7, 50.8) = 0.29, 
 p = 0.8 
Day 7 
Genotype F(1, 19) = 2.6,  
p = 0.12 
Interval F(3.4, 65.1) = 13.0,  
p < 0.001 
Interval x Genotype F(3.4, 65.1) = 6.2,  
p < 0.001 
Day 8 
Genotype F(1, 19) = 0.16,  
p = 0.69 
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Table 18: Statistical analysis of contextual fear conditioning (0.5 mA) separated for 
context  
(2-way ANOVA for repeated measurements) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Statistical Parameter Glu-CB1 
Interval F(2.4, 46.4) = 2.7, 
p = 0.065 
Interval x genotype F(2.4, 46.4) = 0.29, 
p = 0.8 
Day 1 neutral context 
Genotype F(1, 19) = 0.3,  
p = 0.6 
Interval F(2.9, 55.5) = 0.4, 
p = 0.73 
Interval x genotype F(2.9, 55.5) = 0.26, 
p = 0.9 
Day 1 shock context 
Genotype F(1, 19) = 2.0,  
p = 0.18 
Interval F(4, 76) = 1.7,  
p = 0.15 
Interval x genotype F(4, 76) = 2.3,  
p = 0.071 
Day 2 neutral context 
Genotype F(1, 19) = 0.12,  
p = 0.7 
Interval F(2.9, 55.9) = 2.4, 
p = 0.08 
Interval x genotype F(2.9, 55.9) = 2.9, 
p < 0.05 
Day 2 shock context 
Genotype F(1, 19) = 1.5, 
 p = 0.23 
Interval F(2.9, 64.7) = 1.0, 
p = 0.4 
Interval x genotype F(2.9, 64.7) = 1.8, 
p = 0.16 
Day 7 neutral context 
Genotype F(1, 22) = 0.001,  
p = 0.9 
Interval F(2.7, 51.0) = 1.7, 
p = 0.2 
Interval x genotype F(2.7, 51.0) = 0.8, 
p = 0.5 
Day 7 shock context 
Genotype F(1, 19) = 3.0,  
p = 0.097 
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Table 19: Statistical analysis of contextual fear conditioning (0.5 mA) in terms of 
context comparison separately per genotype  
(2-way ANOVA for repeated measurements) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 20: Statistical analysis of the development of contextual fear conditioning 
over days (0.5 mA) separately per context  
(2-way ANOVA for repeated measurements) 
 
 
 
 
 
 
 
Table 21: Statistical analysis of contextual fear conditioning over days (0.5 mA) in 
terms of context discrimination  
(3-way ANOVA for repeated measurements) 
 
 
 
 
 
 
 
 
 
 
Parameter Statistical Parameter Glu-CB1 
ko: context F(1, 11) = 0.5,  
p = 0.5 
ko: context x interval F(2.5, 27.7) = 0.7, 
p = 0.5 
wt: context F(1, 8) = 1.2,  
p = 0.3 
Day 1  
wt: context x interval F(2.7, 21.5) = 1.9, 
p = 0.2 
ko: context F(1, 11) = 0.7, 
 p = 0.4 
ko: context x interval F(4, 44) = 2.8,  
p < 0.05 
wt: context F(1, 8) = 0.08,  
p = 0.8 
Day 2 
wt: context x interval F(2.1, 16.9) = 3.4, 
p < 0.05 
ko: context F(1, 11) = 1.0,  
p = 0.4 
ko: context x interval F(2.5, 27.6) = 0.4, 
p = 0.7 
wt: context F(1, 8) = 4.2,  
p = 0.075 
Day 7 
wt: context x interval F(4, 32) = 2.4,  
p = 0.07 
Parameter Statistical Parameter Glu-CB1 
Day F(2, 38) = 5.0,  
p < 0.01 
Day x genotype F(2, 38) = 0.08,  
p = 0.9 
Neutral context 
Genotype F(1, 19) = 0.8,  
p = 0.4 
Day F(1.3, 25.3) = 7.6, 
p < 0.01 
Day x genotype F(1.3, 25.3) = 0.3, 
p = 0.6 
Shock context 
Genotype F(1, 19) = 3.0,  
p = 0.1 
Parameter Statistical Parameter Glu-CB1 
Context x genotype F(1, 19) = 1.1,  
p = 0.3 
Day x genotype F(2, 38) = 0.2,  
p = 0.8 
Context x day x genotype F(2, 38) = 0.09,  
p = 0.9 
0.5 mA 
Genotype F(1, 19) = 2.3,  
p = 0.2 
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Table 22: Statistical analysis of baseline freezing in novel context before tone on 
day 8  
(2-way ANOVA for repeated measurements 
 
Table 23: Statistical analysis of elevated plus-maze, day 1 and 2  
(unpaired t-test, two-sided) 
 
Table 24: Statistical analysis of elevated plus-maze in terms of animals which 
refrained from exploring the open arms at all  
(chi-square test, two-sided) 
 
 
 
 
 
 
 
 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Interval F(1.2, 31.1) = 2.1, 
p = 0.15 
F(2, 56) = 4.6,  
p < 0.01 
F(2, 44) = 1.8,  
p = 0.18 
Interval x genotype F(1.2, 31.1) = 1.2, 
p = 0.28 
F(2, 56) = 1.2, 
 p = 0.3 
F(2, 44) = 0.36,  
p = 0.7 
0.7 mA 
Genotype F(1, 26) = 3.4,  
p = 0.076 
F(1, 28) = 0.53,  
p = 0.47 
F(1, 22) = 0.03, 
 p = 0.87 
Interval F(1.3, 26.9) = 0.8, 
p = 0.4 
F(1.4, 29.8) = 1.6, 
p = 0.2 
F(2, 42) = 7.6, 
 p < 0.01 
Interval x genotype F(1.3, 26.9) = 0.54, 
p = 0.51 
F(1.4, 29.8) = 0.3, 
p = 0.65  
F(2, 42) = 1.1,  
p = 0.34  
1.5 mA 
Genotype F(1, 21) = 0.15,  
p = 0.7 
F(1, 22) = 9.3,  
p < 0.01 
F(1, 21) = 0.8,  
p = 0.38  
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Genotype t(39) = 1.78,  
p = 0.08 
t(37) = 1.94,  
p = 0.06 
t(34) = 0.008,  
p = 0.99  
Open arm entries, day 1 
Sample size Wt = 23   
Ko = 18  
Wt = 19   
Ko = 20   
Wt = 16   
Ko = 20   
Genotype t(39) = 1.74,  
p = 0.09 
t(37) = 1.25,  
p = 0.22 
t(34) = 0.30,  
p = 0.76  
Open arm time, day 1 
Sample size Wt = 23  
Ko = 18   
Wt = 19  
Ko = 20   
Wt = 16  
Ko = 20   
Genotype t(39) = 1.56,  
p = 0.13 
t(37) = 0.44,  
p = 0.66 
t(34) = 0.56,  
p = 0.58  
Total arm entries, day 1  
Sample size Wt = 23   
Ko = 18   
Wt = 19  
Ko = 20   
Wt = 16  
Ko = 20   
Genotype t(39) = 1.5,  
p = 0.14 
t(37) = 0.20,  
p = 0.84 
t(33) = 1.66,  
p = 0.11  
Open arm entries, day 2 
Sample size Wt = 23   
Ko = 18   
Wt =19   
Ko = 20   
Wt = 15   
Ko = 20   
Genotype t(39) = 1.7,  
p = 0.097 
t(37) = 0.16,  
p = 0.87 
t(33) = 1.09,  
p = 0.28  
Open arm time, day 2 
Sample size Wt = 23   
Ko = 18   
Wt = 19   
Ko = 20   
Wt = 15   
Ko = 20   
Genotype t(39) = 1.5,  
p = 0.13 
t(37) = 0.75, 
p = 0.46 
t(33) = 1.07,  
p = 0.29  
Total arm entries, day 2  
Sample size Wt = 23   
Ko = 18   
Wt = 19   
Ko = 20   
Wt = 15   
Ko = 20   
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Genotype t(1) = 0.67,  
p = 0.41 
t(1) = 0.69,  
p = 0.41 
t(1) = 0.69,  
p = 0.41  
Non-explorer, day 1  
Sample size Wt = 22   
Ko = 18   
Wt = 19   
Ko = 20   
Wt = 16   
Ko = 20   
Genotype t(1) = 4.8,  
p < 0.05 
t(1) = 0.02,  
p = 0.89 
t(1) = 6.08,  
p < 0.01  
Non-explorer, day 2 
Sample size Wt = 22   
Ko = 18   
Wt = 19   
Ko = 20   
Wt = 15   
Ko = 20   
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Table 25: Statistical analysis of dark/light box-test  
(2-way ANOVA for repeated measurements) 
 
 
Table 26: Statistical analysis of novel object and novel juvenile exploration  
(unpaired t-test, two-sided) 
 
Table 27: Statistical analysis of marble burying  
(unpaired t-test, two-sided) 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Interval F(2.6, 49.4) = 3.4, 
p < 0.05  
F(2.36, 42.45) = 
3.3, p < 0.05  
F(2.4, 31.2) = 1.53, 
p = 0.23  
Genotype x interval F(2.6, 49.4) = 0.9, 
p = 0.44 
F(2.36, 42.5) = 
0.38, p = 0.72  
F(2.4, 31.2) = 1.07, 
p = 0.37  
Time in lit compartment 
Genotype F(1, 19) = 2.2,  
p = 0.15  
F(1, 18) = 0.08,  
p = 0.78 
F(1, 13) = 0.65,  
p = 0.44  
Interval F(2.5, 47.6) = 2.66, 
p = 0.068  
F(2.3, 42.4) = 3.2, 
p < 0.05 
F(2.2, 28.9) = 0.97, 
p = 0.4  
Genotype x interval F(2.5, 47.6) = 0.68, 
p = 0.55  
F(2.3, 42.4) = 0.73, 
p = 0.51  
F(2.2, 28.9) = 1.02 
p = 0.38 
Total distance moved in 
lit compartment 
Genotype F(1, 19) = 2.36,  
p = 0.14  
F(1, 18) = 0.08, 
 p = 0.78  
F(1, 13) = 0.7,  
p = 0.41  
Interval F(3.1, 59.0) = 0.96, 
p = 0.42  
F(2.1, 38.0) = 0.87, 
p = 0.43  
F(4, 52) = 0.76,  
p = 0.55  
Genotype x interval F(3.1, 59.0) = 0.32, 
p = 0.82 
F(2.1, 38.0) = 1.1, 
p = 0.34  
F(4, 52) = 0.75,  
p = 0.56  
Entries into lit 
compartment 
Genotype F(1, 19) = 0.84,  
p = 0.37 
F(1, 18) = 0.67,  
p = 0.42 
F(1, 13) = 1.5,  
p = 0.25 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Genotype t(51) = 1.04,  
p = 0.30 
t(28) = 2.25,  
p < 0.05 
t(22) = 3.10,  
p < 0.01  
Novel object exploration, 
30 lux 
Sample size Wt = 25  
Ko = 28 
Wt = 17 
Ko = 13 
Wt = 10  
Ko = 14  
Genotype t(22) = 3.5,  
p < 0.005 
t(40) = 2.22,  
p < 0.05 
t(19) = 3.7,  
p < 0.001  
Novel object exploration, 
500 lux 
Sample size Wt = 12  
Ko = 12  
Wt = 22  
Ko = 20  
Wt = 10  
Ko = 11  
Genotype t(22) = 0.85,  
p = 0.40 
t(22) = 0.54,  
p = 0.59 
t(14) = 0.52, 
p = 0.61  
Novel juvenile 
exploration,  
0 lux  Sample size Wt = 12  
Ko = 12 
Wt = 12  
Ko = 12 
Wt = 9  
Ko = 7  
Genotype t(22) = 2.8,  
p < 0.01 
t(21) = 1.1,  
p = 0.28 
t(21) = 3.17,  
p < 0.01  
Novel juvenile 
exploration,  
500 lux Sample size Wt = 11  
Ko = 13  
Wt = 11  
Ko = 12  
Wt = 13  
Ko = 10  
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Genotype t(19) = 0.27,  
p = 0.79 
t(18) = 0.57,  
p = 0.58 
t(13) = 1.53,  
p = 0.15 
Buried marbles 
Sample size Wt = 12  
Ko = 9 
Wt = 10  
Ko = 10 
Wt = 7 
Ko = 8 
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Table 28: Statistical analysis of open field, day 1, 0 lux  
(2-way ANOVA for repeated measurements) 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Interval F(5.9, 164.7) = 4.5, 
p < 0.001 
F(9, 6.4) = 1.1,  
p = 3.5 
F(5.0, 110.6) = 1.4,  
p = 0.35 
Genotype x interval F(5.9, 164.7) = 4.5,  
p < 0.01 
F(9, 6.4) = 1.2,  
p = 3.1 
F(5.0, 110.6) = 4.2, 
 p < 0.01 
Rearing 
Genotype F(1, 28) = 0.24,  
p = 0.629 
F(1, 28) = 2.13,  
p = 0.16 
F(1, 22) = 3.1,  
p = 0.09 
Interval F(9, 252) = 25.4,  
p < 0.001 
F(4.8, 135.5) = 26.8,  
p < 0.001 
F(4.6, 101.6) = 19.0,  
p < 0.001 
Genotype x interval F(9, 252) = 5.8, 
 p < 0.001 
F(4.8, 135.5) = 1.3,  
p = 0.27 
F(4.6, 101.6) = 2.3,  
p < 0.05 
Total distance 
moved 
Genotype F(1, 28) = 0.001, 
 p < 0.97 
F(1, 28) = 1.7, 
 p = 0.21 
F(1, 22) = 0.17,  
p = 0.68 
Interval F(9, 252) = 40.4, 
 p < 0.001 
F(5.6, 157.6) = 32.2,  
p < 0.001 
F(4.8, 105.2) = 24.8,  
p < 0.001 
Genotype x interval F(9, 252) = 3.3,  
p < 0.001 
F(5.6, 157.6) = 0.89,  
p = 0.51 
F(4.8, 105.2) = 2.2,  
p = 0.13 
Immobility 
Genotype F(1, 28) = 0.48,  
p = 0.49 
F(1, 28) = 2.7,  
p = 0.11 
F(1, 22) = 0.73,  
p = 0.4 
Interval F(9, 252) = 1.61,  
p = 0.15 
F(9, 252) = 1.1,  
p = 0.38 
F(5.0, 108.6) = 0.9,  
p = 0.5 
Genotype x interval F(9, 2.52) = 1.2,  
p = 0.32 
F(9, 252) = 0.4, 
p = 0.91 
F(5.0, 108.6) = 2.4,  
p < 0.05 
Margin Distance 
Genotype F(1, 28) = 11.5,  
p < 0.05 
F(1, 28) = 0.11,  
p = 0.75 
F(1, 22) = 1.3,  
p = 0.3 
 
Table 29: Statistical analysis of open field, day 1, 700 lux  
(2-way ANOVA for repeated measurements) 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Interval F(3.6, 73.9) = 4.3,  
p < 0.001 
F(9, 198) = 1.1,  
p = 0.42 
F(9, 180) = 1.7,  
p = 0.1 
Genotype x interval F(3.6, 73.9) = 0.42,  
p = 0.46 
F(9, 198) = 1.9,  
p = 0.3 
F(9, 180) = 0.34,  
p = 0.96 
Rearing 
Genotype F(1, 22) = 3.31 
p < 0.05 
F(1, 22) = 0.68,  
p = 0.2 
F(1, 20) = 0.56,  
p = 0.26 
Interval F(2.7, 59.9) = 2.6,  
p < 0.05 
F(4.8, 104.4) = 18.9,  
p < 0.001 
F(4.7, 94.5) = 15.9,  
p < 0.001 
Genotype x interval F(2.7, 59.9) = 0.6,  
p = 0.63 
F(4.8, 104.4) = 0.97,  
p = 0.44 
F(4.7, 94.5) = 1.1,  
p = 0.35 
Total distance 
moved 
Genotype F(1, 22) = 4.5, 
 p < 0.05 
F(1, 22) = 3.0,  
p = 0.097 
F(1, 20) = 0.45,  
p = 0.51 
Interval F(2.7, 59.8) = 2.0,  
p = 0.13 
F(9, 198) = 27.9,  
p < 0.001 
F(4.5, 89.9) = 20.6, 
 p < 0.001 
Genotype x interval F(2.7, 59.8) = 0.49,  
p = 0.67 
F(9, 198) = 1.2,  
p = 0.32 
F(4.5, 89.9) = 1.0,  
p = 0.41 
Immobility 
Genotype F(1, 22) = 2.7,  
p = 0.11 
F(1, 22) = 0.7,  
p = 0.4 
F(1, 20) = 0.15,  
p = 0.71 
Interval F(4.5, 99.6) = 1.2,  
p = 0.3 
F(5.0, 110.5) = 3.9,  
p < 0.001 
F(9, 180) = 4.7, 
 p < 0.001 
Genotype x interval F(4.5, 99.6) = 1.6,  
p = 0.18 
F(5.0, 110.5) = 2.8,  
p < 0.05 
F(9, 180) = 1.3,  
p = 0.2 
Margin Distance 
Genotype F(1, 22) = 4.9,  
p < 0.05 
F(1, 22) = 0.04,  
p = 0.84 
F(1, 20) = 5.8,  
p < 0.05 
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Table 30: Statistical analysis of open field, day 2, 0 lux  
(2-way ANOVA for repeated measurements) 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Interval F(5.1, 136.4) = 3.9,  
p < 0.05 
F(5.2, 145.8) = 0.6,  
p = 0.64 
F(4.8, 104.7) = 2.3,  
p < 0.05 
Genotype x interval F(5.1, 136.4) = 3.4,  
p < 0.01 
F(5.2, 145.8) = 0.3,  
p = 0.9 
F(4.8, 104.7) = 1.4, 
 p < 0.2 
Rearing 
Genotype F(1, 27) = 1.7,  
p = 0.2 
F(1, 28) = 1.2,  
p = 0.29 
F(1, 22) = 5.5,  
p = 0.05 
Interval F(5.3, 143.4) = 10.3,  
p < 0.001 
F(5.8, 161.7) = 21.6,  
p < 0.001 
F(4.9, 107.0) = 20.8,  
p < 0.001 
Genotype x interval F(5.3, 143.4) = 2.0,  
p = 0.078 
F(5.8, 161.7) = 1.0,  
p = 0.42 
F(4.9, 107.0) = 1.2,  
p = 0.3 
Total distance 
moved 
Genotype F(1, 27) = 0.21,  
p = 0.65 
F(1, 28) = 0.34,  
p = 0.57 
F(1, 22) = 2.9,  
p = 0.1 
Interval F(5.0, 134.8) = 12.2,  
p < 0.001 
F(9, 252) = 22.7,  
p < 0.001 
F(4.5, 99.9) = 15.4, 
 p < 0.001 
Genotype x interval F(5.0, 134.8) = 1.2,  
p = 0.33 
F(9, 252) = 1.2,  
p = 0.3 
F(4.5, 99.9) = 1.3,  
p = 0.28 
Immobility 
Genotype F(1, 27) = 0.03,  
p = 0.86 
F(1, 28) = 0.59,  
p = 0.45 
F(1, 22) = 5.4,  
p < 0.05 
Interval F(9, 252) = 10.9,  
p = 0.001 
F(5.9, 166.4) = 7.0,  
p = 0.001 
F(4.7, 104.4) = 6.9,  
p = 0.001 
Genotype x interval F(9, 252) = 2.1,  
p < 0.05 
F(5.9, 166.4) = 1.2,  
p = 0.31 
F(4.7, 104.4) = 0.58, 
 p = 0.71 
Margin Distance 
Genotype F(1, 28) = 14.9,  
p < 0.01 
F(1, 28) = 0.70,  
p = 0.41 
F(1, 22) = 1.2,  
p = 0.29 
 
Table 31: Statistical analysis of open field, day 2, 700 lux  
(2-way ANOVA for repeated measurements) 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Interval F(2.9, 63.7) = 7.3,  
p < 0.001 
F(4.8, 106.3) = 4.0,  
p < 0.05 
F(4.8, 95.9) = 5.0,  
p < 0.001 
Genotype x Interval F(2.9, 63.7) = 1.9,  
p = 0.14 
F(4.8, 106.3) = 0.6,  
p = 0.7 
F(4.8, 95.9) = 1.2,  
p = 0.3 
Rearing 
Genotype F(1, 22) = 13.2,  
p < 0.001 
F(1, 22) = 0.001,  
p = 0.98 
F(1, 20) = 5.9, 
 p < 0.05 
Interval F(3.9, 86.3) = 0.64,  
p = 0.64 
F(9, 198) = 21.2, 
 p < 0.001 
F(4.2, 84.5) = 11.8,  
p < 0.001 
Genotype x Interval F(3.9, 86.3) = 1.1,  
p = 0.34 
F(9, 198) = 0.39,  
p = 0.86 
F(4.2, 84.5) = 0.74,  
p = 0.58 
Total distance 
moved 
Genotype F(1, 22) = 5.3,  
p < 0.05 
F(1, 22) = 6.0,  
p = 0.45 
F(1, 20) = 4.4,  
p < 0.05 
Interval F(3.8, 82.8) = 1.2,  
p = 0.33 
F(4.3, 94.9) = 19.2,  
p < 0.001 
F(4.0, 79.7) = 14.4,  
p < 0.001 
Genotype x Interval F(3.8, 82.8) = 0.64,  
p = 0.63 
F(4.3, 94.9) = 0.28,  
p = 0.89 
F(4.0, 79.7) = 1.6,  
p = 0.17 
Immobility 
Genotype F(1, 22) = 3.8,  
p = 0.063 
F(1, 22) = 0.08,  
p = 0.79 
F(1, 20) = 3.0,  
p = 0.099 
Interval F(4.9, 107.8) = 9.0, 
 p < 0.001 
F(5.2, 114.7) = 5.1,  
p < 0.001 
F(9, 180) = 5.5, 
 p < 0.001 
Genotype x Interval F(4.9, 107.8) = 0.3, 
 p = 0.9 
F(5.2, 114.7) = 0.7,  
p = 0.6 
F(9, 180) = 2.5,  
p < 0.05 
Margin Distance 
Genotype F(1, 22) = 1.4,  
p = 0.25 
F(1, 22) = 0.001,  
p = 0.99 
F(1, 20) = 7.6,  
p < 0.05 
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Table 32: Statistical analysis of open field habituation, 0 lux  
(2-way ANOVA for repeated measurements) 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Day F(1, 27) = 0.34,  
p = 0.56 
F(1, 28) = 1.6,  
p = 0.22 
F(1, 22) = 3.2,  
p = 0.089 
Day x genotype F(1, 27) = 2.6,  
p = 0.12 
F(1, 28) = 0.37,  
p = 0.6 
F(1, 22) = 0.99,  
p = 0.33 
Rearing 
Genotype F(1, 27) = 0.73,  
p = 0.4 
F(1, 28) = 1.8,  
p = 0.19 
F(1, 22) = 5.2,  
p = 0.05 
Day F(1, 27) = 5.7,  
p < 0.05 
F(1, 28) = 20.3,  
p < 0.001 
F(1, 22) = 23.3,  
p < 0.001 
Day x genotype F(1, 27) = 0.15,  
p = 0.7 
F(1, 28) = 1.4,  
p = 0.24 
F(1, 22) = 2.0,  
p = 0.18 
Total distance 
moved 
Genotype F(1, 27) = 0.14,  
p = 0.7 
F(1, 28) = 0.9,  
p = 0.34 
F(1, 22) = 1.2,  
p = 0.28 
Day F(1, 27) = 14.1,  
p < 0.001 
F(1, 28) = 22.8,  
p < 0.001 
F(1, 22) = 23.3,  
p < 0.001 
Day x genotype F(1, 27) = 0.43,  
p = 0.52 
F(1, 28) = 0.95,  
p = 0.34 
F(1, 22) = 3.1,  
p = 0.19 
Immobility 
Genotype F(1, 27) = 0.013,  
p = 0.99 
F(1, 28) = 1.5,  
p = 0.23 
F(1, 22) = 3.1,  
p < 0.088 
Day F(1, 28) = 0.19,  
p = 0.66 
F(1, 28) = 0.075,  
p = 0.79 
F(1, 22) = 1.6,  
p = 0.22 
Day x genotype F(1, 28) = 0.37,  
p = 0.86 
F(1, 28) = 2.5,  
p = 0.13 
F(1, 22) = 6.4,  
p < 0.05 
Margin Distance 
Genotype F(1, 28) = 14.1, 
 p < 0.001 
F(1, 28) = 0.07, 
 p = 0.8 
F(1, 22) = 0.26,  
p = 0.61 
 
Table 33: Statistical analysis of open field habituation, 700 lux  
(2-way ANOVA for repeated measurements) 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Day F(1, 22) = 44.8,  
p < 0.001 
F(1, 22) = 75.6,  
p < 0.001 
F(1, 20) = 86.2,  
p < 0.001 
Day x genotype F(1, 22) = 2.91,  
p = 0.1 
F(1, 22) = 7.0,  
p < 0.05 
F(1, 20) = 4.8,  
p < 0.05 
Rearing 
Genotype F(1, 22) = 11.2,  
p < 0.05 
F(1, 22) = 5.3,  
p = 0.5 
F(1, 20) = 3.5,  
p = 0.075 
Day F(1, 22) = 154.0,  
p < 0.001 
F(1, 22) = 103.7, 
p < 0.001 
F(1, 20) = 104.3,  
p < 0.001 
Day x genotype F(1, 22) = 2.8,  
p = 0.11 
F(1, 22) = 1.8,  
p = 0.2 
F(1, 20) = 6.2,  
p < 0.05 
Total distance 
moved 
Genotype F(1, 22) = 4.7,  
p < 0.05 
F(1, 22) = 1.6,  
p = 0.22 
F(1, 20) = 2.3,  
p = 0.15 
Day F(1, 22) = 321.0,  
p < 0.001 
F(1, 22) = 64.9,  
p < 0.001 
F(1, 20) = 78.2,  
p < 0.001 
Day x genotype F(1, 22) = 1.6,  
p = 0.22 
F(1, 22) = 0.13,  
p = 0.72 
F(1, 20) = 7.1,  
p < 0.05 
Immobility 
Genotype F(1, 22) = 2.8,  
p = 0.12 
F(1, 22) = 0.3,  
p = 0.61 
F(1, 20) = 1.2,  
p = 0.3 
Day F(1, 22) = 12.4,  
p < 0.05 
F(1, 22) = 18.4,  
p < 0.001 
F(1, 20) = 0.001,  
p < 0.001 
Day x genotype F(1, 22) = 0.88,  
p = 0.36 
F(1, 22) = 0.29,  
p = 0.60 
F(1, 20) = 0.87,  
p = 0.36 
Margin Distance 
Genotype F(1, 22) = 2.2,  
p = 0.15 
F(1, 22) = 0.002,  
p = 0.96 
F(1, 20) = 7.0,  
p < 0.05 
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Table 34: Statistical analysis of open field habituation for individual genotypes at 0 
lux  
(paired t-test) 
 
Table 35: Statistical analysis of open field habituation for individual genotypes at 
700 lux  
(paired t-test) 
 
 
Table 36: Statistical analysis of open field habituation within the first session for 
individual genotypes at 0 lux  
(2-way ANOVA for repeated measurements) 
 
 
Table 37: Statistical analysis of open field habituation within the first session for 
individual genotypes at 700 lux  
(2-way ANOVA for repeated measurements) 
 
 
 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
wt t(12) = 1,  
p = 0.34, n = 13 
t(17) = 1.19,  
p = 0.25, n = 18 
t(9) = 0.55,  
p = 0.60, n = 10 
Rearing 
ko t(15) = 1.34,  
p = 0.19, n = 16 
t(11) = 0.99,  
p = 0.35, n = 12 
t(13) = 2.25,  
p < 0.05, n = 14 
wt t(12) = 2.64,  
p < 0.05, n = 13  
t(17) = 4.47,  
p < 0.001, n = 18 
t(9) = 3.24,  
p < 0.01, n = 10 
Total distance moved 
ko t(15) = 0.13,  
p = 0.23, n = 16  
t(11) = 2.16,  
p < 0.05, n = 12 
t(13) = 3.8,  
p < 0.01, n = 13 
wt t(12) = 3.65,  
p < 0.01, n = 13  
t(17) = 5.1,  
p < 0.001, n = 18 
t(9) = 3.72,  
p < 0.005, n = 10 
Immobility 
ko t(15) = 2.05,  
p = 0.058, n = 16 
t(11) = 2.13,  
p = 0.056, n = 12 
t(13) = 3.78,  
p < 0.01, n = 14 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
wt t(11) = 6.37,  
p < 0.001, n = 12 
t(11) = 5.34,  
p < 0.001, n = 12 
t(12) = 5.53,  
p < 0.001, n = 13 
Rearing 
ko t(11) = 3.31,  
p < 0.01, n = 12 
t(11) = 6.67,  
p < 0.001, n = 12 
t(8) = 7.50,  
p < 0.001, n = 9 
wt t(11) = 16.12,  
p < 0.001, n = 12  
t(11) = 8.0,  
p < 0.001, n = 12 
t(12) = 5.60,  
p < 0.001, n = 13 
Total distance moved 
ko t(11) = 5.97,  
p < 0.001, n = 12  
t(11) = 7.05,  
p < 0.001, n = 12 
t(8) = 9.5,  
p < 0.001, n = 9 
wt t(11) = 22.72,  
p < 0.001, n = 12  
t(11) = 5.66,  
p < 0.001, n = 12 
t(12) = 5.11,  
p < 0.001, n = 13 
Immobility 
ko t(11) = 10.31,  
p < 0.001, n = 12 
t(11) = 5.78,  
p <0.001 , n = 12 
t(8) = 6.95,  
p < 0.001, n = 9 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
wt: interval F(4.2, 54.9) = 5.2, 
p < 0.001 
F(9, 153) = 21.8,  
p < 0.001 
F(3.5, 34.7) = 6.1, 
p < 0.01 
Total distance moved 
ko: interval F(4.9, 73.1) = 24.2, 
p < 0.001 
F(3.3, 36.4) = 8.9, 
p < 0.001 
F(9, 108) = 15.1,  
p < 0.001 
wt: interval F(9, 117) = 16.3,  
p < 0.001 
F(9, 153) = 23.6,  
p < 0.001 
F(4.2, 41.5) = 12.8, 
p < 0.001 
Immobility 
ko: interval F(9, 135) = 27.2,  
p < 0.001 
F(9, 99) = 11.6, 
 p < 0.001 
F(9, 108) = 15.8,  
p < 0.001 
Parameter Statistical Parameter total-CB1 GABA-CB1 Glu-CB1 
Wt: interval F(3.9, 43.3) = 4.1, 
p < 0.001 
F(9, 90) = 16.7, 
 p < 0.001 
F(3.9, 46.3) = 12.9, 
p < 0.001 
Total distance moved 
Ko: interval F(2.3, 24.9) = 0.9, 
p = 0.5 
F(9, 108) = 7.6, 
 p < 0.001 
F(9, 72) = 5.5,  
P < 0.001 
Wt: interval F(9, 99) = 4.4,  
p < 0.001 
F(9, 90) = 18.1, 
 p < 0.001 
F(3.1, 37.3) = 17.0, 
p < 0.001 
Immobility 
Ko: interval F(2.3, 25.7) = 0.8, 
p = 0.6 
F(9, 108) = 12.4,  
p < 0.001 
F(9, 72) = 6.7,  
p < 0.001 
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Figure 35: Background contextual fear conditioning of Glu-CB1-ko mice at 0.5 mA. Freezing 
levels Glu-CB1-ko mice and the respective wildtype littermates in the contextual fear conditioning 
paradigm on day 1, 2 and 7 after conditioning (A). Mice were conditioned with 0.5 mA. Grey insets and 
square symbols highlight the freezing values in the shock context compared to the grid context with 
diamond symbols. Data are shown in 1-min-intervals. Freezing levels of Glu-CB1-ko mice and the 
respective wildtype littermates for the auditory cue in the background contextual fear conditioning 
paradigm on day 8 (B). Values are means +/- S.E.M. Asterisks indicate post-hoc comparisons 
following significant genotype x interval interaction. ↑ p < 0.05, ↑↑ p < 0.01 and ** p < 0.01. Effects 
close to significance are indicated by the given p value. Sample sizes are indicated for genotypes. 
Please see Table 17+18 for statistical details. 
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